<SEC-DOCUMENT>0001193125-22-291720.txt : 20221123
<SEC-HEADER>0001193125-22-291720.hdr.sgml : 20221123
<ACCEPTANCE-DATETIME>20221123094753
ACCESSION NUMBER:		0001193125-22-291720
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20221123
DATE AS OF CHANGE:		20221123

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNIVERSAL HEALTH SERVICES INC
		CENTRAL INDEX KEY:			0000352915
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				232077891
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276
		FILM NUMBER:		221412903

	BUSINESS ADDRESS:	
		STREET 1:		367 S GULPH RD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		6107683300

	MAIL ADDRESS:	
		STREET 1:		367 S GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LANCASTER HOSPITAL CORP
		CENTRAL INDEX KEY:			0000834441
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-132
		FILM NUMBER:		221413037

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		6107683300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BEHAVIORAL HEALTHCARE LLC
		CENTRAL INDEX KEY:			0000909173
		IRS NUMBER:				621516830
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-200
		FILM NUMBER:		221413095

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BEHAVIORAL HEALTHCARE CORP
		DATE OF NAME CHANGE:	19930715

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RAMSAY MANAGED CARE LLC
		CENTRAL INDEX KEY:			0000932275
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				721249464
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-160
		FILM NUMBER:		221413056

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RAMSAY MANAGED CARE INC
		DATE OF NAME CHANGE:	19941102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HORIZON HEALTH CORP /DE/
		CENTRAL INDEX KEY:			0000935007
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				752293354
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-41
		FILM NUMBER:		221412944

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			TX
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			TX
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HORIZON MENTAL HEALTH MANAGEMENT INC
		DATE OF NAME CHANGE:	19950106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Riveredge Hospital Holdings, Inc.
		CENTRAL INDEX KEY:			0001255302
		IRS NUMBER:				223682759
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-35
		FILM NUMBER:		221412935

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AERIES HEALTHCARE CORP
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BENCHMARK BEHAVIORAL HEALTH SYSTEM, INC.
		CENTRAL INDEX KEY:			0001255304
		IRS NUMBER:				930893928
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-199
		FILM NUMBER:		221413094

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOUNTIFUL PSYCHIATRIC HOSPITAL INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brynn Marr Hospital, Inc.
		CENTRAL INDEX KEY:			0001255306
		IRS NUMBER:				561317433
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-210
		FILM NUMBER:		221413118

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EAST CAROLINA PSYCHIATRIC SERVICES CORP
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GREAT PLAINS HOSPITAL, INC.
		CENTRAL INDEX KEY:			0001255307
		IRS NUMBER:				431328523
		STATE OF INCORPORATION:			MS
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-233
		FILM NUMBER:		221413099

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GREAT PLAINS HOSPITAL INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H.C. CORP
		CENTRAL INDEX KEY:			0001255309
		IRS NUMBER:				630870528
		STATE OF INCORPORATION:			AL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-230
		FILM NUMBER:		221413137

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H C CORP
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H C PARTNERSHIP
		CENTRAL INDEX KEY:			0001255310
		IRS NUMBER:				630862148
		STATE OF INCORPORATION:			AL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-137
		FILM NUMBER:		221413042

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAVENWYCK HOSPITAL INC
		CENTRAL INDEX KEY:			0001255311
		IRS NUMBER:				382409580
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-54
		FILM NUMBER:		221412953

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			PENNSYLVANIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			PENNSYLVANIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS LAUREL RIDGE HOSPITAL LP
		CENTRAL INDEX KEY:			0001255312
		IRS NUMBER:				432002326
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-10
		FILM NUMBER:		221412910

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TEXAS LAURAL RIDGE HOSPITAL LP
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS SAN MACROS TREATMENT CENTER LP
		CENTRAL INDEX KEY:			0001255314
		IRS NUMBER:				432002231
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-07
		FILM NUMBER:		221412907

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS WEST OAKS HOSPITAL LP
		CENTRAL INDEX KEY:			0001255315
		IRS NUMBER:				621864265
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-146
		FILM NUMBER:		221413006

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LAUREL OAKS BEHAVIORAL HEALTH CENTER, INC.
		CENTRAL INDEX KEY:			0001255321
		IRS NUMBER:				522090040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-131
		FILM NUMBER:		221413036

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PREMIER BEHAVIORAL SOLUTIONS OF ALABAMA, INC
		DATE OF NAME CHANGE:	20050808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RAMSAY YOUTH SERVICES OF ALABAMA INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RAMSAY YOUTH SERVICES OF GEORGIA INC
		CENTRAL INDEX KEY:			0001255322
		IRS NUMBER:				352174803
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-38
		FILM NUMBER:		221412938

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PALMETTO BEHAVIORAL HEALTH HOLDINGS, LLC
		CENTRAL INDEX KEY:			0001255323
		IRS NUMBER:				223600673
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-174
		FILM NUMBER:		221413070

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF SOUTH CAROLINA, INC
		DATE OF NAME CHANGE:	20050808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RAMSAY YOUTH SERVICES OF SOUTH CAROLINA INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SUNSTONE BEHAVIORAL HEALTH LLC
		CENTRAL INDEX KEY:			0001255327
		IRS NUMBER:				800051894
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-19
		FILM NUMBER:		221412919

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUNSTONE BEHAVIORAL HEALTH INC
		DATE OF NAME CHANGE:	20030718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS CYPRESS CREEK HOSPITAL LP
		CENTRAL INDEX KEY:			0001255328
		IRS NUMBER:				621864266
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-12
		FILM NUMBER:		221412912

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HSA HILL CREST CORP
		CENTRAL INDEX KEY:			0001255962
		IRS NUMBER:				953900761
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-159
		FILM NUMBER:		221413055

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MICHIGAN PSYCHIATRIC SERVICES INC
		CENTRAL INDEX KEY:			0001255966
		IRS NUMBER:				382423002
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-184
		FILM NUMBER:		221413079

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEURO INSTITUTE OF AUSTIN LP
		CENTRAL INDEX KEY:			0001255967
		IRS NUMBER:				562274069
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-181
		FILM NUMBER:		221413077

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEDAR SPRINGS HOSPITAL, INC.
		CENTRAL INDEX KEY:			0001255968
		IRS NUMBER:				743081810
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-204
		FILM NUMBER:		221413112

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSI CEDAR SPRINGS HOSPITAL INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEXAS HOSPITAL HOLDINGS, INC.
		CENTRAL INDEX KEY:			0001255970
		IRS NUMBER:				621871091
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-11
		FILM NUMBER:		221412911

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSI HOSPITALS INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PSYCHIATRIC SOLUTIONS HOSPITALS, LLC
		CENTRAL INDEX KEY:			0001255976
		IRS NUMBER:				621658476
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-163
		FILM NUMBER:		221413059

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS HOSPITALS INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PREMIER BEHAVIORAL SOLUTIONS, INC.
		CENTRAL INDEX KEY:			0001255982
		IRS NUMBER:				630857352
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-166
		FILM NUMBER:		221413062

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF CORAL GABLES INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PSYCHIATRIC SOLUTIONS OF VIRGINIA INC
		CENTRAL INDEX KEY:			0001255985
		IRS NUMBER:				621732340
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-162
		FILM NUMBER:		221413058

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF FLORIDA INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLLY HILL HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001255986
		IRS NUMBER:				621692189
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-43
		FILM NUMBER:		221412945

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF NORTH CAROLINA INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SHADOW MOUNTAIN BEHAVIORAL HEALTH SYSTEM, LLC
		CENTRAL INDEX KEY:			0001255987
		IRS NUMBER:				432001465
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-27
		FILM NUMBER:		221412927

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSYCHIATRIC SOLUTIONS OF OKLAHOMA INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PREMIER BEHAVIORAL SOLUTIONS OF FLORIDA, INC
		CENTRAL INDEX KEY:			0001256061
		IRS NUMBER:				650816927
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-167
		FILM NUMBER:		221413063

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RAMSAY YOUTH SERVICES OF FLORIDA INC
		DATE OF NAME CHANGE:	20030722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC HOLDINGS, INC
		CENTRAL INDEX KEY:			0001266914
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				920189593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-223
		FILM NUMBER:		221413130

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARDENT HEALTH SERVICES INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001266918
		IRS NUMBER:				020567575
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-247
		FILM NUMBER:		221413140

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AHS CUMBERLAND HOSPITAL LLC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC PINNACLE POINTE HOSPITAL INC
		CENTRAL INDEX KEY:			0001266925
		IRS NUMBER:				621658502
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-217
		FILM NUMBER:		221413124

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC SIERRA VISTA HOSPITAL INC
		CENTRAL INDEX KEY:			0001266927
		IRS NUMBER:				621658512
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-215
		FILM NUMBER:		221413122

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC STREAMWOOD HOSPITAL INC
		CENTRAL INDEX KEY:			0001266929
		IRS NUMBER:				621658515
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-214
		FILM NUMBER:		221413121

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VALLE VISTA HOSPITAL PARTNERS, LLC
		CENTRAL INDEX KEY:			0001266930
		IRS NUMBER:				621658516
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-107
		FILM NUMBER:		221413012

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC VALLE VISTA HOSPITAL INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BLOOMINGTON MEADOWS G P
		CENTRAL INDEX KEY:			0001266932
		IRS NUMBER:				351858510
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-213
		FILM NUMBER:		221413154

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VALLE VISTA LLC
		CENTRAL INDEX KEY:			0001266943
		IRS NUMBER:				621740366
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-106
		FILM NUMBER:		221413011

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KIN OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KIN OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WILLOW SPRINGS LLC
		CENTRAL INDEX KEY:			0001266945
		IRS NUMBER:				621814471
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-105
		FILM NUMBER:		221413003

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		6152963000

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC ALHAMBRA HOSPITAL INC
		CENTRAL INDEX KEY:			0001266979
		IRS NUMBER:				621658521
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-198
		FILM NUMBER:		221413093

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC BELMONT PINES HOSPITAL INC
		CENTRAL INDEX KEY:			0001266981
		IRS NUMBER:				621658523
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-197
		FILM NUMBER:		221413092

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COLUMBUS HOSPITAL PARTNERS, LLC
		CENTRAL INDEX KEY:			0001266988
		IRS NUMBER:				621664739
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-195
		FILM NUMBER:		221413090

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC COLUMBUS HOSPITAL INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC FAIRFAX HOSPITAL INC
		CENTRAL INDEX KEY:			0001266989
		IRS NUMBER:				621658528
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-228
		FILM NUMBER:		221413135

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC FOX RUN HOSPITAL INC
		CENTRAL INDEX KEY:			0001266992
		IRS NUMBER:				621658531
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-227
		FILM NUMBER:		221413134

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC FREMONT HOSPITAL INC
		CENTRAL INDEX KEY:			0001266995
		IRS NUMBER:				621658532
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-226
		FILM NUMBER:		221413133

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC HEALTH SERVICES OF NEVADA INC
		CENTRAL INDEX KEY:			0001267003
		IRS NUMBER:				880300031
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-225
		FILM NUMBER:		221413132

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC HERITAGE OAKS HOSPITAL INC
		CENTRAL INDEX KEY:			0001267005
		IRS NUMBER:				621658494
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-224
		FILM NUMBER:		221413131

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC INTERMOUNTAIN HOSPITAL INC
		CENTRAL INDEX KEY:			0001267012
		IRS NUMBER:				621658493
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-222
		FILM NUMBER:		221413129

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lebanon Hospital Partners, LLC
		CENTRAL INDEX KEY:			0001267014
		IRS NUMBER:				621664738
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-130
		FILM NUMBER:		221413035

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC LEBANON HOSPITAL INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC MONTEVISTA HOSPITAL INC
		CENTRAL INDEX KEY:			0001267037
		IRS NUMBER:				880299907
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-220
		FILM NUMBER:		221413127

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC NORTHWEST PSYCHIATRIC HOSPITAL LLC
		CENTRAL INDEX KEY:			0001267038
		IRS NUMBER:				200085660
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-219
		FILM NUMBER:		221413126

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC OF INDIANA GENERAL PARTNERSHIP
		CENTRAL INDEX KEY:			0001267039
		IRS NUMBER:				621780700
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-218
		FILM NUMBER:		221413125

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NORTHERN INDIANA PARTNERS, LLC
		CENTRAL INDEX KEY:			0001267040
		IRS NUMBER:				621664737
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-179
		FILM NUMBER:		221413075

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC OF NORTHERN INDIANA INC
		DATE OF NAME CHANGE:	20031015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wellstone Regional Hospital Acquisition, LLC
		CENTRAL INDEX KEY:			0001335540
		IRS NUMBER:				203062075
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-144
		FILM NUMBER:		221413004

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATION CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATION CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Summit Oaks Hospital, Inc.
		CENTRAL INDEX KEY:			0001335550
		IRS NUMBER:				201021210
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-20
		FILM NUMBER:		221412920

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PSI Summit Hospital, Inc.
		DATE OF NAME CHANGE:	20050808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			North Spring Behavioral Healthcare, Inc.
		CENTRAL INDEX KEY:			0001335551
		IRS NUMBER:				201215130
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-180
		FILM NUMBER:		221413076

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Psychiatric Solutions of Leesburg, Inc.
		DATE OF NAME CHANGE:	20050808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cumberland Hospital Partners, LLC
		CENTRAL INDEX KEY:			0001335564
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-193
		FILM NUMBER:		221413088

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BHC Newco 2, LLC
		DATE OF NAME CHANGE:	20050808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC Mesilla Valley Hospital, LLC
		CENTRAL INDEX KEY:			0001335566
		IRS NUMBER:				202612295
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-221
		FILM NUMBER:		221413128

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Palmetto Lowcountry Behavioral Health, L.L.C.
		CENTRAL INDEX KEY:			0001335603
		IRS NUMBER:				571101380
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-172
		FILM NUMBER:		221413068

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Millwood Hospital, L.P.
		CENTRAL INDEX KEY:			0001335606
		IRS NUMBER:				201021264
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-183
		FILM NUMBER:		221413146

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Palmetto Behavioral Health System, L.L.C.
		CENTRAL INDEX KEY:			0001335607
		IRS NUMBER:				571101379
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-173
		FILM NUMBER:		221413069

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fort Lauderdale Hospital, Inc.
		CENTRAL INDEX KEY:			0001335611
		IRS NUMBER:				201021229
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-138
		FILM NUMBER:		221413152

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alliance Health Center, Inc.
		CENTRAL INDEX KEY:			0001335614
		IRS NUMBER:				640777521
		STATE OF INCORPORATION:			MS
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-250
		FILM NUMBER:		221413143

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Laurelwood Center, Inc.
		DATE OF NAME CHANGE:	20050808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canyon Ridge Hospital, Inc.
		CENTRAL INDEX KEY:			0001335621
		IRS NUMBER:				202935031
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-208
		FILM NUMBER:		221413116

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brentwood Acquisition-Shreveport, Inc.
		CENTRAL INDEX KEY:			0001335632
		IRS NUMBER:				200474854
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-212
		FILM NUMBER:		221413120

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brentwood Acquisition, Inc.
		CENTRAL INDEX KEY:			0001335702
		IRS NUMBER:				200773985
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-211
		FILM NUMBER:		221413119

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTERNATIVE BEHAVIORAL SERVICES, INC.
		CENTRAL INDEX KEY:			0001405898
		IRS NUMBER:				541757063
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-249
		FILM NUMBER:		221413142

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABS LINCS VA, INC.
		CENTRAL INDEX KEY:			0001405902
		IRS NUMBER:				541782162
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-252
		FILM NUMBER:		221413155

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABS LINCS SC, INC
		CENTRAL INDEX KEY:			0001405905
		IRS NUMBER:				570840074
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-253
		FILM NUMBER:		221413156

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC RIVER PARK, INC.
		CENTRAL INDEX KEY:			0001405910
		IRS NUMBER:				202652863
		STATE OF INCORPORATION:			WV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-47
		FILM NUMBER:		221412948

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC SOUTH CAROLINA, INC.
		CENTRAL INDEX KEY:			0001405912
		IRS NUMBER:				203854241
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-46
		FILM NUMBER:		221413149

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC ST. SIMONS, INC.
		CENTRAL INDEX KEY:			0001405913
		IRS NUMBER:				203854107
		STATE OF INCORPORATION:			GA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-45
		FILM NUMBER:		221412947

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HORIZON HEALTH AUSTIN, INC.
		CENTRAL INDEX KEY:			0001405916
		IRS NUMBER:				208706107
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-42
		FILM NUMBER:		221413148

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KINGWOOD PINES HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001405927
		IRS NUMBER:				731726285
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-135
		FILM NUMBER:		221413040

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KIDS BEHAVIORAL HEALTH OF UTAH, INC.
		CENTRAL INDEX KEY:			0001405928
		IRS NUMBER:				621681825
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-136
		FILM NUMBER:		221413041

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUGHES CENTER, LLC
		CENTRAL INDEX KEY:			0001405929
		IRS NUMBER:				208711062
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-158
		FILM NUMBER:		221413147

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HORIZON MENTAL HEALTH MANAGEMENT, INC.
		CENTRAL INDEX KEY:			0001405930
		IRS NUMBER:				363709746
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-39
		FILM NUMBER:		221412942

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC POPLAR SPRINGS, INC.
		CENTRAL INDEX KEY:			0001405936
		IRS NUMBER:				200959684
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-48
		FILM NUMBER:		221412949

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC OHIO, INC.
		CENTRAL INDEX KEY:			0001405938
		IRS NUMBER:				201870446
		STATE OF INCORPORATION:			OH
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-50
		FILM NUMBER:		221413150

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC INDIANA, INC.
		CENTRAL INDEX KEY:			0001405940
		IRS NUMBER:				200768028
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-51
		FILM NUMBER:		221413151

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC AUGUSTA, INC.
		CENTRAL INDEX KEY:			0001405941
		IRS NUMBER:				203854156
		STATE OF INCORPORATION:			GA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-53
		FILM NUMBER:		221412952

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALVARY CENTER, INC.
		CENTRAL INDEX KEY:			0001405985
		IRS NUMBER:				200380961
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-209
		FILM NUMBER:		221413117

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATLANTIC SHORES HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001406004
		IRS NUMBER:				203788069
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-229
		FILM NUMBER:		221413136

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HICKORY TRAIL HOSPITAL, L.P.
		CENTRAL INDEX KEY:			0001406009
		IRS NUMBER:				204976326
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-44
		FILM NUMBER:		221412946

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC DELAWARE, INC.
		CENTRAL INDEX KEY:			0001406010
		IRS NUMBER:				203854210
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-52
		FILM NUMBER:		221412951

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SP BEHAVIORAL, LLC
		CENTRAL INDEX KEY:			0001406058
		IRS NUMBER:				205202539
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-24
		FILM NUMBER:		221412924

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SHC-KPH, LP
		CENTRAL INDEX KEY:			0001406062
		IRS NUMBER:				731726290
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-26
		FILM NUMBER:		221412926

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROLLING HILLS HOSPITAL, LLC
		CENTRAL INDEX KEY:			0001406067
		IRS NUMBER:				205566098
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-33
		FILM NUMBER:		221412933

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SPRINGFIELD HOSPITAL, INC.
		CENTRAL INDEX KEY:			0001406080
		IRS NUMBER:				260388272
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-22
		FILM NUMBER:		221412922

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WINDMOOR HEALTHCARE OF PINELLAS PARK, INC.
		CENTRAL INDEX KEY:			0001406110
		IRS NUMBER:				593480410
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-103
		FILM NUMBER:		221413001

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FIRST HOSPITAL CORP OF VIRGINIA BEACH
		CENTRAL INDEX KEY:			0001406171
		IRS NUMBER:				541414205
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-191
		FILM NUMBER:		221413086

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZEUS ENDEAVORS, LLC
		CENTRAL INDEX KEY:			0001406188
		IRS NUMBER:				593653864
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-101
		FILM NUMBER:		221412999

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WINDMOOR HEALTHCARE INC.
		CENTRAL INDEX KEY:			0001406202
		IRS NUMBER:				232922437
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-104
		FILM NUMBER:		221413002

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIBERTY POINT BEHAVIORAL HEALTHCARE, LLC
		CENTRAL INDEX KEY:			0001406207
		IRS NUMBER:				201989730
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-129
		FILM NUMBER:		221413034

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			THREE RIVERS HEALTHCARE GROUP, LLC
		CENTRAL INDEX KEY:			0001406229
		IRS NUMBER:				203842446
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-05
		FILM NUMBER:		221412905

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DIAMOND GROVE CENTER, LLC
		CENTRAL INDEX KEY:			0001406247
		IRS NUMBER:				204537541
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-244
		FILM NUMBER:		221413153

	BUSINESS ADDRESS:	
		STREET 1:		6640 CAROTHERS PARKWAY, SUITE 500
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-312-5700

	MAIL ADDRESS:	
		STREET 1:		6640 CAROTHERS PARKWAY, SUITE 500
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNIVERSITY BEHAVIORAL, LLC
		CENTRAL INDEX KEY:			0001406249
		IRS NUMBER:				205202458
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-108
		FILM NUMBER:		221413013

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19402
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19402

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SAMSON PROPERTIES, LLC
		CENTRAL INDEX KEY:			0001406290
		IRS NUMBER:				593653863
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-29
		FILM NUMBER:		221412929

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			THREE RIVERS BEHAVIORAL HEALTH, LLC
		CENTRAL INDEX KEY:			0001406768
		IRS NUMBER:				571106645
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-06
		FILM NUMBER:		221412906

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Sahara, Inc.
		CENTRAL INDEX KEY:			0001513586
		IRS NUMBER:				203955217
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-117
		FILM NUMBER:		221413022

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aiken Regional Medical Centers, Inc.
		CENTRAL INDEX KEY:			0001513587
		IRS NUMBER:				232791808
		STATE OF INCORPORATION:			SC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-251
		FILM NUMBER:		221413144

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arbour, Inc.
		CENTRAL INDEX KEY:			0001513588
		IRS NUMBER:				232238962
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-145
		FILM NUMBER:		221413005

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CCS/Lansing, Inc.
		CENTRAL INDEX KEY:			0001513592
		IRS NUMBER:				621681824
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-205
		FILM NUMBER:		221413113

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Children's Comprehensive Services, Inc.
		CENTRAL INDEX KEY:			0001513593
		IRS NUMBER:				621240866
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-196
		FILM NUMBER:		221413091

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Frontline Behavioral Health, Inc.
		CENTRAL INDEX KEY:			0001513595
		IRS NUMBER:				721539453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-237
		FILM NUMBER:		221413103

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			McAllen Medical Center, Inc.
		CENTRAL INDEX KEY:			0001513596
		IRS NUMBER:				233069210
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-187
		FILM NUMBER:		221413082

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Merion Building Management, Inc.
		CENTRAL INDEX KEY:			0001513597
		IRS NUMBER:				232309517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-185
		FILM NUMBER:		221413080

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Meridell Achievement Center, Inc.
		CENTRAL INDEX KEY:			0001513598
		IRS NUMBER:				741655289
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-186
		FILM NUMBER:		221413081

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Merridell Achievement Center, Inc.
		DATE OF NAME CHANGE:	20110222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Del Amo Hospital, Inc.
		CENTRAL INDEX KEY:			0001513599
		IRS NUMBER:				232646424
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-246
		FILM NUMBER:		221413139

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Northwest Texas Healthcare System, Inc.
		CENTRAL INDEX KEY:			0001513600
		IRS NUMBER:				232238976
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-178
		FILM NUMBER:		221413074

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Oak Plains Academy of Tennessee, Inc.
		CENTRAL INDEX KEY:			0001513601
		IRS NUMBER:				621725123
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-177
		FILM NUMBER:		221413073

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Park Healthcare Co
		CENTRAL INDEX KEY:			0001513602
		IRS NUMBER:				621166882
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-171
		FILM NUMBER:		221413067

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pennsylvania Clinical Schools, Inc.
		CENTRAL INDEX KEY:			0001513603
		IRS NUMBER:				621735966
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-168
		FILM NUMBER:		221413064

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Psychiatric Solutions, Inc.
		CENTRAL INDEX KEY:			0001513605
		IRS NUMBER:				232491707
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-161
		FILM NUMBER:		221413057

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			River Oaks, Inc.
		CENTRAL INDEX KEY:			0001513606
		IRS NUMBER:				720687735
		STATE OF INCORPORATION:			LA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-36
		FILM NUMBER:		221412936

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Southeastern Hospital Corp
		CENTRAL INDEX KEY:			0001513607
		IRS NUMBER:				621606554
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-25
		FILM NUMBER:		221412925

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sparks Family Hospital, Inc.
		CENTRAL INDEX KEY:			0001513608
		IRS NUMBER:				880159958
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-23
		FILM NUMBER:		221412923

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Stonington Behavioral Health, Inc.
		CENTRAL INDEX KEY:			0001513609
		IRS NUMBER:				200687971
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-21
		FILM NUMBER:		221412921

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Turning Point Care Center, Inc.
		CENTRAL INDEX KEY:			0001513610
		IRS NUMBER:				581534607
		STATE OF INCORPORATION:			GA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-03
		FILM NUMBER:		221412941

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Two Rivers Psychiatric Hospital, Inc.
		CENTRAL INDEX KEY:			0001513611
		IRS NUMBER:				232279129
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-98
		FILM NUMBER:		221412997

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Children's Services, Inc.
		CENTRAL INDEX KEY:			0001513612
		IRS NUMBER:				203577381
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-93
		FILM NUMBER:		221412992

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Holding Company, Inc.
		CENTRAL INDEX KEY:			0001513613
		IRS NUMBER:				232367472
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-91
		FILM NUMBER:		221412990

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Benton, Inc.
		CENTRAL INDEX KEY:			0001513614
		IRS NUMBER:				200930981
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-02
		FILM NUMBER:		221412940

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Cornerstone Holdings, Inc.
		CENTRAL INDEX KEY:			0001513615
		IRS NUMBER:				203184635
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-85
		FILM NUMBER:		221412984

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Cornerstone, Inc.
		CENTRAL INDEX KEY:			0001513616
		IRS NUMBER:				203184613
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-84
		FILM NUMBER:		221412983

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of D.C., Inc.
		CENTRAL INDEX KEY:			0001513617
		IRS NUMBER:				232896723
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-83
		FILM NUMBER:		221412982

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Delaware, Inc.
		CENTRAL INDEX KEY:			0001513618
		IRS NUMBER:				232369986
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-82
		FILM NUMBER:		221412981

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Denver, Inc.
		CENTRAL INDEX KEY:			0001513619
		IRS NUMBER:				205227927
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-81
		FILM NUMBER:		221412980

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Fairmount, Inc.
		CENTRAL INDEX KEY:			0001513620
		IRS NUMBER:				233044432
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-79
		FILM NUMBER:		221412978

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Fuller, Inc.
		CENTRAL INDEX KEY:			0001513621
		IRS NUMBER:				232801395
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-78
		FILM NUMBER:		221412977

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Georgia, Inc.
		CENTRAL INDEX KEY:			0001513622
		IRS NUMBER:				233044429
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-76
		FILM NUMBER:		221412975

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Greenville, Inc.
		CENTRAL INDEX KEY:			0001513623
		IRS NUMBER:				233044427
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-75
		FILM NUMBER:		221412974

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Hampton, Inc.
		CENTRAL INDEX KEY:			0001513624
		IRS NUMBER:				232985430
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-74
		FILM NUMBER:		221412973

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Hartgrove, Inc.
		CENTRAL INDEX KEY:			0001513625
		IRS NUMBER:				232983574
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-73
		FILM NUMBER:		221412972

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Oklahoma, Inc.
		CENTRAL INDEX KEY:			0001513626
		IRS NUMBER:				233041933
		STATE OF INCORPORATION:			OK
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-67
		FILM NUMBER:		221412966

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Puerto Rico, Inc.
		CENTRAL INDEX KEY:			0001513627
		IRS NUMBER:				232937744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-61
		FILM NUMBER:		221412960

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of River Parishes, Inc.
		CENTRAL INDEX KEY:			0001513628
		IRS NUMBER:				232238966
		STATE OF INCORPORATION:			LA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-59
		FILM NUMBER:		221412958

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Spring Mountain, Inc.
		CENTRAL INDEX KEY:			0001513629
		IRS NUMBER:				200930346
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-127
		FILM NUMBER:		221413032

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Texoma, Inc.
		CENTRAL INDEX KEY:			0001513630
		IRS NUMBER:				205908627
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-124
		FILM NUMBER:		221413029

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Westwood Pembroke, Inc.
		CENTRAL INDEX KEY:			0001513632
		IRS NUMBER:				233061361
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-120
		FILM NUMBER:		221413025

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Wyoming, Inc.
		CENTRAL INDEX KEY:			0001513633
		IRS NUMBER:				203367209
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-119
		FILM NUMBER:		221413024

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BHC Properties, LLC
		CENTRAL INDEX KEY:			0001513635
		IRS NUMBER:				621660875
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-216
		FILM NUMBER:		221413123

	BUSINESS ADDRESS:	
		STREET 1:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Emerald Coast Behavioral Hospital, LLC
		CENTRAL INDEX KEY:			0001513636
		IRS NUMBER:				270720873
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-241
		FILM NUMBER:		221413107

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fort Duncan Medical Center, L.P.
		CENTRAL INDEX KEY:			0001513637
		IRS NUMBER:				233044530
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-239
		FILM NUMBER:		221413105

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Frontline Hospital, LLC
		CENTRAL INDEX KEY:			0001513638
		IRS NUMBER:				721539530
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-236
		FILM NUMBER:		221413102

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Frontline Residential Treatment Center, LLC
		CENTRAL INDEX KEY:			0001513639
		IRS NUMBER:				721539254
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-235
		FILM NUMBER:		221413101

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Horizon Health Hospital Services, LLC
		CENTRAL INDEX KEY:			0001513640
		IRS NUMBER:				203798133
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-40
		FILM NUMBER:		221412943

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keys Group Holdings LLC
		CENTRAL INDEX KEY:			0001513641
		IRS NUMBER:				621863023
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-156
		FILM NUMBER:		221413053

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Continuum, LLC
		CENTRAL INDEX KEY:			0001513642
		IRS NUMBER:				481274107
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-155
		FILM NUMBER:		221413052

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Education & Youth Services, LLC
		CENTRAL INDEX KEY:			0001513643
		IRS NUMBER:				621842126
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-153
		FILM NUMBER:		221413051

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Marion, LLC
		CENTRAL INDEX KEY:			0001513644
		IRS NUMBER:				743108285
		STATE OF INCORPORATION:			VA

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-152
		FILM NUMBER:		221413050

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Memphis, LLC
		CENTRAL INDEX KEY:			0001513645
		IRS NUMBER:				621837606
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-150
		FILM NUMBER:		221413049

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Newport News, LLC
		CENTRAL INDEX KEY:			0001513646
		IRS NUMBER:				320066225
		STATE OF INCORPORATION:			VA

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-149
		FILM NUMBER:		221413048

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone Richland Center, LLC
		CENTRAL INDEX KEY:			0001513648
		IRS NUMBER:				481274207
		STATE OF INCORPORATION:			OH

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-142
		FILM NUMBER:		221413046

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone WSNC, L.L.C.
		CENTRAL INDEX KEY:			0001513649
		IRS NUMBER:				201943356
		STATE OF INCORPORATION:			NC

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-141
		FILM NUMBER:		221413045

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone/CCS Partners LLC
		CENTRAL INDEX KEY:			0001513650
		IRS NUMBER:				731657607
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-140
		FILM NUMBER:		221413044

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KMI Acquisition, LLC
		CENTRAL INDEX KEY:			0001513651
		IRS NUMBER:				205048153
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-134
		FILM NUMBER:		221413039

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			La Amistad Residental Treatment Center, LLC
		CENTRAL INDEX KEY:			0001513652
		IRS NUMBER:				581791069
		STATE OF INCORPORATION:			FL

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-133
		FILM NUMBER:		221413038

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Keystone NPS LLC
		CENTRAL INDEX KEY:			0001513654
		IRS NUMBER:				680520286
		STATE OF INCORPORATION:			CA

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-143
		FILM NUMBER:		221413047

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Manatee Memorial Hospital, L.P.
		CENTRAL INDEX KEY:			0001513655
		IRS NUMBER:				232798290
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-128
		FILM NUMBER:		221413033

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ocala Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001513656
		IRS NUMBER:				320235544
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-176
		FILM NUMBER:		221413072

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pendleton Methodist Hospital, L.L.C.
		CENTRAL INDEX KEY:			0001513657
		IRS NUMBER:				753128254
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-169
		FILM NUMBER:		221413065

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PSJ Acquisition, LLC
		CENTRAL INDEX KEY:			0001513658
		IRS NUMBER:				264314533
		STATE OF INCORPORATION:			ND
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-165
		FILM NUMBER:		221413061

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TBD Acquisition, LLC
		CENTRAL INDEX KEY:			0001513659
		IRS NUMBER:				205048087
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-17
		FILM NUMBER:		221412917

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TBJ Behavioral Center, LLC
		CENTRAL INDEX KEY:			0001513660
		IRS NUMBER:				204865566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-16
		FILM NUMBER:		221412916

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tennessee Clinical Schools, LLC
		CENTRAL INDEX KEY:			0001513661
		IRS NUMBER:				621715237
		STATE OF INCORPORATION:			TN

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-13
		FILM NUMBER:		221412913

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Toledo Holding Co., LLC
		CENTRAL INDEX KEY:			0001513662
		IRS NUMBER:				270607591
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-04
		FILM NUMBER:		221412904

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Kentucky Holdings, L.L.C.
		CENTRAL INDEX KEY:			0001513663
		IRS NUMBER:				205396036
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-90
		FILM NUMBER:		221412989

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Bowling Green, LLC
		CENTRAL INDEX KEY:			0001513664
		IRS NUMBER:				200931121
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-87
		FILM NUMBER:		221412986

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Centennial Peaks, L.L.C.
		CENTRAL INDEX KEY:			0001513665
		IRS NUMBER:				263973154
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-86
		FILM NUMBER:		221412985

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Dover, L.L.C.
		CENTRAL INDEX KEY:			0001513666
		IRS NUMBER:				205093162
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-80
		FILM NUMBER:		221412979

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Doylestown, L.L.C.
		CENTRAL INDEX KEY:			0001513667
		IRS NUMBER:				208179692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-01
		FILM NUMBER:		221412939

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Lakeside, LLC
		CENTRAL INDEX KEY:			0001513668
		IRS NUMBER:				233044425
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-72
		FILM NUMBER:		221412971

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Laurel Heights, L.P.
		CENTRAL INDEX KEY:			0001513669
		IRS NUMBER:				233045288
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-70
		FILM NUMBER:		221412969

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Parkwood, Inc.
		CENTRAL INDEX KEY:			0001513670
		IRS NUMBER:				233044435
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-66
		FILM NUMBER:		221412965

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Peachford, L.P.
		CENTRAL INDEX KEY:			0001513671
		IRS NUMBER:				233044978
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-65
		FILM NUMBER:		221412964

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Pennsylvania,Inc.
		CENTRAL INDEX KEY:			0001513672
		IRS NUMBER:				232842434
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-64
		FILM NUMBER:		221412963

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Provo Canyon, Inc.
		CENTRAL INDEX KEY:			0001513673
		IRS NUMBER:				233044423
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-62
		FILM NUMBER:		221412961

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Ridge, LLC
		CENTRAL INDEX KEY:			0001513674
		IRS NUMBER:				233044431
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-60
		FILM NUMBER:		221412959

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Rockford, LLC
		CENTRAL INDEX KEY:			0001513675
		IRS NUMBER:				233044421
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-58
		FILM NUMBER:		221412957

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Salt Lake City, L.L.C.
		CENTRAL INDEX KEY:			0001513676
		IRS NUMBER:				260464201
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-57
		FILM NUMBER:		221412956

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Savannah, L.L.C.
		CENTRAL INDEX KEY:			0001513677
		IRS NUMBER:				200931196
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-56
		FILM NUMBER:		221412955

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Springwoods, L.L.C.
		CENTRAL INDEX KEY:			0001513678
		IRS NUMBER:				205395878
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-126
		FILM NUMBER:		221413031

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Summitridge, LLC
		CENTRAL INDEX KEY:			0001513679
		IRS NUMBER:				262203865
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-125
		FILM NUMBER:		221413030

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Timpanogos, Inc.
		CENTRAL INDEX KEY:			0001513680
		IRS NUMBER:				203687800
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-122
		FILM NUMBER:		221413027

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Oklahoma City LLC
		CENTRAL INDEX KEY:			0001513681
		IRS NUMBER:				202901605
		STATE OF INCORPORATION:			OK
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-118
		FILM NUMBER:		221413023

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS-Corona, Inc.
		CENTRAL INDEX KEY:			0001513682
		IRS NUMBER:				521247839
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-115
		FILM NUMBER:		221413020

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			United Healthcare of Hardin, Inc.
		CENTRAL INDEX KEY:			0001513683
		IRS NUMBER:				621244469
		STATE OF INCORPORATION:			TN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-112
		FILM NUMBER:		221413017

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Universal Health Services of Palmdale, Inc.
		CENTRAL INDEX KEY:			0001513684
		IRS NUMBER:				233101502
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-111
		FILM NUMBER:		221413016

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Universal Health Services of Rancho Springs, Inc.
		CENTRAL INDEX KEY:			0001513685
		IRS NUMBER:				233059262
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-110
		FILM NUMBER:		221413015

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Valley Hospital Medical Center, Inc.
		CENTRAL INDEX KEY:			0001513686
		IRS NUMBER:				232117855
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-151
		FILM NUMBER:		221413009

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 S. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wekiva Springs Center, LLC
		CENTRAL INDEX KEY:			0001513687
		IRS NUMBER:				204865588
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-148
		FILM NUMBER:		221413008

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wellington Regional Medical Center, Inc
		CENTRAL INDEX KEY:			0001513688
		IRS NUMBER:				232306491
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-147
		FILM NUMBER:		221413007

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH. GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			McAllen Hospitals, L.P.
		CENTRAL INDEX KEY:			0001513836
		IRS NUMBER:				233069260
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-188
		FILM NUMBER:		221413083

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Anchor, L.P.
		CENTRAL INDEX KEY:			0001513837
		IRS NUMBER:				233044975
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-88
		FILM NUMBER:		221412987

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Georgia Holdings, Inc.
		CENTRAL INDEX KEY:			0001513838
		IRS NUMBER:				233044428
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-77
		FILM NUMBER:		221412976

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of New Orleans, Inc.
		CENTRAL INDEX KEY:			0001513839
		IRS NUMBER:				720802368
		STATE OF INCORPORATION:			LA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-68
		FILM NUMBER:		221412967

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HHC Pennsylvania, LLC
		CENTRAL INDEX KEY:			0001514293
		IRS NUMBER:				205353753
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-49
		FILM NUMBER:		221412950

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Timberlawn, Inc.
		CENTRAL INDEX KEY:			0001514317
		IRS NUMBER:				232853139
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-123
		FILM NUMBER:		221413028

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wisconsin Avenue Psychiatric Center, Inc.
		CENTRAL INDEX KEY:			0001952275
		IRS NUMBER:				593480410
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-102
		FILM NUMBER:		221413000

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Salt Lake Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952278
		IRS NUMBER:				271365684
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-31
		FILM NUMBER:		221412931

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Valley Health System LLC
		CENTRAL INDEX KEY:			0001952280
		IRS NUMBER:				232937646
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-154
		FILM NUMBER:		221413010

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Funding, LLC
		CENTRAL INDEX KEY:			0001952284
		IRS NUMBER:				842891450
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-92
		FILM NUMBER:		221412991

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			University Behavioral Health of El Paso, LLC
		CENTRAL INDEX KEY:			0001952286
		IRS NUMBER:				208364461
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-109
		FILM NUMBER:		221413014

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Texas Oaks Psychiatric Hospital, L.P.
		CENTRAL INDEX KEY:			0001952288
		IRS NUMBER:				841618661
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-09
		FILM NUMBER:		221412909

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Psychiatric Realty, LLC
		CENTRAL INDEX KEY:			0001952289
		IRS NUMBER:				208364925
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-164
		FILM NUMBER:		221413060

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RR Recovery, LLC
		CENTRAL INDEX KEY:			0001952291
		IRS NUMBER:				260269878
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-32
		FILM NUMBER:		221412932

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Capitol Acquisition, LLC
		CENTRAL INDEX KEY:			0001952294
		IRS NUMBER:				882396608
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-100
		FILM NUMBER:		221412998

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHP, LP
		CENTRAL INDEX KEY:			0001952297
		IRS NUMBER:				203078922
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-94
		FILM NUMBER:		221412993

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHSL, L.L.C.
		CENTRAL INDEX KEY:			0001952300
		IRS NUMBER:				261544573
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-113
		FILM NUMBER:		221413018

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Beach 77, LP
		CENTRAL INDEX KEY:			0001952301
		IRS NUMBER:				203078353
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-203
		FILM NUMBER:		221413111

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Madera, Inc.
		CENTRAL INDEX KEY:			0001952302
		IRS NUMBER:				843480733
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-69
		FILM NUMBER:		221412968

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			National Deaf Academy, LLC
		CENTRAL INDEX KEY:			0001952304
		IRS NUMBER:				593653865
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-08
		FILM NUMBER:		221412908

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Riverside Medical Clinic Patient Services, L.L.C.
		CENTRAL INDEX KEY:			0001952308
		IRS NUMBER:				330848805
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-34
		FILM NUMBER:		221412934

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHSD, L.L.C.
		CENTRAL INDEX KEY:			0001952310
		IRS NUMBER:				261544392
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-114
		FILM NUMBER:		221413019

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CAT Seattle, LLC
		CENTRAL INDEX KEY:			0001952311
		IRS NUMBER:				452538281
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-206
		FILM NUMBER:		221413114

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UBH of Phoenix, LLC
		CENTRAL INDEX KEY:			0001952313
		IRS NUMBER:				270355566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-95
		FILM NUMBER:		221412994

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Milwaukee Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952314
		IRS NUMBER:				831464210
		STATE OF INCORPORATION:			WI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-182
		FILM NUMBER:		221413078

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Lancaster, LLC
		CENTRAL INDEX KEY:			0001952322
		IRS NUMBER:				813333435
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-71
		FILM NUMBER:		221412970

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Salt Lake Psychiatric Realty, LLC
		CENTRAL INDEX KEY:			0001952324
		IRS NUMBER:				262885163
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-30
		FILM NUMBER:		221412930

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CAT Realty, LLC
		CENTRAL INDEX KEY:			0001952325
		IRS NUMBER:				452538395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-207
		FILM NUMBER:		221413115

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Behavioral Health Management, LLC
		CENTRAL INDEX KEY:			0001952328
		IRS NUMBER:				272849780
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-202
		FILM NUMBER:		221413110

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mayhill Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952330
		IRS NUMBER:				274126263
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-189
		FILM NUMBER:		221413084

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Independence Physician Management, LLC
		CENTRAL INDEX KEY:			0001952334
		IRS NUMBER:				455296314
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-157
		FILM NUMBER:		221413054

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Sub III, LLC
		CENTRAL INDEX KEY:			0001952335
		IRS NUMBER:				474762288
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-116
		FILM NUMBER:		221413021

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Behavioral Health Realty, LLC
		CENTRAL INDEX KEY:			0001952340
		IRS NUMBER:				272849723
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-201
		FILM NUMBER:		221413096

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AZ Holding 4, LLC
		CENTRAL INDEX KEY:			0001952344
		IRS NUMBER:				834517050
		STATE OF INCORPORATION:			AZ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-192
		FILM NUMBER:		221413087

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UBH of Phoenix Realty, LLC
		CENTRAL INDEX KEY:			0001952348
		IRS NUMBER:				270355691
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-96
		FILM NUMBER:		221412995

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ridge Outpatient Counseling, L.L.C.
		CENTRAL INDEX KEY:			0001952350
		IRS NUMBER:				251872645
		STATE OF INCORPORATION:			KY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-37
		FILM NUMBER:		221412937

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Harbor Point Behavioral Health Center, Inc.
		CENTRAL INDEX KEY:			0001952353
		IRS NUMBER:				541465094
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-55
		FILM NUMBER:		221412954

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Temple Behavioral Healthcare Hospital, Inc.
		CENTRAL INDEX KEY:			0001952355
		IRS NUMBER:				832014977
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-14
		FILM NUMBER:		221412914

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Tucson, LLC
		CENTRAL INDEX KEY:			0001952357
		IRS NUMBER:				463600310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-121
		FILM NUMBER:		221413026

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UBH of Oregon, LLC
		CENTRAL INDEX KEY:			0001952358
		IRS NUMBER:				262343447
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-97
		FILM NUMBER:		221412996

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS of Phoenix, LLC
		CENTRAL INDEX KEY:			0001952363
		IRS NUMBER:				464207180
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-63
		FILM NUMBER:		221412962

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bridgeway, LLC
		CENTRAL INDEX KEY:			0001952364
		IRS NUMBER:				232238973
		STATE OF INCORPORATION:			AR
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-139
		FILM NUMBER:		221413043

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pasteur Healthcare Properties, LLC
		CENTRAL INDEX KEY:			0001952365
		IRS NUMBER:				861734170
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-170
		FILM NUMBER:		221413066

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Palm Point Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952372
		IRS NUMBER:				471584533
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-175
		FILM NUMBER:		221413071

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DHP 2131 K St, LLC
		CENTRAL INDEX KEY:			0001952373
		IRS NUMBER:				452919095
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-245
		FILM NUMBER:		221413138

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			District Hospital Partners, L.P.
		CENTRAL INDEX KEY:			0001952374
		IRS NUMBER:				232896725
		STATE OF INCORPORATION:			DC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-243
		FILM NUMBER:		221413109

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DVH Hospital Alliance LLC
		CENTRAL INDEX KEY:			0001952375
		IRS NUMBER:				812660258
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-242
		FILM NUMBER:		221413108

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FRN, INC.
		CENTRAL INDEX KEY:			0001952377
		IRS NUMBER:				320229751
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-238
		FILM NUMBER:		221413104

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coral Shores Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952378
		IRS NUMBER:				463794548
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-194
		FILM NUMBER:		221413089

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Schick Shadel Of Florida, LLC
		CENTRAL INDEX KEY:			0001952379
		IRS NUMBER:				383925621
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-28
		FILM NUMBER:		221412928

	BUSINESS ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		UNIVERSAL CORPORATE CENTER
		STREET 2:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TBD Acquisition II, LLC
		CENTRAL INDEX KEY:			0001952380
		IRS NUMBER:				822306092
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-18
		FILM NUMBER:		221412918

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Garfield Park Hospital, LLC
		CENTRAL INDEX KEY:			0001952381
		IRS NUMBER:				460775763
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-234
		FILM NUMBER:		221413100

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Forest View Psychiatric Hospital, Inc.
		CENTRAL INDEX KEY:			0001952382
		IRS NUMBER:				232285657
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-190
		FILM NUMBER:		221413085

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gulf Coast Treatment Center, Inc.
		CENTRAL INDEX KEY:			0001952383
		IRS NUMBER:				561341134
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-232
		FILM NUMBER:		221413098

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fannin Management Services, LLC
		CENTRAL INDEX KEY:			0001952384
		IRS NUMBER:				320456095
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-240
		FILM NUMBER:		221413106

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Temecula Valley Hospital, Inc.
		CENTRAL INDEX KEY:			0001952385
		IRS NUMBER:				461246570
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-15
		FILM NUMBER:		221412915

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gulph Mills Associates, LLC
		CENTRAL INDEX KEY:			0001952386
		IRS NUMBER:				455358222
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-231
		FILM NUMBER:		221413097

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		(610) 768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ascend Health Corp
		CENTRAL INDEX KEY:			0001952402
		IRS NUMBER:				800109304
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-248
		FILM NUMBER:		221413141

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UHS Midwest Behavioral Health, LLC
		CENTRAL INDEX KEY:			0001952648
		IRS NUMBER:				822409085
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-89
		FILM NUMBER:		221412988

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABS LINCS KY, LLC
		CENTRAL INDEX KEY:			0001952669
		IRS NUMBER:				611267294
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268276-254
		FILM NUMBER:		221413145

	BUSINESS ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
		BUSINESS PHONE:		610-768-3300

	MAIL ADDRESS:	
		STREET 1:		367 SOUTH GULPH ROAD
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d391216d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML><HEAD>
<TITLE>424B3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:71%; font-size:10pt; font-family:Times New Roman"><B>Filed Pursuant to Rule 424(b)(3)<BR>Registration No. 333-268276 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g391216g11a11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Universal Health Services, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>OFFER TO EXCHANGE ITS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1.650% Senior
Secured Notes due 2026, 2.650% Senior Secured Notes due 2030 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and 2.650% Senior Secured Notes due 2032 and related guarantees
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>that have been registered under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR AN EQUAL AMOUNT OF ITS OUTSTANDING </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1.650% Senior Secured Notes due 2026, 2.650% Senior Secured Notes due 2030 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and 2.650% Senior Secured Notes due 2032, and related guarantees, as applicable, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>that were issued and sold in transactions exempt from registration under the Securities Act. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby offer to exchange, upon the terms and conditions set forth in this prospectus and the accompanying letter of transmittal, up to
$700,000,000 in aggregate principal amount of our 1.650% Senior Secured Notes due 2026, $800,000,000 in aggregate principal amount of our 2.650% Senior Secured Notes due 2030, and $500,000,000 in aggregate principal amount of our 2.650% Senior
Secured Notes due 2032 (collectively, the &#147;Exchange Notes&#148;), and the related guarantees, for an equal amount of our outstanding 1.650% Senior Secured Notes due 2026, 2.650% Senior Secured Notes due 2030 and 2.650% Senior Secured Notes due
2032 (collectively, the &#147;Original Notes&#148;) and related guarantees. The terms of the Exchange Notes and related guarantees are substantially identical to the terms of the Original Notes and related guarantees, except that the Exchange Notes
and related guarantees will be registered under the Securities Act and certain transfer restrictions, registration rights and additional interest provisions relating to the Original Notes do not apply to the Exchange Notes. For a description of the
principal terms of the Exchange Notes and the related guarantees, see &#147;Description of Notes.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exchange offer will expire at
5:00 p.m., New York City time, on December 22, 2022, unless we extend the offer. At any time prior to the expiration time, you may withdraw your tender of any Original Notes; otherwise, such tender is irrevocable. We will receive no cash proceeds
from the exchange offer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Original Notes not tendered and accepted in the exchange offer will remain outstanding. To the extent
Original Notes are tendered and accepted in the exchange offer, your ability to sell untendered, and tendered but unaccepted, Original Notes could be adversely affected. Following consummation of the exchange offer, the Original Notes will continue
to be subject to their existing transfer restrictions and we will generally have no further obligations to provide for the registration of the Original Notes under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each broker-dealer that receives Exchange Notes for its own account pursuant to the exchange offer must acknowledge that it will deliver a
prospectus meeting the requirements of the Securities Act (or, to the extent permitted by law, make available a prospectus meeting the requirements of the Securities Act to purchasers) in connection with any resale of such Exchange Notes. The letter
of transmittal states that by so acknowledging and by delivering a prospectus, a broker-dealer will not be deemed to admit that it is an &#147;underwriter&#148; within the meaning of the Securities Act. This prospectus, as it may be amended or
supplemented from time to time, may be used by a broker-dealer in connection with resales of the Exchange Notes received in exchange for the Original Notes where such Original Notes were acquired by such broker-dealer as a result of market-making or
other trading activities. We have agreed that, for a period of 180 days following the expiration of the exchange offer, we will make this prospectus available to any broker-dealer for use in connection with any such resale. See &#147;Plan of
Distribution.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>You should carefully consider the <A HREF="#rom391216_3">risk factors</A> beginning on page&nbsp;11 of this
prospectus before participating in the exchange offer. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus and the letter of transmittal are first being mailed to all
holders of the Original Notes on or about November 23, 2022. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission (the &#147;SEC&#148;) nor
any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is November 23, 2022. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless stated otherwise or the context indicates otherwise, references to &#147;UHS,&#148;
the &#147;Company,&#148; &#147;our Company,&#148; &#147;we,&#148; &#147;our,&#148; &#147;ours&#148; and &#147;us&#148; refer to Universal Health Services, Inc. together with its direct and indirect domestic subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus incorporates important business and financial information about UHS that is not included in or delivered with this prospectus.
Documents incorporated by reference are available from UHS without charge upon written or oral request. Any person, including any beneficial owner, to whom this prospectus is delivered may obtain documents incorporated by reference in, but not
delivered with, this prospectus by requesting them by telephone or in writing at the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">UNIVERSAL HEALTH SERVICES, INC.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Universal Corporate Center </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">367 South Gulph Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">King of
Prussia, Pennsylvania 19406 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(610) <FONT STYLE="white-space:nowrap">768-3300</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn.: Investor Relations </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To
obtain timely delivery, you must request these documents no later than five business days before the expiration time of the exchange offer, or December 15, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information incorporated by reference or provided in this prospectus. We have not authorized anyone else to
provide you with information different from that contained in this prospectus. We are offering to exchange Exchange Notes for Original Notes only in jurisdictions where such offer is permitted. You should not assume that the information in the
incorporated documents or this prospectus is accurate as of any other date other than the date on the front of these documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No
dealer, salesperson or other person has been authorized to give any information or to make any representations other than those contained or incorporated by reference in this prospectus in connection with the exchange offer, and, if given or made,
such information or representations must not be relied upon as having been authorized by UHS. This prospectus does not constitute an offer of any securities other than those to which it relates or an offer or a solicitation by anyone in any
jurisdiction in which such offer or solicitation is not authorized or in which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation in such jurisdiction.
Neither the delivery of this prospectus nor any exchange made hereunder shall under any circumstance create an implication that there has been no change in the affairs of our Company since the date of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- i - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_1">Cautionary Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">iii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_2">Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_3">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_4">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_5">The Exchange Offer</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_6">Description of the Notes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_7">Description of Other Indebtedness</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_8">Material U.S. Federal Income Tax Considerations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_9">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_10">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_11">Incorporation by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_12">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom391216_13">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- ii - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_1"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, the documents incorporated by reference in this prospectus and our other public statements contain &#147;forward-looking
statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect our current estimates, expectations and projections about our future results, performance, prospects and opportunities. Forward-looking
statements include, among other things, the information concerning our possible future results of operations, business and growth strategies, financing plans, expectations that regulatory developments or other matters will not have a material
adverse effect on our business or financial condition, our competitive position and the effects of competition, the projected growth of the industry in which we operate, and the benefits and synergies to be obtained from our completed and any future
acquisitions, and statements of our goals and objectives, and other similar expressions concerning matters that are not historical facts. Words such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148;
&#147;predicts,&#148; &#147;potential,&#148; &#147;continue,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;future,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;appears,&#148;
&#147;projects&#148; and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be
accurate indications of the times at, or by which, such performance or results will be achieved. Forward-looking information is based on information available at the time and/or our good faith belief with respect to future events, and is subject to
risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. In evaluating those statements, you should specifically consider the following important factors, along with the risk
factors identified under &#147;Risk Factors&#148; and the risk factors incorporated by reference herein, which could affect future results and cause those results to differ materially from those expressed in the forward-looking statements: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are subject to risks associated with public health threats and epidemics, including the health concerns
relating to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. In January 2020, the Centers for Disease Control and Prevention (&#147;CDC&#148;) confirmed the spread of the disease to the United States. In March 2020, the World Health
Organization declared the <FONT STYLE="white-space:nowrap">COVID-19</FONT> outbreak a pandemic. The federal government has declared <FONT STYLE="white-space:nowrap">COVID-19</FONT> a national emergency, as many federal and state authorities have
implemented aggressive measures to &#147;flatten the curve&#148; of confirmed individuals diagnosed with <FONT STYLE="white-space:nowrap">COVID-19</FONT> in an attempt to curtail the spread of the virus and to avoid overwhelming the health care
system; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, which began during the second half
of March, 2020, has had a material effect on our operations and financial results since that time. The length and extent of the disruptions caused by the COVID-19 pandemic are currently unknown; however, we expect such disruptions to continue into
the future. Since the future volumes and severity of <FONT STYLE="white-space:nowrap">COVID-19</FONT> patients remain highly uncertain and subject to change, including potential increases in future <FONT STYLE="white-space:nowrap">COVID-19</FONT>
patient volumes caused by new variants of the virus, as well as related pressures on staffing and wage rates, we are not able to fully quantify the impact that these factors will have on our future financial results. However, developments related to
the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic could continue to materially affect our financial performance. Even after the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic has subsided, we may continue to experience
materially adverse impacts on our financial condition and our results of operations as a result of its macroeconomic impact, and many of our known risks described in the Risk Factors sections of our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the nationwide shortage of nurses and other clinical staff and support personnel has been a significant operating
issue facing us and other healthcare providers. Like others in the healthcare industry, we continue to experience a shortage of nurses and other clinical staff and support personnel at our acute care and behavioral health care hospitals in many
geographic areas. In some areas, the labor scarcity is putting a strain on our resources and staff, which has required us to utilize higher-cost temporary labor and pay premiums above standard compensation for essential workers. This staffing
shortage has required us to hire expensive temporary personnel and/or enhance wages and benefits to recruit and retain nurses and other clinical staff and support personnel. At certain facilities, particularly within our behavioral health care
segment, we have been unable to fill all vacant positions and, consequently, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- iii - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
have been required to limit patient volumes. These factors, which had a material unfavorable impact on our results of operations during the first nine months of 2022, are expected to continue to
have an unfavorable material impact on our results of operations for the foreseeable future; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Centers for Medicare and Medicaid Services (&#147;CMS&#148;) issued an Interim Final Rule (&#147;IFR&#148;)
effective November&nbsp;5, 2021 mandating <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccinations for all applicable staff at all Medicare and Medicaid certified facilities. Under the IFR, facilities covered by this regulation must establish a
policy ensuring all eligible staff have received the <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccine prior to providing any care, treatment, or other services. All eligible staff must have received the necessary shots to be fully
vaccinated. The regulation also provides for exemptions based on recognized medical conditions or religious beliefs, observances, or practices. Under the IFR, facilities must develop a similar process or plan for permitting exemptions in alignment
with federal law. If facilities fail to comply with the IFR by the deadlines established, they are subject to potential termination from the Medicare and Medicaid program for <FONT STYLE="white-space:nowrap">non-compliance.</FONT> We cannot predict
at this time the potential viability or impact of any additional vaccination requirements. Implementation of these rules could have an impact on staffing at our facilities for those employees that are not vaccinated in accordance with IFR
requirements, and associated loss of revenues and increased costs resulting from staffing issues could have a material adverse effect on our financial results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Coronavirus Aid, Relief, and Economic Security Act (the &#147;CARES Act&#148;), a stimulus package signed
into law on March&nbsp;27, 2020, authorizes $100&nbsp;billion in grant funding to hospitals and other healthcare providers to be distributed through the Public Health and Social Services Emergency Fund (the &#147;PHSSEF&#148;). These funds are not
required to be repaid provided the recipients attest to and comply with certain terms and conditions, including limitations on balance billing and not using PHSSEF funds to reimburse expenses or losses that other sources are obligated to reimburse.
However, since the expenses and losses will be ultimately measured over the life of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, potential retrospective unfavorable adjustments in future periods, of funds recorded as revenues in
prior periods, could occur. The U.S. Department of Health and Human Services (&#147;HHS&#148;) initially distributed $30&nbsp;billion of this funding based on each provider&#146;s share of total Medicare <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">fee-for-service</FONT></FONT> reimbursement in 2019. Subsequently, HHS determined that CARES Act funding (including the $30&nbsp;billion already distributed) would be allocated proportional to providers&#146; share of 2018
net patient revenue. We have received payments from these initial distributions of the PHSSEF as disclosed in documents incorporated by reference herein. HHS has indicated that distributions of the remaining $50&nbsp;billion will be targeted
primarily to hospitals in <FONT STYLE="white-space:nowrap">COVID-19</FONT> high impact areas, to rural providers, safety net hospitals and certain Medicaid providers and to reimburse providers for <FONT STYLE="white-space:nowrap">COVID-19</FONT>
related treatment of uninsured patients. We have received payments from these targeted distributions of the PHSSEF, as disclosed in documents incorporated by reference herein. The CARES Act also makes other forms of financial assistance available to
healthcare providers, including through Medicare and Medicaid payment adjustments and an expansion of the Medicare Accelerated and Advance Payment Program, which made available accelerated payments of Medicare funds in order to increase cash flow to
providers. On April&nbsp;26, 2020, CMS announced it was reevaluating and temporarily suspending the Medicare Accelerated and Advance Payment Program in light of the availability of the PHSSEF and the significant funds available through other
programs. We have received accelerated payments under this program during 2020, and returned early all of those funds during the first quarter of 2021, as disclosed in documents incorporated by reference herein. The Paycheck Protection Program and
Health Care Enhancement Act (the &#147;PPPHCE Act&#148;), a stimulus package signed into law on April&nbsp;24, 2020, includes additional emergency appropriations for <FONT STYLE="white-space:nowrap">COVID-19</FONT> response, including
$75&nbsp;billion to be distributed to eligible providers through the PHSSEF. A third phase of PHSSEF allocations made $24.5&nbsp;billion available for providers who previously received, rejected or accepted PHSSEF payments. Applicants that had not
yet received PHSSEF payments of 2&nbsp;percent of patient revenue were to receive a payment that, when combined with prior payments (if any), equals 2&nbsp;percent of patient care revenue. Providers that have already received payments of
approximately 2&nbsp;percent of annual revenue from patient care were potentially eligible for an additional payment. Recipients will not be required to repay </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- iv - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
the government for PHSSEF funds received, provided they comply with HHS defined terms and conditions. On December&nbsp;27, 2020, the Consolidated Appropriations Act, 2021 (&#147;CAA&#148;) was
signed into law. The CAA appropriated an additional $3&nbsp;billion to the PHSSEF, codified flexibility for providers to calculate lost revenues, and permitted parent organizations to allocate PHSSEF targeted distributions to subsidiary
organizations. The CAA also provides that not less than 85&nbsp;percent of the unobligated PHSSEF amounts and any future funds recovered from health care providers should be used for additional distributions that consider financial losses and
changes in operating expenses in the third or fourth quarters of 2020 and the first quarter of 2021 that are attributable to the coronavirus. The CAA provided additional funding for testing, contact tracing and vaccine administration. Providers
receiving payments were required to sign terms and conditions regarding utilization of the payments. Any provider receiving funds in excess of $10,000 in the aggregate will be required to report data elements to HHS detailing utilization of the
payments, and we will be required to file such reports. We, and other providers, will report healthcare related expenses attributable to <FONT STYLE="white-space:nowrap">COVID-19</FONT> that have not been reimbursed by another source, which may
include general and administrative or healthcare related operating expenses. Funds may also be applied to lost revenues, represented as a negative change in year-over-year net patient care operating income. The deadline for using all Provider Relief
Fund payments depends on the date of the payment received period; payments received in the first period of April&nbsp;10, 2020 to June&nbsp;30, 2020 were to have been expended by June&nbsp;30, 2021 and payments received in the fourth period of
July&nbsp;1, 2021 to December&nbsp;31, 2021 must be expended by December&nbsp;31, 2022. The American Rescue Plan Act of 2021 (&#147;ARPA&#148;), enacted on March&nbsp;11, 2021, included funding directed at detecting, diagnosing, tracing, and
monitoring <FONT STYLE="white-space:nowrap">COVID-19</FONT> infections; establishing community vaccination centers and mobile vaccine units; promoting, distributing, and tracking <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccines; and
reimbursing rural hospitals and facilities for healthcare-related expenses and lost revenues attributable to <FONT STYLE="white-space:nowrap">COVID-19.</FONT> ARPA increased the eligibility for, and amount of, premium tax credits to purchase health
coverage through Patient Protection and Affordable Care Act, as amended by the Health and Education Reconciliation Act (collectively, the &#147;Legislation&#148;). Further, ARPA set the Medicaid program&#146;s federal medical assistance percentage
(&#147;FMAP&#148;) at 100&nbsp;percent for amounts expended for <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccines and vaccine administration. ARPA also increases the FMAP by 5&nbsp;percent for eight calendar quarters to incentivize states to
expand their Medicaid programs. Finally, ARPA provides subsidies to cover 100&nbsp;percent of health insurance premiums under the Consolidated Omnibus Budget Reconciliation Act through September&nbsp;30, 2021. There is a high degree of uncertainty
surrounding the implementation of the CARES Act, the PPPHCE Act, the CAA and ARPA, and the federal government may consider additional stimulus and relief efforts, but we are unable to predict whether additional stimulus measures will be enacted or
their impact. There can be no assurance as to the total amount of financial and other types of assistance we will receive under the CARES Act, the PPPHCE Act, the CAA and the ARPA, and it is difficult to predict the impact of such legislation on our
operations or how they will affect operations of our competitors. Moreover, we are unable to assess the extent to which anticipated negative impacts on us arising from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic will be offset by
amounts or benefits received or to be received under the CARES Act, the PPPHCE Act, the CAA and the ARPA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to comply with the existing laws and government regulations, and/or changes in laws and government
regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increasing number of legislative initiatives have been passed into law that may result in major changes in the
health care delivery system on a national or state level. For example, Congress has reduced to $0 the penalty for failing to maintain health coverage that was part of the original Legislation as part of the Tax Cuts and Jobs Act. President Biden has
undertaken and is expected to undertake additional executive actions that will strengthen the Legislation and reverse the policies of the prior administration. To date, the Biden administration has issued executive orders implementing a special
enrollment period permitting individuals to enroll in health plans outside of the annual open enrollment period and reexamining policies that may undermine the Legislation or the Medicaid program. The Inflation Reduction Act of 2022
(&#147;IRA&#148;) was passed on August&nbsp;16, 2022, which among </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- v - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
other things, allows for CMS to negotiate prices for certain single-source drugs reimbursed under Medicare Part B and Part D. The ARPA&#146;s expansion of subsidies to purchase coverage through a
Legislation exchange, which the IRA continued through 2025, is anticipated to increase exchange enrollment. The Trump Administration had directed the issuance of final rules (i)&nbsp;enabling the formation of association health plans that would be
exempt from certain Legislation requirements such as the provision of essential health benefits, (ii)&nbsp;expanding the availability of short-term, limited duration health insurance, (iii)&nbsp;eliminating cost-sharing reduction payments to
insurers that would otherwise offset deductibles and other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses for health plan enrollees at or below 250&nbsp;percent of the federal poverty level,
(iv)&nbsp;relaxing requirements for state innovation waivers that could reduce enrollment in the individual and small group markets and lead to additional enrollment in short-term, limited duration insurance and association health plans and
(v)&nbsp;incentivizing the use of health reimbursement arrangements by employers to permit employees to purchase health insurance in the individual market. The uncertainty resulting from these Executive Branch policies may have led to reduced
Exchange enrollment in 2018, 2019 and 2020. It is also anticipated that these policies, to the extent that they remain as implemented, may create additional cost and reimbursement pressures on hospitals, including ours. In addition, there have been
numerous political and legal efforts to expand, repeal, replace or modify the Legislation since its enactment, some of which have been successful, in part, in modifying the Legislation, as well as court challenges to the constitutionality of the
Legislation. The U.S. Supreme Court rejected the latest such case on June&nbsp;17, 2021, when the Court held in California v. Texas that the plaintiffs lacked standing to challenge the Legislation&#146;s requirement to obtain minimum essential
health insurance coverage, or the individual mandate. The Court dismissed the case without specifically ruling on the constitutionality of the Legislation. As a result, the Legislation will continue to remain law, in its entirety, likely for the
foreseeable future. On September&nbsp;7, 2022, the Legislation faced its most recent challenge when a Texas Federal District Court judge, in the case of <I>Braidwood Management v. Becerra</I>, ruled that a requirement that certain health plans cover
services without cost sharing violates the Appointments Clause of the U.S. Constitution and that the coverage of certain HIV prevention medication violates the Religious Freedom Restoration Act. Any future efforts to challenge, replace or replace
the Legislation or expand or substantially amend its provision is unknown. See &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Sources of Revenue&#151;Sources of Revenue and Health Care
Reform&#148; in our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended September&nbsp;30, 2022 for additional disclosure; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">under the Legislation, hospitals are required to make public a list of their standard charges, and effective
January&nbsp;1, 2019, CMS has required that this disclosure be in machine-readable format and include charges for all hospital items and services and average charges for diagnosis-related groups. On November&nbsp;27, 2019, CMS published a final rule
on &#147;Price Transparency Requirements for Hospitals to Make Standard Charges Public.&#148; This rule took effect on January&nbsp;1, 2021 and requires all hospitals to also make public their payor-specific negotiated rates, minimum negotiated
rates, maximum negotiated rates, and cash for all items and services, including individual items and services and service packages, that could be provided by a hospital to a patient. Failure to comply with these requirements may result in daily
monetary penalties. On November&nbsp;2, 2021, CMS released a final rule amending several hospital price transparency policies and increasing the amount of penalties for noncompliance through the use of a scaling factor based on hospital bed count;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as part of the CAA, Congress passed legislation aimed at preventing or limiting patient balance billing in
certain circumstances. The CAA addresses surprise medical bills stemming from emergency services, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> ancillary providers at
<FONT STYLE="white-space:nowrap">in-network</FONT> facilities, and air ambulance carriers. The legislation prohibits surprise billing when <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> emergency
services or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> services at an <FONT STYLE="white-space:nowrap">in-network</FONT> facility are provided, unless informed consent is received. In these
circumstances providers are prohibited from billing the patient for any amounts that exceed <FONT STYLE="white-space:nowrap">in-network</FONT> cost-sharing requirements. HHS, the Department of Labor and the Department of the Treasury have issued an
interim final rules, which begins to implement the legislation. The rules are expected to limit our ability to receive payment for services at usually higher
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> rates in certain </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- vi - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
circumstances and prohibit <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-network</FONT></FONT> payments in other circumstances. On February&nbsp;28, 2022, a district
judge in the Eastern District of Texas invalidated portions of the rule governing aspects of the Independent Dispute Resolution (&#147;IDR&#148;) process. In light of this decision, the government issued a final rule on August&nbsp;19, 2022
eliminating the rebuttable presumption in favor of the qualifying payment amount (&#147;QPA&#148;) by the IDR entity and providing additional factors the IDR entity should consider when choosing between two competing offers. On September&nbsp;22,
2022, the Texas Medical Association filed a lawsuit challenging the IDR process provided in the updated final rule and alleging that the final rule unlawfully elevates the QPA above other factors the IDR entity must consider. The American Hospital
Association and American Medical Association have announced their intent to join this case as amici supporting the Texas Medical Association; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">possible unfavorable changes in the levels and terms of reimbursement for our charges by third party payers or
government based payers, including Medicare or Medicaid in the United States, and government based payers in the United Kingdom; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to enter into managed care provider agreements on acceptable terms and the ability of our competitors
to do the same; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of known and unknown litigation, government investigations, false claims act allegations, and
liabilities and other claims asserted against us and the effects of adverse publicity relating to such matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the unfavorable impact on our business of a continued or worsening deterioration in economic, business and credit
market conditions, including a continuation or worsening of inflationary pressures on our operating expenses (most particularly labor and supply costs) since our ability, to pass on to payers, the increased costs associated with providing healthcare
services to our patients (most particularly Medicare and Medicaid patients) is limited; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competition from other healthcare providers (including physician owned facilities) in certain markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">technological and pharmaceutical improvements that increase the cost of providing, or reduce the demand for
healthcare; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain qualified personnel, nurses, physicians and other healthcare professionals and
the impact on our labor expenses resulting from a shortage of nurses and other healthcare professionals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">demographic changes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there is a heightened risk of future cybersecurity threats, including ransomware attacks targeting healthcare
providers. If successful, future cyberattacks could have a material adverse effect on our business. Any costs that we incur as a result of a data security incident or breach, including costs to update our security protocols to mitigate such an
incident or breach could be significant. Any breach or failure in our operational security systems can result in loss of data or an unauthorized disclosure of or access to sensitive or confidential member or protected personal or health information
and could result in significant penalties or fines, litigation, loss of customers, significant damage to our reputation and business, and other losses. Previously, we had experienced a cyberattack in September, 2020 that had an adverse effect on our
operating results during the fourth quarter of 2020, before giving effect to partial recovery of the loss through receipt of commercial insurance proceeds and collection of previously reserved patient accounts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of suitable acquisition and divestiture opportunities and our ability to successfully integrate
and improve our acquisitions since failure to achieve expected acquisition benefits from certain of our prior or future acquisitions could result in impairment charges for goodwill and purchased intangibles; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of severe weather conditions, including the effects of hurricanes and climate change;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- vii - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we receive revenues from various state and county-based programs, including Medicaid in all the states in which
we operate. We receive annual Medicaid revenues of approximately $100&nbsp;million, or greater, from each of Texas, California, Nevada, Illinois, Pennsylvania, Washington, D.C., Kentucky, Florida and Massachusetts. We also receive Medicaid
disproportionate share hospital payments in certain states including Texas and South Carolina. We are therefore particularly sensitive to potential reductions in Medicaid and other state-based revenue programs as well as regulatory, economic,
environmental and competitive changes in those states. We can provide no assurance that reductions to revenues earned pursuant to these programs, and the effect of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on state budgets,
particularly in the above-mentioned states, will not have a material adverse effect on our future results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to continue to obtain capital on acceptable terms, including borrowed funds, to fund the future
growth of our business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inpatient acute care and behavioral health care facilities may experience decreasing admission and length of
stay trends; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial statements reflect large amounts due from various commercial and private payers and there can be no
assurance that failure of the payers to remit amounts due to us will not have a material adverse effect on our future results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Budget Control Act of 2011 (the &#147;2011 Act&#148;) imposed annual spending limits for most federal
agencies and programs aimed at reducing budget deficits by $917&nbsp;billion between 2012 and 2021, according to a report released by the Congressional Budget Office. Among its other provisions, the law established a bipartisan Congressional
committee, known as the Joint Select Committee on Deficit Reduction (the &#147;Joint Committee&#148;), which was tasked with making recommendations aimed at reducing future federal budget deficits by an additional $1.5 trillion over 10 years. The
Joint Committee was unable to reach an agreement by the November&nbsp;23, 2011 deadline and, as a result, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">across-the-board</FONT></FONT> cuts to discretionary, national defense and
Medicare spending were implemented on March&nbsp;1, 2013 resulting in Medicare payment reductions of up to 2% per fiscal year with a uniform percentage reduction across all Medicare programs. The Bipartisan Budget Act of 2015, enacted on
November&nbsp;2, 2015, continued the 2% reductions to Medicare reimbursement imposed under the 2011 Act. Recent legislation has suspended payment reductions through December&nbsp;31, 2021 in exchange for extended cuts through 2030. Subsequent
legislation extended the payment reduction suspension through March&nbsp;31, 2022, with a 1% payment reduction from then until June&nbsp;30, 2022 and the full 2% payment reduction thereafter. We cannot predict whether Congress will restructure the
implemented Medicare payment reductions or what other federal budget deficit reduction initiatives may be proposed by Congress going forward; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uninsured and <FONT STYLE="white-space:nowrap">self-pay</FONT> patients treated at our acute care facilities
unfavorably impact our ability to satisfactorily and timely collect our <FONT STYLE="white-space:nowrap">self-pay</FONT> patient accounts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in our business strategies or development plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in June, 2016, the United Kingdom affirmatively voted in a <FONT STYLE="white-space:nowrap">non-binding</FONT>
referendum in favor of the exit of the United Kingdom (&#147;U.K.&#148;) from the European Union (the &#147;Brexit&#148;) and it was approved by vote of the British legislature. On March&nbsp;29, 2017, the United Kingdom triggered Article 50 of the
Lisbon Treaty, formally starting negotiations regarding its exit from the European Union. On January&nbsp;31, 2020, the U.K. formally exited the European Union. On December&nbsp;24, 2020, the United Kingdom and the European Union reached a
post-Brexit trade and cooperation agreement that created new business and security requirements and preserved the United Kingdom&#146;s tariff- and quota-free access to the European Union member states. The trade and cooperation agreement was
provisionally applied as of January&nbsp;1, 2021 and entered into force on May&nbsp;1, 2021, following ratification by the European Union. We do not know to what extent Brexit will ultimately impact the business and regulatory environment in the
U.K., the European Union, or other countries. Any of these effects of Brexit, and others we cannot anticipate, could harm our business, financial condition and results of operations; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- viii - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in 2021, the rate of inflation in the United States began to increase and has since risen to levels not
experienced in over 40 years. We are experiencing inflationary pressures, primarily in personnel costs, and we anticipate impacts on other cost areas within the next twelve months. The extent of any future impacts from inflation on our business and
our results of operations will be dependent upon how long the elevated inflation levels persist and the extent to which the rate of inflation further increases, if at all, neither of which we are able to predict. If elevated levels of inflation were
to persist or if the rate of inflation were to accelerate, our expenses could increase faster than anticipated and we may utilize our capital resources sooner than expected. Further, given the complexities of the reimbursement landscape in which we
operate, our payors may be unwilling or unable to increase reimbursement rates to compensate for inflationary impacts. Although we have hedged some of our floating rate indebtedness, the rapid increase in interest rates have increased our interest
expense significantly increasing our expenses and reducing our free cash flow. As such, the effects of inflation may adversely impact our results of operations, financial condition and cash flows; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have exposure to fluctuations in foreign currency exchange rates, primarily the pound sterling. We have
international subsidiaries that operate in the United Kingdom. We routinely hedge our exposures to foreign currencies with certain financial institutions in an effort to minimize the impact of certain currency exchange rate fluctuations, but these
hedges may be inadequate to protect us from currency exchange rate fluctuations. To the extent that these hedges are inadequate, our reported financial results or the way we conduct our business could be adversely affected. Furthermore, if a
financial counterparty to our hedges experiences financial difficulties or is otherwise unable to honor the terms of the foreign currency hedge, we may experience material financial losses, and; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other factors referenced herein or in our other filings with the Securities and Exchange Commission.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional information concerning these and other risk factors is contained in the section titled &#147;Risk
Factors&#148; in this prospectus and the documents incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given these uncertainties, risks and assumptions, as
outlined above, you are cautioned not to place undue reliance on such forward-looking statements. Our actual results and financial condition could differ materially from those expressed in, or implied by, the forward-looking statements.
Forward-looking statements speak only as of the date the statements are made. We assume no obligation to publicly update any forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting
forward-looking information, except as may be required by law. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- ix - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_2"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary contains basic information about us and this exchange offer. It does not contain all of the information that you should
consider before deciding whether to participate in the exchange offer. You should carefully read this prospectus and the documents incorporated by reference herein for a more complete understanding of our business. Additionally, you should read the
&#147;Risk Factors&#148; section of this prospectus and in documents incorporated by reference into this prospectus before making an investment decision. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal business is
owning and operating, through our subsidiaries, acute care hospitals and outpatient facilities and behavioral health care facilities. As of September&nbsp;30, 2022, we owned and/or operated 359 inpatient facilities and 41 outpatient and other
facilities including the following located in 39 U.S. states, Washington, D.C., the United Kingdom and Puerto Rico: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Acute care
facilities located in the U.S.: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">28 inpatient acute care hospitals; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">21 free-standing emergency departments, and; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">7 outpatient centers and 1 surgical hospital. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Behavioral health care facilities (331 inpatient facilities and 12 outpatient facilities): </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Located in the U.S.: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">185 inpatient behavioral health care facilities, and; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">10 outpatient behavioral health care facilities. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Located in the U.K.: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">143 inpatient behavioral health care facilities, and; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2 outpatient behavioral health care facilities. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Located in Puerto Rico: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3 inpatient behavioral health care facilities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a percentage of our consolidated net revenues, net revenues from our acute care hospitals, outpatient facilities and commercial health
insurer accounted for 56% of our consolidated net revenues during 2021 and 55% during 2020. Net revenues from our acute care hospitals, outpatient facilities and commercial health insurer accounted for 58% during each of the three-month periods
ended September&nbsp;30, 2022 and 2021, respectively, and 57% and 56% during the nine-month periods ended September&nbsp;30, 2022 and 2021, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net revenues from our behavioral health care facilities and commercial health insurer accounted for 44% of our consolidated net revenues
during 2021 and 45% during 2020. Net revenues from our behavioral health care facilities and commercial health insurer accounted for 43% and 42% of our consolidated net revenues during the three-month periods ended September&nbsp;30, 2022 and 2021,
respectively, and 43% and 44% during the nine-month periods ended September&nbsp;30, 2022 and 2021, respectively. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 1 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our behavioral health care facilities located in the U.K. generated net revenues of
approximately $688&nbsp;million in 2021 and $584&nbsp;million in 2020. Our behavioral health care facilities located in the U.K. generated net revenues of approximately $167&nbsp;million and $174&nbsp;million during the three-month periods ended
September&nbsp;30, 2022 and 2021, respectively, and $516&nbsp;million and $511&nbsp;million during the nine-month periods ended September&nbsp;30, 2022 and 2021, respectively. Total assets at our U.K. behavioral health care facilities were
approximately $1.119&nbsp;billion as of September&nbsp;30, 2022 and $1.351&nbsp;billion as of December&nbsp;31, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Services provided
by our hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. We provide
capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel
management, marketing and public relations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate headquarters and principal executive offices are located at Universal Corporate Center, 367 South Gulph Road, King of Prussia,
Pennsylvania 19406. Our telephone number is (610) <FONT STYLE="white-space:nowrap">768-3300.</FONT> We maintain a website at www.uhs.com where our Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT
STYLE="white-space:nowrap">10-Q,</FONT> Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and all amendments to those reports are available without charge, as soon as reasonably practicable following the time they are filed with or
furnished to the SEC. The information on or accessible through our website is not incorporated into or part of this prospectus (except for our SEC reports expressly incorporated by reference herein). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus may include trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade
names included in this prospectus are the property of their respective owners </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of Exchange Offer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;21, 2020, UHS issued $800&nbsp;million in aggregate principal amount of its 2.650% Senior Secured Notes due 2030 (the
&#147;2030 Original Notes&#148;) and on August&nbsp;24, 2021 UHS issued $700&nbsp;million in aggregate principal amount of its 1.650% Senior Secured Notes due 2026 (the &#147;2026 Original Notes&#148;) and $500&nbsp;million in aggregate principal
amount of its 2.650% Senior Secured Notes due 2032 (the &#147;2032 Original Notes&#148; and together with the 2026 Original Notes and the 2030 Original Notes, the &#147;Original Notes&#148;), each with related guarantees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering of the 2030 Original Notes, we entered into a registration rights agreement with the initial purchasers of the
2030 Original Notes in which we agreed (i)&nbsp;to use commercially reasonable best efforts to cause an exchange offer registration statement (of which this prospectus is a part) to be filed, and to have such registration statement declared
effective promptly, and (ii)&nbsp;to use commercially reasonable best efforts to complete the exchange offer not later than 60 days after such effective date; provided that the 2030 Original Notes will begin accruing default interest if the exchange
offer is not completed before March&nbsp;21, 2023. In connection with the offering of the 2026 Original Notes and the 2032 Original Notes, we entered into a registration rights agreements with the initial purchasers of the 2026 Original Notes and
the 2032 Original Notes in which we agreed to (i)&nbsp;to use commercially reasonable best efforts to cause an exchange offer registration statement (of which this prospectus is a part) to be filed, and to have such registration statement declared
effective promptly, and (ii)&nbsp;to use commercially reasonable best efforts to complete the exchange offer not later than 60 days after such effective date; provided that the 2026 Original Notes and the 2032 Original Notes will begin accruing
default interest if the exchange offer is not completed before February&nbsp;24, 2024. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Exchange Notes issued pursuant to this prospectus will be accepted for clearance through
The Depository Trust Company (&#147;DTC&#148;) with a new CUSIP and ISIN number and common code for each series of the Exchange Notes. You should read the discussions under the headings &#147;The Exchange Offer&#148; and &#147;Description of the
Notes,&#148; respectively, for more information about the exchange offer and Exchange Notes. After the exchange offer is completed, you will no longer be entitled to any exchange or, with limited exceptions, registration rights for your Original
Notes. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>The Exchange Offer </B></P></TD>
<TD>UHS is offering to exchange its 1.650% Senior Secured Notes due 2026 (the &#147;2026 Exchange Notes&#148;), 2.650% Senior Secured Notes due 2030 (the &#147;2030 Exchange Notes&#148;), and 2.650% Senior Secured Notes due 2032 (the &#147;2032
Exchange Notes&#148; and, together with the 2026 Exchange Notes and the 2030 Exchange Notes, the &#147;Exchange Notes&#148;), which have been registered under the Securities Act of 1933, as amended, for an equal amount of its outstanding 2026
Original Notes, 2030 Original Notes and 2032 Original Notes and related guarantees, none of which have been registered under the Securities Act of 1933, as amended. We refer to the Exchange Notes and the Original Notes, collectively, as the
&#147;Notes.&#148; Original Notes may only be exchanged in a principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of the date of this prospectus, $700,000,000 in aggregate principal amount of the 2026 Original Notes, $800,000,000 in aggregate principal amount 2030 Original Notes and $500,000,000 in aggregate principal amount of
2032 Original Notes are outstanding. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The terms of the Exchange Notes are identical in all material respects to those of the Original Notes, except the Exchange Notes will not be subject to transfer restrictions and holders of the Exchange Notes, with
limited exceptions, will have no registration rights. Also, the Exchange Notes will not include provisions contained in the Original Notes that required payment of additional interest in the event we failed to satisfy our registration obligations
with respect to the Original Notes. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Original Notes that are not tendered for exchange will continue to be subject to transfer restrictions and, with limited exceptions, will not have registration rights. Therefore, the market for secondary resales of
Original Notes that are not tendered for exchange is likely to be substantially limited. However, no market currently exists for the Exchange Notes and we can offer no assurance that such a market will develop. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">UHS will issue Exchange Notes promptly after the expiration of the exchange offer. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The exchange offer is not subject to any federal or state regulatory requirements or approvals other than securities laws and blue sky laws. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Expiration Time </B></P></TD>
<TD>The exchange offer will expire at 5:00 p.m., New York City time, on December 22, 2022, unless we decide to extend the expiration time. Please read &#147;The Exchange Offer&#151;Extensions, Delay in Acceptance, Termination or Amendment&#148; for
more information about extending the expiration time. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Withdrawal of Tenders </B></P></TD>
<TD>You may withdraw your tender of Original Notes at any time prior to the expiration time. We will return to you, without charge, promptly after the expiration or termination of the exchange offer any Original Notes that you tendered but that were
not accepted for exchange. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Conditions to the Exchange Offer </B></P></TD>
<TD>The exchange offer is subject to certain customary conditions, which we may amend or waive. We have the right, in our sole discretion, to terminate or withdraw the exchange offer if any of the conditions described in this prospectus are not
satisfied or waived. The exchange offer is not conditioned on any minimum aggregate principal amount of Original Notes being tendered. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Please read &#147;The Exchange Offer&#151;Conditions to the Exchange Offer&#148; for more information about the conditions to the exchange offer. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Procedures for Tendering Original Notes</B> </P></TD>
<TD>If your Original Notes are held through DTC and you wish to participate in the exchange offer, you may do so through DTC&#146;s automated tender offer program. If you tender under this program, you will agree to be bound by the letter of
transmittal that we are providing with this prospectus as though you had signed the letter of transmittal. By signing or agreeing to be bound by the letter of transmittal, you will represent to us that, among other things: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any Exchange Notes that you receive will be acquired in the ordinary course of your business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you have no arrangement or understanding with any person to participate in a distribution (within the meaning of
the Securities Act) of the Exchange Notes in violations of the Securities Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are not an &#147;affiliate,&#148; as defined in Rule 405 under the Securities Act, of us or any guarantor, or
if you are such an affiliate, you will comply with the registration and prospectus delivery requirements of the Securities Act to the extent applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are not engaged in and do not intend to engage in a distribution of the Exchange Notes; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if you are a broker-dealer that will receive Exchange Notes for your own account in exchange for Original Notes
that were acquired as a result of market-making or other trading activities and that you will deliver a prospectus meeting the requirements of the Securities Act (or, to the extent permitted by law, make
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="44%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
available a prospectus meeting the requirements of the Securities Act to purchasers) in connection with any resale of such Exchange Notes. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Special Procedures for Beneficial Owner</B> </P></TD>
<TD>If you own a beneficial interest in Original Notes that are registered in the name of a broker, dealer, commercial bank, trust company or other nominee and you wish to tender the Original Notes in the exchange offer, please contact the
registered holder as soon as possible and instruct the registered holder to tender on your behalf and to comply with our instructions described in this prospectus. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Resales </B></P></TD>
<TD>Except as indicated in this prospectus, we believe that the Exchange Notes will be freely transferable by holders other than our affiliates after the exchange offer without further registration under the Securities Act if: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are acquiring the Exchange Notes in the ordinary course of your business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are not participating, do not intend to participate and have no arrangement or understanding with any person
to participate in the distribution of the Exchange Notes; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are not an affiliate of UHS or any guarantor. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Our belief is based on existing interpretations of the Securities Act by the SEC staff set forth in several <FONT STYLE="white-space:nowrap">no-action</FONT> letters to third parties that are not related to us. We do
not intend to seek our own <FONT STYLE="white-space:nowrap">no-action</FONT> letter, and there is no assurance that the SEC staff would make a similar determination with respect to the Exchange Notes. If this interpretation is inapplicable, and you
transfer any Exchange Notes without delivering a prospectus meeting the requirements of the Securities Act or without an exemption from such requirements, you may incur liability under the Securities Act. We do not assume, or indemnify holders
against, such liability. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each broker-dealer that is issued Exchange Notes for its own account in exchange for Original Notes that were acquired by the broker-dealer as a result of market-making or other trading activities must acknowledge that
it will deliver a prospectus meeting the requirements of the Securities Act (or, to the extent permitted by law, make available a prospectus meeting the requirements of the Securities Act) to purchasers in connection with any resale of the Exchange
Notes. See &#147;Plan of Distribution.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>United States Federal Income Tax Considerations</B> </P></TD>
<TD>The exchange of Exchange Notes for Original Notes in the exchange offer will not be a taxable exchange for United States federal income tax purposes. Please see &#147;Material U.S. Federal Income Tax Considerations.&#148; </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Use of Proceeds </B></P></TD>
<TD>We will not receive any proceeds from the issuance of the Exchange Notes pursuant to the exchange offer. We will pay certain expenses incident to the exchange offer. See &#147;The Exchange Offer&#151;Transfer Taxes.&#148; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P></TD>
<TD>If we fail to complete the exchange offer as required by the registration rights agreements, we may be obligated to pay additional interest to holders of the Original Notes. Please see &#147;The Exchange Offer&#151;Additional Interest&#148; for
more information regarding your rights as a holder of the Original Notes. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exchange Agent </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have appointed U.S. Bank Trust Company, National Association as exchange agent for the exchange offer. Please direct questions and requests
for assistance and requests for additional copies of this prospectus or of the letter of transmittal to the exchange agent. As described in more detail under the caption &#147;The Exchange Offer&#151;Procedures for Tendering,&#148; if you are not
tendering under DTC&#146;s automated tender offer program, you should send the letter of transmittal, any notice of guaranteed delivery and any other required documents to the exchange agent as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>U.S. Bank Trust Company, National Association </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>For Information or to Confirm by Telephone: </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(800) <FONT STYLE="white-space:nowrap">934-6802</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>By Mail:</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">U.S. Bank National Association</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Global Corporate Trust</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 Fillmore
Ave E</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Mail Station <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">EP-MN-WS2N</FONT></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">St. Paul, MN 55107</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:
Specialized Finance Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>If by Hand or Overnight Mail:</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">U.S. Bank National Association</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Global Corporate Trust</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 Fillmore
Ave E</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">St. Paul, MN 55107</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Specialized Finance Group</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Exchange Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The form and terms of the Exchange Notes to be issued in the exchange offer are substantially identical to the form and terms of the Original
Notes, except that the Exchange Notes will be registered under the Securities Act and, therefore, will not bear legends restricting their transfer, will not contain terms providing for additional interest if we fail to perform our registration
obligations with respect to the Original Notes and, with limited exceptions, will not be entitled to registration rights. The following summarizes the material terms of the Exchange Notes, which will evidence the same debt as the Original Notes, and
both the Original Notes and the Exchange Notes are governed by the same indentures. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Issuer </B></P></TD>
<TD>Universal Health Services, Inc. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Securities </B></P></TD>
<TD>Up to $700,000,000 in aggregate principal amount of 1.650% Senior Secured Notes due 2026. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Up to $800,000,000 in aggregate principal amount of 2.650% Senior Secured Notes due 2030. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Up to $500,000,000 in aggregate principal amount of 2.650% Senior Secured Notes due 2032. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Maturity </B></P></TD>
<TD>The 2026 Exchange Notes will mature on September&nbsp;1, 2026, the 2030 Exchange Notes will mature on October&nbsp;15, 2030 and the 2032 Exchange Notes will mature on January&nbsp;15, 2032. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Interest Payment Dates </B></P></TD>
<TD>Each series of Exchange Notes will have the same interest payment dates as the corresponding series of Original Notes for which they are being offered in exchange. With respect to each series of Exchange Notes, interest will accrue from the date
of original issuance or, if interest has already been paid on the corresponding Original Notes exchanged therefor, the date it was most recently paid on such Original Notes. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Interest on the 2026 Exchange Notes will be payable on March&nbsp;1 and September&nbsp;1 of each year. Interest on the 2030 Exchange Notes will be payable on April&nbsp;15 and October&nbsp;15 of each year. Interest on
the 2032 Exchange Notes will be payable on January&nbsp;15 and July&nbsp;15 of each year. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Optional Redemption </B></P></TD>
<TD>We may redeem some or all of the 2026 Exchange Notes at any time prior to August&nbsp;1, 2026, some or all of the 2030 Exchange Notes at any time prior to July&nbsp;15, 2030, and some or all of the 2032 Exchange Notes at any time prior to
October&nbsp;15, 2031, in each case at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest and additional interest (as described under &#147;The Exchange Offer&#151;Additional Interest&#148;), plus a &#147;make
whole&#148; premium. Each of the 2026 Exchange Notes, 2030 Exchange Notes and 2032 Exchange Notes may be redeemed on or after the applicable date specified in the preceding sentence at a redemption price equal to 100% of the principal amount of such
Notes of such series plus accrued and unpaid interest and additional interest, if any, to such redemption date. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Ranking </B></P></TD>
<TD>The Exchange Notes and the related guarantees will be our and the subsidiary guarantors&#146; senior secured obligations and will: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="39%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rank senior in right of payment to any of our and the subsidiary guarantors&#146; future subordinated
indebtedness; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="39%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rank equally in right of payment with all of our and the subsidiary guarantors&#146; existing and future senior
indebtedness; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="39%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rank equally with our obligations under our senior secured credit facility to the extent of the value of the
collateral; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="39%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rank effectively senior to our and the subsidiary guarantors&#146; existing and future unsecured debt to the
extent of the value of the assets securing the Notes and the note guarantees; </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="39%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">effectively rank equal to all future debt that shares in the first-priority liens that secure the Notes; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="39%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be structurally subordinated to obligations of our <FONT STYLE="white-space:nowrap">non-guarantor</FONT>
subsidiaries. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See &#147;Risk Factors&#151;Risks Related to the Notes&#151;The Notes will be structurally subordinated to all obligations of our existing and future subsidiaries that are not and do not become guarantors of the
Notes.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Note Guarantees </B></P></TD>
<TD>The Exchange Notes will be guaranteed on a senior secured basis by all of our existing and future direct and indirect subsidiaries that guarantee our senior secured credit facility or our other first lien obligations or any junior lien
obligations (the &#147;Guarantees&#148;). Under certain circumstances, the subsidiary guarantors may be released from their Guarantees without the consent of the holders of the Exchange Notes, including if the Exchange Notes then have investment
grade ratings, no default has occurred and is continuing, the guarantees of other first lien and any junior lien obligations have been released and liens on the collateral securing all first lien obligations and any junior lien obligations have been
released. Any Guarantee will also be released if that subsidiary guarantor&#146;s guarantees of the senior credit facility, other first lien obligations and any junior lien obligations are released. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Collateral </B></P></TD>
<TD>The Exchange Notes and the Guarantees will be secured by first-priority liens, subject to permitted liens, on certain of our assets and certain assets of those subsidiary guarantors that have pledged those assets to secure certain of our other
indebtedness or indebtedness of those subsidiary guarantors (the &#147;secured guarantors&#148;) now owned or acquired in the future by us and our secured guarantors (other than our real property, accounts receivable sold pursuant to our accounts
receivable securitization program and certain other excluded assets). Our obligations with respect to the Exchange Notes, the obligations of the subsidiary guarantors under the Guarantees and the performance of all our and our subsidiary
guarantors&#146; other obligations under the indentures governing the Exchange Notes will be secured equally and ratably with our and our secured guarantors&#146; obligations under our senior secured credit facility by a perfected first-priority
security interest, subject to permitted liens, in the collateral owned by us and our secured guarantors, whether now owned or hereafter acquired. However, the liens on the collateral securing the Exchange Notes and the Guarantees of the secured
guarantors will be released if (i)(x) the Exchange Notes then have investment grade ratings, (y)&nbsp;no default has occurred and is continuing and (z)&nbsp;the liens on the collateral securing all first lien obligations (including the senior
secured credit facility) and any junior lien obligations have been released or (ii)&nbsp;the collateral under the senior secured credit facility, any other first lien obligations and any junior lien obligations has been released or no longer
required to be pledged. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Exchange Notes and the Guarantees will not be secured by the assets of <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries. For a more detailed discussion, see &#147;Description of the
Notes&#151;Security General.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">No appraisal of the value of the collateral has been made in connection with this offering, and the value of the collateral in the event of liquidation may be materially different from the book value. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Some of our assets are excluded from the collateral, as described in &#147;Description of the Notes&#151;Certain Limitations on the Collateral.&#148; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Change of Control </B></P></TD>
<TD>If, upon the occurrence of certain kinds of changes of control, the Exchange Notes will not have investment grade ratings, holders of the Notes of each series will have the right to cause us to repurchase the Notes of such series at 101% of the
principal amount thereof, plus accrued and unpaid interest and additional interest, if any, to, but excluding, the repurchase date. See &#147;Description of the Notes&#151;Repurchase at the Option of Holders&#151;Change of Control.&#148;
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Certain Covenants </B></P></TD>
<TD>The indentures governing the Exchange Notes will contain covenants that, among other things, limit our ability and the ability of our subsidiaries to: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consolidate, merge, sell or otherwise dispose of all or substantially all of its assets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">create mortgages on certain of our principal properties to secure debt; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="41%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engage in certain sale and lease-back transactions. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P></TD>
<TD>The Issuer does not intend to apply for the Exchange Notes to be listed on any securities exchange or to arrange for the Exchange Notes to be quoted on any quotation system. </TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Denominations </B></P></TD>
<TD>The Exchange Notes will be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Absence of Public Market for the Notes</B> </P></TD>
<TD>A liquid market for the Exchange Notes may not be available if you wish to sell your Exchange Notes. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">There may be cease to be a market for the Original Notes and the Exchange Notes. If an active public trading market for the Original Notes and the Exchange Notes ceases to exist, the market price and liquidity of the
Exchange Notes may be adversely affected. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Trustee </B></P></TD>
<TD>The Trustee for the Exchange Notes will be U.S. Bank Trust Company, National Association. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P></TD>
<TD>The Exchange Notes, the indentures governing the Exchange Notes and the Guarantees will be governed by the laws of the State of New&nbsp;York. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>Risk Factors </B></P></TD>
<TD>You should consider carefully all of the information set forth in this prospectus and the documents incorporated by reference herein and, in particular, you should carefully evaluate the specific factors under &#147;Risk Factors&#148; beginning
on page 11 of this prospectus and those risk factors incorporated by reference herein. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Prior to making a decision to participate in the exchange offer, you should carefully consider the risks described below, as well as the
risks and other information contained or incorporated by reference in this prospectus, including the &#147;Risk Factors&#148; in Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021, filed
on February&nbsp;24, 2022. If any of the risks described in this prospectus, or the risks described in any documents incorporated by reference in this prospectus, actually occur, our business, prospects, financial condition or operating results
could be harmed. In such case, the trading price of the Notes could decline, and you may lose all or part of your investment. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to the
Exchange Offer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Your Original Notes will not be accepted for exchange if you fail to follow the exchange offer procedures. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will issue Exchange Notes pursuant to the exchange offer only after a timely receipt of your Original Notes, a properly completed and duly
executed letter of transmittal and all other required documents. Therefore, if you want to tender your Original Notes, please allow sufficient time to ensure timely delivery. If we do not receive your Original Notes, letter of transmittal and other
required documents by the expiration time of the exchange offer, we will not accept your Original Notes for exchange. We are generally under no duty to give notification of defects or irregularities with respect to the tenders of Original Notes for
exchange. If there are defects or irregularities with respect to your tender of Original Notes, we may not accept your Original Notes for exchange. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If you do not exchange your Original Notes, your Original Notes will continue to be subject to the existing transfer restrictions and you may be unable
to sell your outstanding Original Notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We did not register the Original Notes and do not intend to do so following the exchange
offer. Original Notes that are not tendered will therefore continue to be subject to the existing transfer restrictions and may be transferred only in limited circumstances under applicable securities laws. Because we anticipate that most holders of
the Original Notes will elect to exchange their Original Notes for Exchange Notes due to the absence of restrictions on the resale of Exchange Notes under the Securities Act, we anticipate that the liquidity of the market for any Original Notes
remaining after the completion of this exchange offer may be substantially limited. If you do not exchange your Original Notes, you will lose your right, except in limited circumstances, to have your Original Notes registered under the federal
securities laws. As a result, if you hold Original Notes after the exchange offer, you may be unable to sell your Original Notes and the value of the Original Notes may decline. We have no obligation, except in limited circumstances, and do not
currently intend, to file an additional registration statement to cover the resale of Original Notes that did not tender in the exchange offer or to <FONT STYLE="white-space:nowrap">re-offer</FONT> to exchange the Exchange Notes for Original Notes
following the expiration of the exchange offer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Some persons who participate in the exchange offer must deliver a prospectus in connection with
resales of the Exchange Notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on interpretations of the staff of the SEC contained in Exxon Capital Holdings Corp., SEC <FONT
STYLE="white-space:nowrap">no-action</FONT> letter (April 13, 1988), Morgan Stanley&nbsp;&amp; Co. Inc., SEC <FONT STYLE="white-space:nowrap">no-action</FONT> letter (June 5, 1991) and Shearman&nbsp;&amp; Sterling, SEC
<FONT STYLE="white-space:nowrap">no-action</FONT> letter (July 2, 1993), we believe that you may offer for resale, resell or otherwise transfer the Exchange Notes without compliance with the registration and prospectus delivery requirements of the
Securities Act. However, in some instances described in this prospectus under &#147;Plan of Distribution,&#148; you will remain obligated to comply with the registration and prospectus delivery requirements of the Securities Act to transfer your
Exchange Notes. In these cases, if you transfer any Exchange Note without delivering a prospectus meeting the requirements of the Securities Act or without an exemption from registration of your Exchange Notes under the Securities Act, you may incur
liability under the Securities Act. We do not and will not assume, or indemnify you against, this liability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to the Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to generate sufficient cash to service all of our indebtedness, including the Notes, and may be forced to take other actions to
satisfy our obligations under our indebtedness, which may not be successful. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to make scheduled payments on or
refinance our debt obligations, including the Notes, depends on our financial condition and operating performance, which are subject to prevailing economic and competitive conditions and to certain financial, business, legislative, regulatory and
other factors beyond our control. We may be unable to maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on our indebtedness, including the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our cash flows and capital resources are insufficient to fund our debt service obligations, we could face substantial liquidity problems
and could be forced to reduce or delay investments and capital expenditures or to dispose of material assets or operations, seek additional debt or equity capital or restructure or refinance our indebtedness, including the Notes. We may not be able
to effect any such alternative measures, if necessary, on commercially reasonable terms or at all and, even if successful, those alternative actions may not allow us to meet our scheduled debt service obligations. The credit agreement that governs
our senior secured credit facility, as described in &#147;Description of Other Indebtedness&#148; (the &#147;credit agreement&#148;) restricts our ability to dispose of assets and use the proceeds from those dispositions and may also restrict our
ability to raise debt or equity capital to be used to repay other indebtedness when it becomes due. We may not be able to consummate those dispositions or to obtain proceeds in an amount sufficient to meet any debt service obligations then due. See
&#147;Description of Other Indebtedness.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we conduct our operations through our subsidiaries, certain of which are not,
or in the future may not be, guarantors of the Notes or our other indebtedness. Accordingly, repayment of our indebtedness, including the Notes, is dependent on the generation of cash flow by our subsidiaries and their ability to make such cash
available to us, by dividend, debt repayment or otherwise. Unless they are guarantors of the Notes or our other indebtedness, our subsidiaries do not have any obligation to pay amounts due on the Notes or our other indebtedness or to make funds
available for that purpose. Our subsidiaries may not be able to, or may not be permitted to, make distributions to enable us to make payments in respect of our indebtedness, including the Notes. Each subsidiary is a distinct legal entity, and, under
certain circumstances, legal and contractual restrictions may limit our ability to obtain cash from our subsidiaries. While the agreements governing certain of our other existing indebtedness limit the ability of our subsidiaries to incur consensual
restrictions on their ability to pay dividends or make other intercompany payments to us, these limitations are subject to qualifications and exceptions. In the event that we do not receive distributions from our subsidiaries, we may be unable to
make required principal and interest payments on our indebtedness, including the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our inability to generate sufficient cash flows
to satisfy our debt obligations, or to refinance our indebtedness on commercially reasonable terms or at all, would materially and adversely affect our financial position and results of operations and our ability to satisfy our obligations under the
Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we cannot make scheduled payments on our debt, we will be in default and holders of the Notes could declare all outstanding
principal and interest to be due and payable, the lenders under our credit agreement could terminate their commitments to loan money, our secured lenders could foreclose against the assets securing their borrowings and we could be forced into
bankruptcy or liquidation. All of these events could result in your losing your investment in the Notes offered hereby. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Despite our current level
of indebtedness, we and our subsidiaries may still be able to incur substantially more debt. This could further exacerbate the risks to our financial condition described above. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and our subsidiaries may be able to incur significant additional indebtedness in the future. Although our credit agreement contains
restrictions on the incurrence of additional indebtedness and our credit agreement and the Notes contain restrictions on our ability to incur liens to secure additional indebtedness, these restrictions are
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 12 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subject to a number of qualifications and exceptions, and the additional indebtedness incurred in compliance with these restrictions could be substantial. These restrictions also will not prevent
us from incurring obligations that do not constitute indebtedness. In addition, if we incur any additional indebtedness secured by liens that rank equally with the Notes, subject to collateral arrangements, the holders of that debt will be entitled
to share ratably with you in any proceeds distributed in connection with any insolvency, liquidation, reorganization, dissolution or other winding up of our company. This may have the effect of reducing the amount of proceeds paid to you. These
restrictions also will not prevent us from incurring obligations that do not constitute indebtedness. In addition, as of September&nbsp;30, 2022, our credit agreement provided for unused commitments of $1.007&nbsp;billion. In addition, the credit
agreement allows us to request additional amounts such that the pro forma consolidated secured leverage ratio is not more than 3.75 to 1.00, and amounts borrowed under any such commitments would be secured on a first-priority lien basis by the same
collateral securing our credit agreement and the Notes. We also had $20&nbsp;million of capacity as of September&nbsp;30, 2022 pursuant to the terms of our accounts receivable securitization program. If new debt is added to our current anticipated
debt levels, the related risks that we and the subsidiary guarantors now face could intensify. See &#147;Description of Other Indebtedness&#148; and &#147;Description of the Notes.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The terms of our credit agreement and the indentures governing the Notes restrict our current and future operations, particularly our ability to respond
to changes or to take certain actions. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our credit agreement contains a number of restrictive covenants that impose significant
operating and financial restrictions on us and may limit our ability to engage in acts that may be in our long-term best interest, including restrictions on our ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur additional indebtedness and guarantee indebtedness; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pay dividends or make other distributions or repurchase or redeem capital stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prepay, redeem or repurchase certain debt; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make loans and investments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur liens; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into transactions with affiliates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">alter the businesses we conduct; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into agreements restricting our subsidiaries&#146; ability to pay dividends; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consolidate, merge or sell all or substantially all of our assets. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the restrictive covenants in the credit agreement require us to maintain specified financial ratios and satisfy other financial
condition tests. Our ability to meet those financial ratios and tests may be affected by events beyond our control, and we may be unable to meet them. You should read the discussions under the headings &#147;Description of Other Indebtedness&#148;
and &#147;Description of the Notes&#151;Certain Covenants&#148; for further information about these covenants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A breach of the covenants
under our credit agreement or under the indentures governing the Notes could result in an event of default under the applicable indebtedness. Such a default may allow the creditors to accelerate the related debt and may result in the acceleration of
any other debt to which a cross-acceleration or cross-default provision applies. In addition, an event of default under our credit agreement would permit the lenders to terminate all commitments to extend further credit under the credit agreement.
In the event our lenders or noteholders accelerate the repayment of our borrowings, we and our subsidiaries may not have sufficient assets to repay that indebtedness. As a result of these restrictions, we may be: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limited in how we conduct our business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unable to raise additional debt or equity financing to operate during general economic or business downturns; or
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 13 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unable to compete effectively or to take advantage of new business opportunities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These restrictions may affect our ability to grow in accordance with our strategy. In addition, our financial results, our substantial
indebtedness and our credit ratings could adversely affect the availability and terms of our financing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our variable rate indebtedness subjects us
to interest rate risk, which could cause our debt service obligations to increase significantly. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Borrowings under our credit
agreement are at variable rates of interest and expose us to interest rate risk. If interest rates increase, our debt service obligations on the variable rate indebtedness will increase even though the amount borrowed remained the same, and our net
income and cash flows, including cash available for servicing our indebtedness, will correspondingly decrease. Assuming all revolving loans are fully drawn, each quarter point change in interest rates would result in a $3&nbsp;million change in
annual interest expense on our indebtedness under our revolving credit facility. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even though the holders of the Notes will benefit from a
first-priority lien on the collateral that secures our credit agreement, the representative of the lenders under the credit agreement will initially control actions with respect to that collateral. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the security agreement that relates to the collateral in which the lenders under the credit agreement and the holders of the Notes, any
actions that may be taken with respect to such collateral (including the ability to commence any judicial or <FONT STYLE="white-space:nowrap">non-judicial</FONT> foreclosure proceedings with respect to, seek to have a trustee, receiver, liquidator
or similar official appointed for or over, attempt any action to take possession of, exercise any right, remedy or power with respect to, or otherwise take any action to enforce its interests in or realize upon, or take any other action available to
it in respect of, such collateral) will be at the direction of the authorized representative of the lenders under the credit agreement until the earlier of (1)&nbsp;our obligations under the credit agreement are discharged (which discharge does not
include certain refinancings or replacements of the credit agreement) and (2) 90 days after the occurrence of an event of default under the indentures governing the Notes or other applicable agreements for a series of first priority lien
obligations. Under the circumstances described in clause (2)&nbsp;of the preceding sentence, the authorized representative of the holders of the indebtedness that represents the largest outstanding principal amount of indebtedness secured by a
first-priority lien on the collateral (other than the credit agreement) and has complied with the applicable notice provisions gains the right to take actions with respect to the collateral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if the authorized representative of the Notes gains the right to direct the collateral agent in the circumstances described in clause
(2)&nbsp;above, the authorized representative must stop doing so (and those powers with respect to the collateral would revert to the authorized representative of the lenders under the credit agreement) if the lenders&#146; authorized representative
has commenced and is diligently pursuing any enforcement action with respect to the collateral or the grantor of the security interest in that collateral (whether our company or the applicable guarantor) is then a debtor under or with respect to (or
otherwise subject to) an insolvency or liquidation proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the credit agreement and the indentures governing the Notes
permit us to issue additional series of Notes that also have a first-priority lien on the same collateral. As explained above, any time that the representative of the lenders under the credit agreement does not have the right to take actions with
respect to the collateral, that right passes to the authorized representative of the holders of the next largest outstanding principal amount of indebtedness secured by a first-priority lien on the collateral. If we issue additional first lien debt
in the future in a greater principal amount than the aggregate principal amount of the Notes, then the authorized representative for those additional Notes would be earlier in line to exercise rights than the applicable authorized representative for
the Notes offered hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 14 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Notes will be structurally subordinated to all obligations of our existing and future subsidiaries
that are not and do not become guarantors of the Notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will be guaranteed by each of our existing and subsequently
acquired or organized restricted subsidiaries that guarantee the credit agreement, any other first lien obligations or any junior lien obligations or, if no such indebtedness is outstanding, by any such restricted subsidiaries that guarantee certain
of our indebtedness or indebtedness of another guarantor in excess of $50&nbsp;million. Our subsidiaries that do not guarantee the Notes, including all of our <FONT STYLE="white-space:nowrap">non-domestic</FONT> subsidiaries, will have no
obligation, contingent or otherwise, to pay amounts due under the Notes or to make any funds available to pay those amounts, whether by dividend, distribution, loan or other payment. The Notes and Guarantees will be structurally subordinated to all
indebtedness and other obligations of any <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiary such that in the event of insolvency, liquidation, reorganization, dissolution or other winding up of any subsidiary that is not a guarantor,
all of that subsidiary&#146;s creditors (including trade creditors and preferred stockholders, if any) would be entitled to payment in full out of that subsidiary&#146;s assets before we would be entitled to any payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the credit agreement, subject to some limitations, and the indentures governing the Notes permit these subsidiaries to incur
additional indebtedness and will not contain any limitation on the amount of other liabilities, such as trade payables, that may be incurred by these subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the year ended December&nbsp;31, 2021, our subsidiaries in the United Kingdom, which are
<FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries, represented approximately 5% of our net revenues, and together with our remaining <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries represented less than 19% of our
net revenues. As of September&nbsp;30, 2022, subsidiaries in the United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries, represented approximately 3% of our total assets excluding intercompany assets, and
together with our remaining <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries represented less than 20% of our total assets excluding intercompany assets. As of September&nbsp;30, 2022, our
<FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries had less than $23&nbsp;million of long-term debt. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Guarantees may be
automatically released upon the occurrence of certain events. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our subsidiaries that provide, or will provide, Guarantees will be
automatically released upon the occurrence of certain events, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Notes have an investment grade rating from both Moody&#146;s and S&amp;P, no default has occurred and is
continuing, and the liens on the collateral securing all first lien obligations (including the credit agreement) and any junior lien obligations have been released; provided that the guarantees are also released under all other first lien
obligations and junior lien obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation of that subsidiary guarantor as an unrestricted subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the release or discharge of the Guarantee by such subsidiary guarantor, any other first lien obligations and any
junior lien obligations (and if the subsidiary guarantor has become a guarantor under any &#147;additional indebtedness&#148; (as defined in &#147;Description of the Notes&#148;), the release or discharge of the guarantee by such subsidiary
guarantor of such additional indebtedness), including any other guarantee that resulted in the creation of such guarantee, except (i)&nbsp;a discharge or release by or as a result of payment under such guarantee or (ii)&nbsp;by reason on the
termination of our senior credit facility; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sale or other disposition, including the sale of substantially all the assets, of that subsidiary guarantor.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Guarantee is released, no holder of the Notes will have a claim as a creditor against that subsidiary, and the
indebtedness and other liabilities, including trade payables and preferred stock, if any, whether secured or unsecured, of that subsidiary will be effectively senior to the claim of any holders of the Notes. See &#147;Description of the
Notes&#151;Guarantees.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 15 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There may not be sufficient collateral to pay all or any of the Notes. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No appraisal of the value of the collateral has been made in connection with the exchange offer, and the value of the collateral in the event
of liquidation will depend on market and economic conditions, the availability of buyers and other factors. Consequently, liquidating the collateral securing the Notes may not produce proceeds in an amount sufficient to pay any amounts due on the
Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair market value of the collateral securing the Notes is subject to fluctuations based on factors that include, among others,
the markets for the collateral, the ability to sell the collateral in an orderly sale, general economic conditions, the availability of buyers and similar factors. The amount to be received upon a sale of the collateral would be dependent on
numerous factors, including but not limited to the actual fair market value of the collateral at such time and the timing and the manner of the sale. By its nature, portions of the collateral may be illiquid and may have no readily ascertainable
market value. In the event of a foreclosure, liquidation, bankruptcy or similar proceeding, the proceeds from any sale or liquidation of this collateral may not be sufficient to pay our obligations under the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The collateral securing the Notes also secures obligations under the credit agreement and may, subject to the terms of the credit agreement
and the indentures governing the Notes, be pledged to secure other first lien and junior lien obligations. The amount of any such additional indebtedness secured by the collateral may be substantial. In the event of a bankruptcy of us or any of the
secured guarantors, holders of the Notes may be deemed to have an unsecured claim to the extent that our obligations in respect of the Notes and other indebtedness secured by a first priority lien exceed the fair market value of the collateral
securing the Notes. In any bankruptcy proceeding with respect to us or any of the secured guarantors, the bankruptcy trustee, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">debtor-in-possession</FONT></FONT> or competing
creditors may assert that the fair market value of the collateral with respect to the Notes and other indebtedness secured by a first priority lien on the date of the bankruptcy filing was less than the then-current principal amount of the Notes and
other indebtedness secured by a first priority lien. Upon a finding by the bankruptcy court that the Notes are undercollateralized, the claims in the bankruptcy proceeding with respect to the Notes would be bifurcated between a secured claim and an
unsecured claim, and the unsecured claim would not be entitled to the benefits of security in the collateral. In such event, the secured claims of the holders of the Notes and other indebtedness secured by a first priority lien would be limited to
the value of the collateral. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain assets will be excluded from the collateral. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain assets are excluded from the collateral securing the Notes, as described under &#147;&#151;Certain Limitations on the Collateral&#148;
in the &#147;Description of the Notes,&#148; including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any interest in <FONT STYLE="white-space:nowrap">fee-owned</FONT> real property of UHS and the subsidiary
guarantors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any voting stock of any foreign subsidiaries in excess of 65% of the voting stock of those foreign subsidiaries,
and any assets of foreign subsidiaries, unless any such foreign subsidiary is required to become a guarantor under the indentures governing the Notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any deposit accounts (as defined in the New York Uniform Commercial Code); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receivables sold pursuant to our accounts receivable securitization program or other receivables financing
facilities up to a maximum purchase price or loan of the greater of $600.0&nbsp;million and 50% of the sum of (x)&nbsp;our accounts receivable, as set forth on our most recent balance sheet from time to time plus (y)&nbsp;the allowance for doubtful
accounts with respect to such accounts receivable as set forth in the footnotes to our financial statements; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">items as to which a security interest cannot be granted without violating contract rights or applicable law and
certain licenses in which a security interest cannot be created without breach of such license or applicable law. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 16 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the future, we may elect, in our discretion, to provide unsecured guarantees
of the Notes from certain other restricted subsidiaries that are not secured guarantors. If were elect to add unsecured guarantees, any assets held by those unsecured guarantors would not be included in the collateral securing the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an event of default occurs and the Notes are accelerated, the Notes will rank equally with the holders of other unsubordinated and
unsecured indebtedness with respect to those excluded assets. To the extent the claims of note holders exceed the value of the assets securing the Notes and other liabilities, claims related to the excluded assets will rank equally with the claims
of the holders of any other unsecured indebtedness and other indebtedness secured by a first priority lien. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Your rights in the collateral may be
adversely affected by the failure to perfect security interests in certain collateral acquired in the future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trustee and the
collateral agent have no obligation to monitor, and we may fail to inform the trustee or the collateral agent of, the future acquisition of property and rights that constitute collateral, and necessary action may not be taken to properly perfect the
security interest in that after-acquired collateral. The collateral agent for the Notes also has no obligation to monitor the perfection of any security interest in favor of the Notes against third parties. This failure may result in the loss of the
security interest in any additional property or rights that constitute collateral or the priority of the security interest in favor of the Notes against third parties. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There are circumstances other than repayment or discharge of the Notes under which the collateral securing the Notes and Guarantees will be released
automatically, without your consent or the consent of the trustee. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under various circumstances, collateral securing the Notes will
be released automatically, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a sale, transfer or other disposal of the collateral in a transaction not prohibited under the indentures
governing the Notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to collateral held by one or more secured guarantors, upon the release of those secured guarantors
from their Guarantees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent that such collateral is released or no longer required to be pledged pursuant to the terms of the
credit agreement, any other first lien obligations and any junior lien obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with the consent of the holders of at least 75% of the aggregate principal amount of the Notes then outstanding
and affected thereby; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">following any date that the Notes have an investment grade rating from both Moody&#146;s and S&amp;P, no default
has occurred and is continuing, and the liens on the collateral securing all first lien obligations (including the credit agreement) and any junior lien obligations have been released. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we were to receive investment grade corporate ratings from both rating agencies and the other conditions to release of the collateral under
the credit agreement are met, or if we were to amend the credit agreement in the future to otherwise permit the release of the collateral, the collateral securing the Notes and the Guarantees will be released. In that case, you would have an
unsecured claim under the Notes. We cannot assure you whether this will occur, nor can we predict whether any subsequent downgrade by one or both of the rating agencies may occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the other conditions described in the last bullet point above are met, the collateral will be automatically released, and we and the
secured guarantors will not be required to pledge the collateral for the benefit of the noteholders if the rating of the Notes by either rating agency is later downgraded below investment grade, even though we would be required to pledge the
collateral for the benefit of the lenders under the credit agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If such a circumstance were to occur, the Notes would be
subordinated to the borrowings under the credit agreement, and any other first lien obligations and junior lien obligations under which the lien on the collateral is not released, to the extent of the value of that collateral. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 17 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indentures governing the Notes also permit us to designate one or more of our restricted
subsidiaries that is a subsidiary guarantor of the Notes as an unrestricted subsidiary. If we designate a subsidiary guarantor as an unrestricted subsidiary for purposes of the indenture, all of the liens on any collateral owned by such subsidiary
or any of its subsidiaries and any guarantees of the Notes by such subsidiary or any of its subsidiaries will be released under the indentures governing the Notes but not necessarily under our credit agreement. Designation of an unrestricted
subsidiary will reduce the aggregate value of the collateral securing the Notes to the extent that liens on the assets of the unrestricted subsidiary and its subsidiaries are released. In addition, the creditors of the unrestricted subsidiary and
its subsidiaries will have a senior claim on the assets of such unrestricted subsidiary and its subsidiaries. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will in most cases have control
over the collateral. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The security documents generally allow us and the secured guarantors to remain in possession of, to retain
exclusive control over, to freely operate, and to collect, invest and dispose of any income from, the collateral. These rights may adversely affect the value of the collateral at any time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>In the event of our bankruptcy, the ability of the holders of the Notes to realize upon the collateral will be subject to certain bankruptcy law
limitations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ability of holders of the Notes to realize upon the collateral will be subject to certain bankruptcy law
limitations in the event of our bankruptcy. Under applicable federal bankruptcy laws, upon the commencement of a bankruptcy case, an automatic stay goes into effect that, among other things, stays: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commencement or continuation of any action or proceeding against the debtor that was or could have been
commenced before the commencement of the bankruptcy case to recover a claim against the debtor that arose before the commencement of the bankruptcy case; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act to obtain possession of, or control over, property of the bankruptcy estate or the debtor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act to create, perfect or enforce any lien against property of the bankruptcy estate; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act to collect or recover a claim against the debtor that arose before the commencement of the bankruptcy
case. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Thus, upon the commencement of a bankruptcy case, secured creditors are prohibited from repossessing their
collateral from a debtor, or from disposing of that collateral repossessed from such a debtor, without bankruptcy court approval. Moreover, applicable federal bankruptcy laws generally permit the debtor to continue to use, sell or lease collateral
in the ordinary course of its business even though the debtor is in default under the applicable debt instruments. Upon request from a secured creditor, the bankruptcy court will prohibit or condition the use, sale or lease of collateral as is
necessary to provide &#147;adequate protection&#148; of the secured creditor&#146;s interest in the collateral. The meaning of the term &#147;adequate protection&#148; may vary according to the circumstances but is intended generally to protect the
value of the secured creditor&#146;s interest in the collateral at the commencement of the bankruptcy case and may include cash payments or the granting of additional security, if and at such times as the court in its discretion determines any
diminution in the value of the collateral occurs as a result of the debtor&#146;s use, sale or lease of the collateral during the pendency of the bankruptcy case. In view of the lack of a precise definition of the term &#147;adequate
protection&#148; and the broad discretionary powers of a U.S. bankruptcy court, we cannot predict whether payments under the Notes would be made following commencement of and during a bankruptcy case, whether or when the trustee or collateral agent
under the indenture could foreclose upon or sell the collateral or whether or to what extent holders of Notes would be compensated for any delay in payment or loss of value as a result of the use, sale or lease of their collateral through the
requirement of &#147;adequate protection.&#148; A creditor may seek relief from the stay from the bankruptcy court to take any of the acts described above that would otherwise be prohibited by the automatic stay. The U.S. bankruptcy court has broad
discretionary powers in determining whether to grant a creditor relief from the stay. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 18 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Any future pledge of collateral in favor of the holders of Notes might be voidable in bankruptcy.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any future pledge of collateral in favor of the holders of Notes, including pursuant to the security documents delivered after the
date of the indentures governing the Notes, might be voidable by the pledgor (as debtor in possession) or by its trustee in bankruptcy if certain events or circumstances exist or occur, including, under the bankruptcy code, if the pledgor is
insolvent at the time of the pledge, the pledge permits the holders of Notes to receive a greater recovery than if the pledge had not been given and a bankruptcy proceeding in respect of the pledgor is commenced with 90 days following the pledge,
or, in certain circumstances, a longer period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The value of the collateral securing the Notes may not be sufficient to secure post-petition
interest. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a bankruptcy, liquidation, dissolution, reorganization or similar proceeding against us, holders of the
Notes will only be entitled to post-petition interest under the bankruptcy code to the extent that the value of their security interest in the collateral is greater than their <FONT STYLE="white-space:nowrap">pre-bankruptcy</FONT> claim. Holders of
the Notes that have a security interest in the collateral with a value equal to or less than their <FONT STYLE="white-space:nowrap">pre-bankruptcy</FONT> claim will not be entitled to post-petition interest under the bankruptcy code. No appraisal of
the fair market value of the collateral has been prepared in connection with this offering, and the value of the holders&#146; interest in the collateral may not equal or exceed the principal amount of the Notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be required to, but not be able to, repurchase the Notes upon a change of control. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the indentures governing the Notes, if the Notes do not have investment grade ratings from one or both of Moody&#146;s
and S&amp;P, then we will be required to offer to repurchase the Notes if we enter into an agreement to undertake a transaction that would result in a specified kind of change of control, we will be required to offer to repurchase all outstanding
Notes at 101% of their principal amount, plus accrued and unpaid interest to the purchase date. Additionally, under the credit agreement, a change of control (as defined therein) constitutes an event of default that permits the lenders to accelerate
the maturity of borrowings under the respective agreements and terminate their commitments to lend. The source of funds for any purchase of the Notes and repayment of borrowings under our credit agreement would be our available cash or cash
generated from our subsidiaries&#146; operations or other sources, including borrowings, sales of assets or sales of equity. We may not be able to repurchase the Notes upon a change of control because we may not have sufficient financial resources
to purchase all of the debt securities that are tendered upon a change of control and repay our other indebtedness that will become due. If we fail to repurchase the Notes in that circumstance, we will be in default under the indentures governing
the Notes. We may require additional financing from third parties to fund any such purchases, and we may be unable to obtain financing on satisfactory terms or at all. Further, our ability to repurchase the Notes may be limited by law. In order to
avoid the obligations to repurchase the Notes and events of default and potential breaches of the credit agreement, we may have to avoid certain change of control transactions that would otherwise be beneficial to us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, some important corporate events, such as leveraged recapitalizations, may not, under the indentures governing the Notes,
constitute a &#147;change of control&#148; that would require us to repurchase the Notes, even though those corporate events could increase the level of our indebtedness or otherwise adversely affect our capital structure, credit ratings or the
value of the Notes. See &#147;Description of the Notes&#151;Repurchase at the Option of Holders&#151;Change of Control Following a Downgrade from Investment Grade Ratings.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise by the holders of Notes of their right to require us to repurchase the Notes pursuant to a change of control offer could cause a
default under the agreements governing our other indebtedness, including future agreements, even if the change of control itself does not, due to the financial effect of such repurchases on us. In the event a change of control offer is required to
be made at a time when we are prohibited from purchasing Notes, we could attempt to refinance the borrowings that contain such prohibitions. If we do not obtain a consent or repay those borrowings, we will remain prohibited from purchasing Notes. In
that case, our failure to purchase tendered Notes would constitute an event of default under the indentures governing the Notes which could, in turn, constitute a default under our other indebtedness. Further, our ability to pay cash to the holders
of Notes upon a repurchase may be limited by our then existing financial resources. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 19 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Holders of the Notes may not be able to determine when a change of control giving rise to their right
to have the Notes repurchased has occurred following a sale of &#147;substantially all&#148; of our assets, if that covenant is then in effect. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The definition of change of control in the indentures governing the Notes includes a phrase relating to the sale or disposition of &#147;all or
substantially all&#148; of our assets. There is no precise established definition of the phrase &#147;substantially all&#148; under applicable law, and the interpretation of that phrase will likely depend upon particular facts and circumstances.
Accordingly, the ability of a holder of Notes to require us, if the covenant is then applicable, to repurchase its Notes as a result of a sale of less than all our assets to another person may be uncertain. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Federal and state fraudulent transfer laws may permit a court to void the Notes, the Guarantees and/or the grant of collateral, and if that occurs, you
may not receive any payments on the Notes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Federal and state fraudulent transfer and conveyance statutes may apply to the issuance
of the Notes and the incurrence of the Guarantees. Under federal bankruptcy law and comparable provisions of state fraudulent transfer or conveyance laws, which may vary from state to state, the Notes or the Guarantees (or the grant of collateral
securing any such obligations) could be voided as a fraudulent transfer or conveyance if we or any of the subsidiary guarantors, as applicable, (a)&nbsp;issued the Notes or incurred the Guarantees with the intent of hindering, delaying or defrauding
creditors or (b)&nbsp;received less than reasonably equivalent value or fair consideration in return for either issuing the Notes or incurring the Guarantees and, in the case of (b)&nbsp;only, one of the following is also true at the time thereof:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or any of the subsidiary guarantors, as applicable, were insolvent or rendered insolvent by reason of the
issuance of the Notes or the incurrence of the Guarantees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of the Notes or the incurrence of the Guarantees left us or any of the subsidiary guarantors, as
applicable, with an unreasonably small amount of capital or assets to carry on the business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or any of the subsidiary guarantors intended to, or believed that we or such guarantor would, incur debts
beyond our or the subsidiary guarantor&#146;s ability to pay as they mature; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or any of the subsidiary guarantors were a defendant in an action for money damages, or had a judgment for
money damages docketed against us or the subsidiary guarantor if, in either case, the judgment is unsatisfied after final judgment. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a general matter, value is given for a transfer or an obligation if, in exchange for the transfer or obligation, property is transferred or
a valid antecedent debt is secured or satisfied. A court would likely find that a subsidiary guarantor did not receive reasonably equivalent value or fair consideration for its guarantee to the extent the subsidiary guarantor did not obtain a
reasonably equivalent benefit directly or indirectly from the issuance of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot be certain as to the standards a court
would use to determine whether or not we or the subsidiary guarantors were insolvent at the relevant time or, regardless of the standard that a court uses, whether the Notes or the Guarantees would be subordinated to our or any of our
guarantors&#146; other debt. In general, however, a court would deem an entity insolvent if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sum of its debts, including contingent and unliquidated liabilities, was greater than the fair saleable value
of all of its assets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the present fair saleable value of its assets was less than the amount that would be required to pay its probable
liability on its existing debts, including contingent liabilities, as they become absolute and mature; or it could not pay its debts as they became due. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a court were to find that the issuance of the Notes or the incurrence of a Guarantee or the grant of security interest was a fraudulent
transfer or conveyance, the court could void the payment obligations under the Notes or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 20 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that Guarantee, void the grant of collateral, subordinate the Notes or that Guarantee to presently existing and future indebtedness of ours or of the related guarantor or could require the
holders of the Notes to repay any amounts received with respect to that Guarantee. In the event of a finding that a fraudulent transfer or conveyance occurred, you may not receive any repayment on the Notes. Further, the avoidance of the Notes could
result in an event of default with respect to our and our subsidiaries&#146; other debt that could result in acceleration of that debt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Finally, as a court of equity, the bankruptcy court may subordinate the claims in respect of the Notes to other claims against us under the
principle of equitable subordination if the court determines that (1)&nbsp;the holder of Notes engaged in some type of inequitable conduct, (2)&nbsp;the inequitable conduct resulted in injury to our other creditors or conferred an unfair advantage
upon the holders of Notes and (3)&nbsp;equitable subordination is not inconsistent with the provisions of the bankruptcy code. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A lowering or
withdrawal of the ratings assigned to our debt securities by rating agencies may increase our future borrowing costs and reduce our access to capital. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any rating assigned to our debt could be lowered or withdrawn entirely by a rating agency if, in that rating agency&#146;s judgment, future
circumstances relating to the basis of the rating, such as adverse changes, so warrant. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of the Notes. Credit ratings are not recommendations to
purchase, hold or sell the Notes. Additionally, credit ratings may not reflect the potential effect of risks relating to the structure or marketing of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any future lowering of our ratings likely would make it more difficult or more expensive for us to obtain additional debt financing. If any
credit rating initially assigned to the Notes is subsequently lowered or withdrawn for any reason, you may not be able to resell your Notes without a substantial discount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 21 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_4"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any cash proceeds from the issuance of the Exchange Notes. We are making this exchange offer solely to satisfy our
obligations under the registration rights agreements entered into in connection with the offering of the Original Notes. In consideration for issuing the Exchange Notes as contemplated in this prospectus, we will receive in exchange Original Notes
in like principal amount, which will be cancelled, and, as such, issuing the Exchange Notes will not result in any increase in our indebtedness or be financed with new borrowings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 22 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_5"></A>THE EXCHANGE OFFER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Purpose of the Exchange Offer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered
into registration rights agreements (the &#147;registration rights agreements&#148;) with the initial purchasers of the Original Notes, one agreement relating to the 2030 Original Notes and another agreement relating to the 2026 Original Notes and
the 2032 Original Notes. In the registration rights agreements, we and the subsidiary guarantors agreed to, at our cost: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">use our commercially reasonable best efforts to file a registration statement (which we refer to as an exchange
offer registration statement) with the SEC with respect to a registered exchange offer (which we refer to as the &#147;Exchange Offer&#148;) to exchange each series of Original Notes for new Exchange Notes, guaranteed by the subsidiary guarantors
and having terms identical in all material respects to the Original Notes (except that the Exchange Notes will not contain terms with respect to transfer restrictions or additional interest (as defined below)); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">use our commercially best reasonable efforts to cause the registration statement relating to the Exchange Offer
to be declared effective under the Securities Act and to consummate the Exchange Offer not later than 60 days after such effective date. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we agreed to provide that upon the effectiveness of the registration statement relating to the Exchange Offer, we would promptly
commence the Exchange Offer, whereby the Exchange Notes will be offered in exchange for surrender of the Original Notes, and that we will keep the registered Exchange Offer open for not less than 20 business days (or longer if required by applicable
law including in accordance with the requirements of Regulation 14E under the Exchange Act) after the date notice of the Exchange Offer is first mailed, sent or given to the noteholders. For each Original Note surrendered to us for exchange pursuant
to the Exchange Offer, the holder of such Original Note will receive an Exchange Note having a principal amount equal to that of the surrendered Original Note. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Resale of Exchange Notes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on
interpretations by the staff of the SEC, as described in <FONT STYLE="white-space:nowrap">no-action</FONT> letters issued to third parties that are not related to us, including Morgan Stanley&nbsp;&amp; Co., Inc. (available June&nbsp;5, 1991) and
Exxon Capital Holdings Corporation (available May&nbsp;13, 1988), as interpreted in the SEC&#146;s letter to Shearman&nbsp;&amp; Sterling LLP (dated July&nbsp;2, 1993), we believe the Exchange Notes will be freely transferable by holders other than
our affiliates after the Exchange Offer without further registration under the Securities Act if the holder of the Exchange Notes represents to us in the Exchange Offer that it is acquiring the Exchange Notes in the ordinary course of its business,
that it has no arrangement or understanding with any person to participate in the distribution of the Exchange Notes and that it is not our affiliate, as such terms are interpreted by the SEC; provided, however, that broker-dealers
(&#147;Participating Broker-Dealers&#148;) receiving Exchange Notes in the Exchange Offer will have a prospectus delivery requirement with respect to resales of such Exchange Notes. We also believe that Participating Broker-Dealers may fulfill their
prospectus delivery requirements with respect to Exchange Notes (other than a resale of an unsold allotment from the sale of the Original Notes) with this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not entered into any arrangement or understanding with any person who will receive Exchange Notes in the Exchange Offer to distribute
those securities following completion of the Exchange Offer. We are not aware of any person that will participate in the Exchange Offer with a view to distribute the Exchange Notes. If you tender your Original Notes in the Exchange Offer with the
intention of participating in any manner in a distribution of the Exchange Notes, you: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cannot rely on such interpretations of the SEC staff set forth in the
<FONT STYLE="white-space:nowrap">no-action</FONT> letters described above; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">must comply with the registration and prospectus delivery requirements of the Securities Act in order to resell
Exchange Notes, and be identified as an underwriter in the prospectus. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 23 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless an exemption from registration is otherwise available, the resale by any security
holder intending to distribute Exchange Notes should be covered by an effective registration statement under the Securities Act containing the selling security holder&#146;s information required under the Securities Act. This prospectus may be used
for an offer to resell, a resale or other retransfer of Exchange Notes only as specifically described in this prospectus. Each broker-dealer that receives Exchange Notes for its own account in exchange for Original Notes, where such Original Notes
were acquired by such broker-dealer as a result of market-making or other trading activities, must acknowledge that it will deliver a prospectus meeting the requirements of the Securities Act (or, to the extent permitted by law, make available a
prospectus meeting the requirements of the Securities Act to purchasers) in connection with any resale of such Exchange Notes. See &#147;Plan of Distribution.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shelf Registration </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that we
and the subsidiary guarantors determine that a registered exchange offer is not available or may not be completed because it would violate any applicable law or applicable interpretations of the staff of the SEC or, if for any reason the Exchange
Offer is not for any other reason completed on or prior to March&nbsp;21, 2023 (in the case of the 2030 Original Notes) or February&nbsp;24, 2024 (in the case of the 2026 Original Notes and the 2032 Original Notes), or, in certain circumstances, any
initial purchaser so requests in connection with any offer or sale of Original Notes, we and the subsidiary guarantors will use our reasonable best efforts to file and to have become effective a shelf registration statement relating to resales of
the notes and to keep that shelf registration statement effective until the date that the Original Notes cease to be &#147;registrable securities&#148; (as defined in the registration rights agreements), or such shorter period that will terminate
when all Original Notes covered by the shelf registration statement have been sold pursuant to the shelf registration statement. We and the subsidiary guarantors will, in the event of such a shelf registration, provide to each participating holder
of Original Notes copies of a prospectus, notify each participating holder of Original Notes when the shelf registration statement has become effective and take certain other actions to permit resales of the Original Notes. A holder of Original
Notes that sells Original Notes under the shelf registration statement generally will be required to make certain representations to us (as described in the registration rights agreements), to be named as a selling security holder in the related
prospectus and to deliver a prospectus to purchasers, will be subject to certain of the civil liability provisions under the Securities Act in connection with those sales and will be bound by the provisions of the registration rights agreement that
are applicable to such a holder of Original Notes (including certain indemnification obligations). Holders of Original Notes will also be required to suspend their use of the prospectus included in the shelf registration statement under specified
circumstances upon receipt of notice from UHS. Under applicable interpretations of the staff of the SEC, our affiliates will not be permitted to exchange their Original Notes for Exchange Notes in the Exchange Offer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Interest </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If: (1)(a) we have
not exchanged Exchange Notes for all Original Notes validly tendered in accordance with the terms of the Exchange Offer or, if a shelf registration statement is required and is not declared effective on or prior to March&nbsp;21, 2023 (in the case
of the 2030 Original Notes) or February&nbsp;24, 2024 (in the case of the 2026 Original Notes and the 2032 Original Notes) or (b)&nbsp;we receive a request by an initial purchaser to file a shelf registration statement and it does not become
effective by the later of March&nbsp;21, 2023 (in the case of the 2030 Original Notes) or February&nbsp;24, 2024 (in the case of the 2026 Original Notes and the 2032 Original Notes) or the 90th day following such request, or (2)&nbsp;if applicable,
a shelf registration statement covering resales of the Original Notes has been declared effective and such shelf registration statement ceases to be effective or the prospectus contained therein ceases to be usable at any time during the required
effectiveness period, and such failure to remain effective or be usable exists for more than 30 days (whether or not consecutive) or such shelf registration statement ceases to be effective on more than two occasions, in each case, in any <FONT
STYLE="white-space:nowrap">12-month</FONT> period (the 31st such day or such third occasion, as applicable, the &#147;Trigger Date&#148;), then additional interest will accrue on the principal amount of the notes that are &#147;registrable
securities&#148; at a rate of 0.25% per annum (which rate will be increased by an additional 0.25% per annum for each subsequent <FONT STYLE="white-space:nowrap">90-day</FONT> period that such additional interest continues to accrue, provided that
the rate at which such additional interest accrues may in no event exceed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 24 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
0.50% per annum) commencing on (a)&nbsp;March&nbsp;21, 2023 (in the case of the 2030 Original Notes) or February&nbsp;24, 2024 (in the case of the 2026 Original Notes and the 2032 Original
Notes), in the case of (1)&nbsp;above, or (b)&nbsp;the Trigger Date, in the case of (2)&nbsp;above, until the Exchange Offer is completed or the shelf registration statement is declared effective or the prospectus again becomes usable, as
applicable, or such notes cease to be &#147;registrable securities.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any amounts of additional interest due will be payable in cash
on the same original interest payment dates as interest on the notes is payable. The exchange notes will be accepted for clearance through DTC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary of the provisions of the registration rights agreements does not purport to be complete and is subject to, and is qualified in
its entirety by reference to, all the provisions of the registration rights agreement, copies of which are available from us upon request. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Terms of
the Exchange Offer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the terms and subject to the conditions described in this prospectus and in the letter of transmittal, we will
accept for exchange any Original Notes properly tendered and not withdrawn prior to the expiration time of the Exchange Offer. We will issue $1,000 principal amount of Exchange Notes in exchange for each $1,000 principal amount of Original Notes
surrendered under the Exchange Offer and accepted by us. Original Notes may be tendered only in integral multiples of $1,000, subject to a $2,000 minimum, and untendered Original Notes may only be in a minimum denomination of $2,000 and integral
multiples of $1,000 in excess thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the Exchange Notes are identical in all material respects to those of the Original
Notes, except the Exchange Notes will not be subject to transfer restrictions and holders of the Exchange Notes, with limited exceptions, will have no registration rights. Also, the Exchange Notes will not include provisions contained in the
Original Notes that required payment of additional interest in the event we failed to satisfy our registration obligations with respect to the Original Notes. Each series of Exchange Notes will be issued under and entitled to the benefits of the
same indenture that authorized the issuance of the related Original Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Exchange Offer is not conditioned on any minimum aggregate
principal amount of Original Notes being tendered for exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this prospectus, $700,000,000 in aggregate principal
amount of 2026 Original Notes, $800,000,000 in aggregate principal amount of 2030 Original Notes and $500,000,000 in aggregate principal amount of 2030 Original Notes are outstanding. This prospectus and the letter of transmittal are being sent to
all registered holders of the Original Notes. There will be no fixed record date for determining registered holders of the Original Notes entitled to participate in the Exchange Offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to conduct the Exchange Offer in accordance with the provisions of the registration rights agreements, the applicable requirements
of the Securities Act and the Exchange Act, and the SEC rules and regulations. Original Notes that are not tendered for exchange in the Exchange Offer: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will remain outstanding; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will continue to accrue interest; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be entitled to the rights and benefits that holders have under the indenture relating to such notes and,
under limited circumstances, the registration rights agreements. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will be deemed to have accepted for exchange
properly tendered Original Notes when we have given written notice of the acceptance to the exchange agent and complied with the applicable provisions of the registration rights agreement. The exchange agent will act as agent for the tendering
holders for the purposes of receiving the Exchange Notes from us. We will issue the Exchange Notes promptly after the expiration of the Exchange Offer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 25 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you tender Original Notes in the Exchange Offer, you will not be required to pay
brokerage commissions or fees or, subject to the instructions in the letter of transmittal, transfer taxes with respect to the exchange of Original Notes. We will pay all charges and expenses, other than certain applicable taxes described below, in
connection with the Exchange Offer. It is important that you read &#147;&#151;Fees and Expenses&#148; below for more details about fees and expenses incurred in the Exchange Offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will return any Original Notes that we do not accept for exchange for any reason without expense to the tendering holder as promptly as
practicable after the expiration or termination of the Exchange Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Exchange Offer is not subject to any federal or state
regulatory requirements or approvals other than securities laws and blue sky laws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expiration Time </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Exchange Offer will expire at 5:00 p.m., New York City time, on December 22, 2022, unless at our sole discretion we extend the Exchange
Offer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Extensions, Delay in Acceptance, Termination or Amendment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expressly reserve the right, at any time or at various times, to extend the period of time during which the Exchange Offer is open. We may
delay acceptance for exchange of any Original Notes by giving oral or written notice of the extension to their holders. During any such extensions, all Original Notes you have previously tendered will remain subject to the Exchange Offer for that
series, and we may accept them for exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To extend the Exchange Offer, we will notify the exchange agent orally or in writing (if
oral to be promptly confirmed in writing) of any extension. We also will make a public announcement of the extension no later than 9:00 a.m., New York City time, on the next business day after the previously scheduled expiration time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of the conditions described below under &#147;&#151;Conditions to the Exchange Offer&#148; have not been satisfied with respect to the
Exchange Offer, we reserve the right, at our sole discretion: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to extend the Exchange Offer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to delay accepting for exchange any Original Notes; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to terminate the Exchange Offer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will give oral or written notice (if oral to be promptly confirmed in writing) of such extension, delay or termination to the exchange
agent. Subject to the terms of the registration rights agreement, we also reserve the right to amend the terms of the Exchange Offer in any manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such extension, delay in acceptance, termination or amendment will be followed as promptly as practicable by oral or written notice
thereof to the registered holders of the Original Notes. If we amend the Exchange Offer in a manner that we determine to constitute a material change, we will promptly disclose that amendment by means of a prospectus supplement and we will extend
the offer period if necessary so that at least five business days remain in the offer period following notice of the material change. We will distribute the supplement to the registered holders of the Original Notes. Depending on the significance of
the amendment and the manner of disclosure to the registered holders, we may extend, pursuant to the terms of the registration rights agreement and the requirements of federal securities law, the Exchange Offer if the Exchange Offer would otherwise
expire during such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the manner in which we may choose to make public announcements of any extension, delay in
acceptance, termination or amendment of the Exchange Offer, we have no obligation to publish, advertise or otherwise communicate any such public announcement, other than by making a timely release to an appropriate news agency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 26 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conditions to the Exchange Offer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision of the Exchange Offer and subject to the terms of the registration rights agreements, we will not be
required to accept for exchange, or to issue Exchange Notes in exchange for, any Original Notes and may terminate or amend the Exchange Offer, if at any time before the expiration time of the Exchange Offer any of the following events occur: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any injunction, order or decree has been issued by any court or any governmental agency that would prohibit,
prevent or otherwise materially impair our ability to proceed with the Exchange Offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Exchange Offer violates any applicable law or any applicable interpretation of the staff of the SEC.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we will not be obligated to accept for exchange the Original Notes of any holder that has not made to us:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the representations described under &#147;&#151;Procedures for Tendering&#148; and &#147;Plan of
Distribution;&#148; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such other representations as may be reasonably necessary under applicable SEC rules, regulations or
interpretations to make available to us an appropriate form for registering the Exchange Notes under the Securities Act. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expressly reserve the right to amend or terminate the Exchange Offer notwithstanding the satisfaction of the foregoing, and to reject for
exchange any Original Notes upon the occurrence of any of the conditions to the Exchange Offer specified above. We will give oral or written notice of any extension, <FONT STYLE="white-space:nowrap">non-acceptance,</FONT> termination or amendment to
the holders of the Original Notes as promptly as practicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These conditions are for our sole benefit, and we may assert them or waive
them in whole or in part at any time or at various times at our sole discretion. Our failure at any time to exercise any of these rights will not mean that we have waived our rights. Each right will be deemed an ongoing right that we may assert at
any time or at various times. If we waive a condition, we may be required to extend the expiration time of the Exchange Offer in order to comply with applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we will not accept for exchange any Original Notes tendered, and will not issue Exchange Notes in exchange for any such Original
Notes, if at such time any stop order has been threatened or is in effect with respect to the registration statement of which this prospectus constitutes a part or the qualification of the indentures relating to the Exchange Notes under the Trust
Indenture Act of 1939. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Procedures for Tendering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>How to Tender Generally </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only a holder of the Original Notes as determined by our records or those of U.S. Bank Trust Company, National Association, as trustee or DTC
may tender Original Notes in the Exchange Offer. To tender in the Exchange Offer, a holder must either (1)&nbsp;comply with the procedures for physical tender or (2)&nbsp;comply with the automated tender offer program procedures of DTC, described
below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To complete a physical tender, a holder must: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complete, sign and date the letter of transmittal or a facsimile of the letter of transmittal;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have the signature on the letter of transmittal guaranteed if the letter of transmittal so requires;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">mail or deliver the letter of transmittal or facsimile to the exchange agent prior to the expiration time; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">deliver the Original Notes to the exchange agent prior to the expiration time. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 27 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be tendered effectively, the exchange agent must receive any physical delivery of the
letter of transmittal and other required documents at its address provided above under &#147;Prospectus Summary&#151;The Exchange Agent&#148; prior to the expiration time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To complete a tender through DTC&#146;s automated tender offer program, the exchange agent must receive, prior to the expiration time, a
timely confirmation of book-entry transfer of such Original Notes into the exchange agent&#146;s account at DTC according to the procedure for book-entry transfer described below or a properly transmitted agent&#146;s message. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The tender by a holder that is not withdrawn prior to the expiration time and our acceptance of that tender will constitute an agreement
between the holder and us in accordance with the terms and subject to the conditions described in this prospectus and in the letter of transmittal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THE METHOD OF DELIVERY OF ORIGINAL NOTES, THE LETTER OF TRANSMITTAL AND ALL OTHER REQUIRED DOCUMENTS TO THE EXCHANGE AGENT IS AT YOUR ELECTION
AND RISK. RATHER THAN MAIL THESE ITEMS, WE RECOMMEND THAT YOU USE AN OVERNIGHT OR HAND DELIVERY SERVICE. IN ALL CASES, YOU SHOULD ALLOW SUFFICIENT TIME TO ENSURE DELIVERY TO THE EXCHANGE AGENT BEFORE THE EXPIRATION TIME. YOU SHOULD NOT SEND THE
LETTER OF TRANSMITTAL OR ORIGINAL NOTES TO US. YOU MAY REQUEST YOUR BROKER, DEALER, COMMERCIAL BANK, TRUST COMPANY OR OTHER NOMINEE TO EFFECT THE ABOVE TRANSACTIONS FOR YOU. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>How to Tender if You Are a Beneficial Owner </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you beneficially own Original Notes that are registered in the name of a broker, dealer, commercial bank, trust company or other nominee and
you wish to tender those Original Notes, you should contact the registered holder as soon as possible and instruct the registered holder to tender on your behalf. If you are a beneficial owner and wish to tender on your own behalf, you must, prior
to completing and executing the letter of transmittal and delivering your Original Notes, either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make appropriate arrangements to register ownership of the Original Notes in your name, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain a properly completed bond power from the registered holder of your Original Notes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer of registered ownership may take considerable time and may not be completed prior to the expiration time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Signatures and Signature Guarantees </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You must have signatures on a letter of transmittal or a notice of withdrawal described below under &#147;&#151;Withdrawal of Tenders&#148;
guaranteed by an eligible institution unless the Original Notes are tendered: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by a registered holder who has not completed the box entitled &#147;Special Issuance Instructions&#148; or
&#147;Special Delivery Instructions&#148; on the letter of transmittal; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for the account of an eligible institution. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An &#147;eligible institution&#148; is member firm of a registered national securities exchange or of the Financial Industry Regulatory
Authority, Inc., a commercial bank or trust company having an office or correspondent in the United States, or an eligible guarantor institution within the meaning of Rule <FONT STYLE="white-space:nowrap">17Ad-15</FONT> under the Exchange Act, that
is a member of one of the recognized signature guarantee programs identified in the letter of transmittal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>When Endorsements or
Bond Powers Are Needed </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a person other than the registered holder of any Original Notes signs the letter of transmittal, the
Original Notes must be endorsed or accompanied by a properly completed bond power. The registered holder must sign </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 28 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the bond power as the registered holder&#146;s name appears on the Original Notes. An eligible institution must guarantee that signature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the letter of transmittal or any Original Notes or bond powers are signed by trustees, executors, administrators, guardians, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact,</FONT></FONT> or officers of corporations or others acting in a fiduciary or representative capacity, those persons should so indicate when signing. Unless we waive this
requirement, they also must submit evidence satisfactory to us of their authority to deliver the letter of transmittal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Tendering
Through DTC&#146;s Automated Tender Offer Program </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exchange agent and DTC have confirmed that any financial institution that is
a participant in DTC&#146;s system may use DTC&#146;s automated tender offer program to tender. Accordingly, participants in the program may, instead of physically completing and signing the letter of transmittal and delivering it to the exchange
agent, transmit their acceptance of the Exchange Offer electronically. They may do so by causing DTC to transfer the Original Notes to the exchange agent in accordance with its procedures for transfer. DTC will then send an agent&#146;s message to
the exchange agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An agent&#146;s message is a message transmitted by DTC to and received by the exchange agent and forming part of the
book-entry confirmation, stating that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DTC has received an express acknowledgment from a participant in DTC&#146;s automated tender offer program that
is tendering Original Notes that are the subject of such book-entry confirmation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the participant has received and agrees to be bound by the terms of the letter of transmittal, or in the case of
an agent&#146;s message relating to guaranteed delivery, that such participant has received and agrees to be bound by the notice of guaranteed delivery; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may enforce the agreement against such participant. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Determinations under the Exchange Offer </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will determine at our sole discretion all questions as to the validity, form, eligibility, time of receipt, acceptance of tendered Original
Notes and withdrawal of tendered Original Notes. Our determination will be final and binding. We reserve the absolute right to reject any Original Notes not properly tendered or any Original Notes our acceptance of which, in the opinion of our
counsel, might be unlawful. Our interpretation of the terms and conditions of the Exchange Offer, including the instructions in the letter of transmittal, will be final and binding on all parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless waived, any defects or irregularities in connection with tenders of Original Notes must be cured within such time as we determine.
Neither we, the exchange agent nor any other person will be under any duty to give notification of defects or irregularities with respect to tenders of Original Notes, nor will we or those persons incur any liability for failure to give such
notification. Tenders of Original Notes will not be deemed made until such defects or irregularities have been cured or waived. Any Original Notes received by the exchange agent that are not properly tendered and as to which the defects or
irregularities have not been cured or waived will be returned to the tendering holder, unless otherwise provided in the letter of transmittal, as soon as practicable following the expiration time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>When We Will Issue Exchange Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In all cases, we will issue Exchange Notes for Original Notes that we have accepted for exchange in the Exchange Offer only after the exchange
agent timely receives: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Original Notes or a timely book-entry confirmation of transfer of such Original Notes into the exchange
agent&#146;s account at DTC; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 29 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a properly completed and duly executed letter of transmittal and all other required documents or a properly
transmitted agent&#146;s message. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Return of Original Notes Not Accepted or Exchanged </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we do not accept any tendered Original Notes for exchange for any reason described in the terms and conditions of the Exchange Offer or if
Original Notes are submitted for a greater principal amount than the holder desires to exchange, we will return the unaccepted or <FONT STYLE="white-space:nowrap">non-exchanged</FONT> Original Notes without expense to their tendering holder. In the
case of Original Notes tendered by book-entry transfer into the exchange agent&#146;s account at DTC according to the procedures described below, such <FONT STYLE="white-space:nowrap">non-exchanged</FONT> Original Notes will be credited to an
account maintained with DTC. These actions will occur as promptly as practicable after the expiration or termination of the Exchange Offer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Your Representations to Us </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By signing or agreeing to be bound by the letter of transmittal, you will represent to us that, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you hold all right, title and interest in and to the Original Notes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you transfer all right, title and interest in the Original Notes to us in exchange for the Exchange Notes free
and clear of all liens, encumbrances, or rights or interests of third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any Exchange Notes to be received by you will be acquired in the ordinary course of your business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you have no arrangement or understanding with any person to participate in a distribution (within the meaning of
the Securities Act) of the Exchange Notes in violation of the provisions of the Securities Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are not an &#147;affiliate&#148; (as defined in Rule 405 under the Securities Act) of UHS or any subsidiary
guarantor, or if you are such an affiliate, you will comply with the registration and prospectus delivery requirements of the Securities Act to the extent applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">you are not engaged in, and do not intend to engage in, a distribution of the Exchange Notes; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if you are a Participating Broker-Dealer that will receive Exchange Notes for your own account in exchange for
Original Notes acquired as a result of market-making or other trading activities, you will deliver a prospectus meeting the requirements of the Securities Act (or, to the extent permitted by law, make available a prospectus meeting the requirements
of the Securities Act to purchasers) in connection with any resale of such Exchange Notes. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Book-Entry Transfer
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exchange agent will make a request to establish an account with respect to the Original Notes at DTC for purposes of the
Exchange Offer promptly after the date of this prospectus. Any financial institution participating in DTC&#146;s system may make book-entry delivery of Original Notes by causing DTC to transfer such Original Notes into the exchange agent&#146;s
account at DTC in accordance with DTC&#146;s procedures for transfer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Resales </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each broker-dealer that receives Exchange Notes for its own account in exchange for Original Notes, where such Original Notes were acquired by
such broker-dealer as a result of market-making or other trading activities, must acknowledge that it will deliver a prospectus meeting the requirements of the Securities Act (or, to the extent permitted by law, make available a prospectus meeting
the requirements of the Securities Act to purchasers) in connection with any resale of such Exchange Notes. See &#147;Plan of Distribution.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 30 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Withdrawal of Tenders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in this prospectus, you may withdraw your tender at any time prior to the expiration time. For a withdrawal to be
effective: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exchange agent must receive a written notice of withdrawal prior to the expiration time at one of the
addresses listed above under &#147;Prospectus Summary&#151;The Exchange Agent;&#148; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the withdrawing holder must comply with the appropriate procedures of DTC&#146;s automated tender offer program.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice of withdrawal must: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">specify the name of the person who tendered the Original Notes to be withdrawn; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identify the Original Notes to be withdrawn, including the registration number or numbers and the principal
amount of such Original Notes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be signed by the person who tendered the Original Notes in the same manner as the original signature on the
letter of transmittal used to deposit those Original Notes or be accompanied by documents of transfer sufficient to permit the Trustee to register the transfer in the name of the person withdrawing the tender; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">specify the name in which such Original Notes are to be registered, if different from that of the person who
tendered the Original Notes. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Original Notes have been tendered under the procedure for book-entry transfer described
above, any notice of withdrawal must specify the name and number of the account at DTC to be credited with the withdrawn Original Notes and otherwise comply with the procedures of DTC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will determine all questions as to the validity, form, eligibility and time of receipt of notice of withdrawal, and our determination shall
be final and binding on all parties. We will deem any Original Notes so withdrawn not to have been validly tendered for exchange for purposes of the Exchange Offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Original Notes that have been tendered for exchange but that are not exchanged for any reason will be returned to their holder without
cost to the holder, or, in the case of Original Notes tendered by book-entry transfer into the exchange agent&#146;s account at DTC according to the procedures described above, such Original Notes will be credited to an account maintained with DTC
for the Original Notes. This return or crediting will take place as soon as practicable after withdrawal, rejection of tender or termination of the Exchange Offer. You may retender properly withdrawn Original Notes by following one of the procedures
described above under &#147;&#151;Procedures for Tendering&#148; at any time on or prior to the expiration time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Guaranteed
Delivery Procedures </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you wish to tender your Original Notes but your Original Notes are not immediately available or you cannot
deliver your Original Notes, the letter of transmittal or any other required documents to the exchange agent or comply with the procedures under DTC&#146;s Automatic Tender Offer Program in the case of Original Notes, prior to the expiration tine,
you may still tender if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the tender is made through an eligible guarantor institution; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the expiration time, the exchange agent receives from such eligible guarantor institution either a
properly completed and duly executed notice of guaranteed delivery, by facsimile transmission (if the notice of guaranteed delivery does not require a signature guarantee), mail, or hand delivery or a properly transmitted agent&#146;s message, that
(1)&nbsp;sets forth your name and address, the certificate number(s) of such Original Notes and the principal amount of Original Notes tendered; (2)&nbsp;states that the tender is being made thereby; and (3)&nbsp;guarantees that, within three
business days after the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 31 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
expiration time, the letter of transmittal, or copy thereof, together with the Original Notes, and any other documents required by the letter of transmittal or a book-entry confirmation and
agent&#146;s message, will be deposited by the eligible guarantor institution with the exchange agent; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exchange agent receives the properly completed and executed letter of transmittal and all other documents
required by the letter of transmittal, as well as certificate(s) representing all tendered Original Notes in proper form for transfer or a book-entry confirmation of transfer of the Original Notes into the exchange agent&#146;s account at DTC and an
agent&#146;s message within three business days after the expiration time. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon request, the exchange agent will send
to you a form of notice of guaranteed delivery if you wish to tender your Original Notes according to the guaranteed delivery procedures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fees and
Expenses </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will bear the expenses of soliciting tenders. The principal solicitation is being made by mail; however, we may make
additional solicitation by facsimile, email, telephone or in person by our officers and regular employees and those of our affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have not retained any dealer-manager in connection with the Exchange Offer and will not make any payments to broker-dealers or others soliciting acceptances of the Exchange Offer. We will, however, pay the exchange agent reasonable and customary
fees for its services and reimburse it for its related reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses. We may also pay brokerage houses and other custodians, nominees and fiduciaries
the reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by them in forwarding copies of this prospectus, letters of transmittal and related documents to the beneficial owners of
the Original Notes and in handling or forwarding tenders for exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay cash expenses to be incurred in connection with the
Exchange Offer. They include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">SEC registration fees for the Exchange Notes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fees and expenses of the exchange agent and the trustee and exchange agent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accounting and legal fees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">printing costs; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">related fees and expenses. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you tender your
Original Notes for exchange, you will not be required to pay any transfer taxes. We will pay all transfer taxes, if any, applicable to the exchange of Original Notes in the Exchange Offer. The tendering holder will, however, be required to pay any
transfer taxes, whether imposed on the registered holder or any other person, if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certificates representing Exchange Notes or Original Notes for principal amounts not tendered or accepted for
exchange are to be delivered to, or are to be issued in the name of, any person other than the registered holder of the Original Notes tendered; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">tendered Original Notes are registered in the name of any person other than the person signing the letter of
transmittal; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a transfer tax is imposed for any reason other than the exchange of Original Notes for Exchange Notes in the
Exchange Offer. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 32 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If satisfactory evidence of payment of any transfer taxes payable by a tendering holder is
not submitted with the letter of transmittal, the amount of the transfer taxes will be billed directly to that tendering holder. The exchange agent will retain possession of Exchange Notes with a face amount equal to the amount of the transfer taxes
due until it receives payment of the taxes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounting Treatment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will record the Exchange Notes at the same carrying value as the Original Notes as reflected in our accounting records on the date of the
exchange. Accordingly, we will not recognize any gain or loss for accounting purposes upon completion of the Exchange Offer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consequences of Failure
to Exchange </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you do not exchange your Original Notes for Exchange Notes in the Exchange Offer, you will remain subject to the
existing restrictions on transfer of the Original Notes. In general, you may not offer or sell the Original Notes unless either they are registered under the Securities Act or the offer or sale is exempt from or not subject to registration under the
Securities Act and applicable state securities laws. Except as required by the registration rights agreements, we do not intend to register resales of the Original Notes under the Securities Act. We generally have no obligation to <FONT
STYLE="white-space:nowrap">re-offer</FONT> to exchange the Exchange Notes for Original Notes following the expiration of the Exchange Offer. The tender of Original Notes in the Exchange Offer will reduce the outstanding principal amount of the
Original Notes. Due to the corresponding reduction in liquidity, this may have an adverse effect on, and increase the volatility of, the market price of any Original Notes that you continue to hold. See &#147;Risk Factors&#151;Risks Related to the
Exchange Offer&#151;If you do not exchange your Original Notes, your Original Notes will continue to be subject to the existing transfer restrictions and you may be unable to sell your outstanding Original Notes.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participation in the Exchange
Offer is voluntary, and you should carefully consider whether to accept. You are urged to consult your financial and tax advisors in making your decision on what action to take. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the future, we may at our discretion seek to acquire untendered Original Notes in open market or privately negotiated transactions, through
subsequent exchange offers or otherwise. We have no present plan to acquire any Original Notes that are not tendered in the Exchange Offer or to file a registration statement to permit resales of any untendered Original Notes, except as required by
the registration rights agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 33 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_6"></A>DESCRIPTION OF THE NOTES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is a description of the particular terms of the 1.650% Senior Secured Notes due 2026 (the &#147;2026 Original Notes&#148;), the 2.650%
Senior Secured Notes due 2030 (the &#147;2030 Original Notes&#148;), the 2.650% Senior Secured Notes due 2032 (the &#147;2032 Original Notes&#148; and, together with the 2026 Original Notes and the 2030 Original Notes, the &#147;Original
Notes&#148;), the 1.650% Senior Secured Notes due 2026 (the &#147;2026 Exchange Notes&#148;), 2.650% Senior Secured Notes due 2030 (the &#147;2030 Exchange Notes&#148;) and 2.650% Senior Secured Notes due 2032 (the &#147;2032 Exchange Notes&#148;
and together with the 2026 Exchange Notes and the 2030 Exchange Notes, the &#147;Exchange Notes&#148;). In this description of the Notes, all references to &#147;we,&#148; &#147;us&#148; or &#147;our&#148; and the &#147;Company&#148; are to
Universal Health Services, Inc. only (the &#147;Issuer&#148;) and not to any of its subsidiaries. Although for convenience the Original Notes and Exchange Notes are referred to as the &#147;Notes,&#148; each series of Original Notes have been and
each series of Exchange Notes will be issued as a separate series and will not together have any class voting rights. Accordingly, for purposes of this description of the notes, unless the context otherwise requires, references to the
&#147;Notes&#148; shall be deemed to refer to each series of Notes separately, and not to the Original Notes and the Exchange Notes on a combined basis. In this description of the Notes, the 2026 Original Notes and the 2026 Exchange Notes are
referred to collectively as the &#147;2026 Notes,&#148; the 2030 Original Notes and the 2030 Exchange Notes are referred to collectively as the &#147;2030 Notes,&#148; and the 2032 Original Notes and the 2032 Exchange Notes are referred to
collectively as the &#147;2032 Notes.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We issued the 2030 Original Notes and we will issue the 2030 Exchange Notes under an
indenture, dated as of September&nbsp;21, 2020, among UHS, the subsidiary guarantors, U.S. Bank Trust Company, National Association, as trustee (the &#147;Trustee&#148;), and JPMorgan Chase Bank, N.A. as Collateral Agent (the &#147;2020
Indenture&#148;). We issued the 2026 Original Notes and the 2032 Original Notes and we will issue the 2026 Exchange Notes and 2032 Exchange Notes under an indenture, dated as of August&nbsp;24, 2021, among UHS, the subsidiary guarantors, the
Trustee, and JPMorgan Chase Bank, N.A. as Collateral Agent (the &#147;2021 Indenture&#148;). The 2020 Indenture and the 2021 Indenture are referred to in this description as the &#147;Indentures&#148; and each is referred to individually as an
&#147;Indenture.&#148; The Indentures set forth the specific terms applicable to the Notes. This description is intended to be an overview of the material provisions of the Notes and the Indentures. This summary is not complete and is qualified in
its entirety by reference to the Indentures. You should carefully read the summary below. The terms of the Notes include those stated in the Indentures and those made part of the Indentures by reference to the Trust Indenture Act of 1939, as
amended. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brief description of the Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be general senior secured obligations of the Issuer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be secured on a first-priority basis, subject to Permitted Liens, by the Collateral subject to a shared Lien
of equal priority with the existing and future First Lien Obligations, including the Senior Credit Facility Obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be structurally subordinated to any existing and future indebtedness and liabilities of <FONT
STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries, including the Issuer&#146;s Foreign Subsidiaries and any Unrestricted Subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will rank equally in right of payment with all existing and future senior Indebtedness of the Issuer and the
Guarantors but, to the extent of the value of the Collateral, will be effectively senior to all of the Issuer&#146;s and the Guarantors&#146; unsecured senior Indebtedness and any future Junior Lien Obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will be senior in right of payment to any future subordinated Indebtedness of the Issuer; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">will initially be unconditionally guaranteed on a joint and several basis by each Restricted Subsidiary that
guarantees the Senior Credit Facility, all of which Guarantors on the Issue Date will be Secured Guarantors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 34 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Guarantees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Guarantors, as primary obligors and not merely as sureties, will jointly and severally fully and unconditionally guarantee, on a senior
basis, the performance and full and punctual payment when due, whether at maturity, by acceleration or otherwise, of all obligations of the Issuer under the Indentures and the Notes, whether for payment of principal of, premium, if any, or interest
(including Additional Interest, if any) in respect of the Notes, expenses, indemnification or otherwise, on the terms set forth in the Indentures by executing the Indentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Restricted Subsidiaries that guarantee our Senior Credit Facility will initially guarantee the Notes. As of the date of this prospectus,
each of the Guarantors is a Secured Guarantor, and each of the Guarantees of such Secured Guarantors will be general senior secured obligations of such Secured Guarantors and will be secured by a first-priority lien, subject to Permitted Liens, on
the Collateral. The Guarantees of the Secured Guarantors will rank equally in right of payment with all existing and future senior Indebtedness of the Secured Guarantor but, to the extent of the value of the Collateral, will be effectively senior to
all of the Secured Guarantors&#146; unsecured senior Indebtedness and Junior Lien Obligations. In the future, if any Unsecured Guarantor guarantees the Notes as provided in &#147;&#151;Certain Covenants&#151;Additional Subsidiary Guarantees,&#148;
the Guarantee of such Unsecured Guarantor will rank equally in right of payment with all existing and future senior Indebtedness of the Unsecured Guarantor, will rank pari passu with all of the Unsecured Guarantor&#146;s unsecured senior
Indebtedness and will be effectively subordinated to any secured Indebtedness of such Unsecured Guarantor to the extent of the value of the assets securing such secured Indebtedness. The Guarantees of all the Guarantors will be senior in right of
payment to all existing and future subordinated Indebtedness of each Guarantor. The Notes will be structurally subordinated to Indebtedness and other liabilities of Subsidiaries of the Issuer that do not guarantee the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not all of our Subsidiaries will Guarantee the Notes. In the event of a bankruptcy, liquidation or reorganization of any of these <FONT
STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries, the <FONT STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries will pay the holders of their debt and their trade creditors before they will be able to distribute any of their
assets to the Issuer. None of our Subsidiaries that are Foreign Subsidiaries, <FONT STYLE="white-space:nowrap">non-Wholly</FONT> Owned Subsidiaries or any Receivables Subsidiaries will guarantee the Notes. For the year ended December&nbsp;31, 2021,
our subsidiaries in the United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT> subsidiaries, represented approximately 5% of our net revenues, and together with our remaining
<FONT STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries represented less than 19% of our net revenues. As of September&nbsp;30, 2022, Subsidiaries in the United Kingdom, which are <FONT STYLE="white-space:nowrap">non-guarantor</FONT>
Subsidiaries, represented approximately 3% of our total assets excluding intercompany assets, and together with our remaining non guarantor Subsidiaries represented less than 20% of our total assets excluding intercompany assets. As of
September&nbsp;30, 2022, our <FONT STYLE="white-space:nowrap">non-guarantor</FONT> Subsidiaries had less than $23&nbsp;million of long-term debt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations of each Guarantor under its Guarantee will be limited as necessary to prevent the Guarantee from constituting a fraudulent
conveyance under applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any entity that makes a payment under its Guarantee will be entitled upon payment in full of all
guaranteed obligations under the Indentures to a contribution from each other Guarantor in an amount equal to such other Guarantor&#146;s pro rata portion of such payment based on the respective net assets of all the Guarantors at the time of such
payment determined in accordance with GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Guarantee were rendered voidable, it could be subordinated by a court to all other
indebtedness (including guarantees and other contingent liabilities) of the Guarantor, and, depending on the amount of such indebtedness, a Guarantor&#146;s liability on its Guarantee could be reduced to zero. See &#147;Risk factors&#151;Risks
related to the notes-Federal and state fraudulent transfer laws may permit a court to void the notes, guarantees and/ or the grant of collateral, and if that occurs, you may not receive any payments on the notes.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 35 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Guarantee by a Guarantor will provide by its terms that it will be automatically and
unconditionally released and discharged upon: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(a) any sale, exchange or transfer (by merger or otherwise) of the Capital Stock of such Guarantor (including
any sale, exchange or transfer), after which the applicable Guarantor is no longer a Restricted Subsidiary or all or substantially all the assets of such Guarantor, which sale, exchange or transfer is made in compliance with any applicable
provisions of the Indentures; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the release or discharge of the guarantee by such Guarantor of the Senior Credit Facility, any other First Lien
Obligations and any Junior Lien Obligations (and if the Guarantor has become a guarantor under any Additional Indebtedness, the release or discharge of the guarantee by such Guarantor of such Additional Indebtedness), including any other guarantee
that resulted in the creation of such Guarantee, except (i)&nbsp;a discharge or release by or as a result of payment under such guarantee or (ii)&nbsp;by reason of the termination of the Senior Credit Facility; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the designation of any Restricted Subsidiary that is a Guarantor as an Unrestricted Subsidiary in compliance
with the applicable provisions of the Indentures; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the exercise by the Issuer of its legal defeasance option or covenant defeasance option as described under
&#147;&#151;Defeasance&#148; or the discharge of the Issuer&#146;s and the Guarantors&#146; obligations under the Indentures in accordance with the terms of the Indentures; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">upon an Investment Grade Rating Event, but only (i)&nbsp;to the extent described under &#147;&#151;Release of
collateral and guarantees upon investment grade rating event&#148; (which includes the release by the Guarantor of its guarantees of all other First Lien Obligations and Junior Lien Obligations) and (ii)&nbsp;in the case of a Secured Guarantor, if
the Liens on the Collateral of such Secured Guarantor securing its Guarantee of the Notes and the Notes Obligations are also released at such time as described under &#147;&#151;Release of collateral and guarantees upon investment grade rating
event&#148;; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Guarantor delivering to the Trustee an Officers&#146; Certificate and an Opinion of Counsel, each stating
that all conditions precedent provided for in the Indentures and the Security Documents relating to such transaction have been complied with. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Holding Company Structure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UHS is a
holding company for its Subsidiaries, with no material operations of its own and only limited assets other than the Capital Stock of its Subsidiaries. Accordingly, the Issuer is dependent upon the distribution of the earnings of its Subsidiaries,
whether in the form of dividends, advances or payments on account of intercompany obligations, to service its debt obligations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Security General
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations of the Issuer with respect to the Notes, the obligations of the Secured Guarantors under their Guarantees, and the
performance of all other obligations of the Issuer and the Secured Guarantors under the Indentures will be secured by a perfected first-priority security interest, subject to Permitted Liens, in the Collateral owned by the Issuer and the Secured
Guarantors, in each case whether now owned or hereafter acquired subject to a shared Lien of equal priority with the obligations of the Issuer and the Secured Guarantors under the Senior Credit Facility and any other First Lien Obligations. First
Lien Secured Parties other than the Holders of the Notes have rights and remedies with respect to the Collateral that, if exercised, could also adversely affect the value of the Collateral on behalf of the Holders of the Notes, particularly the
rights described below under &#147;&#151;Intercreditor provisions in the security agreement.&#148; For a brief description of the Collateral, see &#147;Description of other indebtedness-Credit agreement-Guarantees and security.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Secured Guarantors are and will be able to incur additional Indebtedness in the future that could share in the Collateral,
including Additional First Lien Obligations, Junior Lien Obligations, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 36 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Obligations secured by Permitted Liens or Mortgages (as applicable). The amount of such additional Obligations will be limited by the covenant described under &#147;&#151;Certain
Covenants&#151;Limitations on Mortgages,&#148; but the covenant is limited in scope and contains a number of exceptions. Under certain circumstances, the amount of any such additional Obligations could be significant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee shall have no responsibility whatsoever to comply with any provision of, nor shall be charged with knowledge of, any document
governing Additional First Lien Obligations to which it is not a party. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>After-Acquired Collateral </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From and after the Issue Date and prior to the Collateral Release Date, subject to certain limitations and exceptions, if the Issuer or any
Secured Guarantor (i)&nbsp;acquires any property or asset that would constitute Collateral or (ii)&nbsp;creates any additional security interest upon any property or asset to secure any First Lien Obligations, it must grant a first-priority
perfected security interest (subject to Permitted Liens) upon such property as security for the Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Liens with Respect to the
Collateral </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer, the Secured Guarantors, the Trustee, the designated agents of each Series of other First Lien Obligations
and the First Lien Collateral Agent have entered into Security Documents with respect to the Collateral defining the terms of the security interests that secure the Notes and the Guarantees with respect to such Collateral. These security interests
will secure the payment and performance when due of all of the Obligations of the Issuers and the Secured Guarantors under the Notes, the Indentures, the applicable Guarantees and the Security Documents, as provided in the Security Documents. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Intercreditor Provisions in the Security Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Security Agreement, the Holders of the Notes will be represented by the Trustee, and the holders of each Series of First Lien
Obligations will be represented by their designated agent (each, an &#147;Authorized Representative&#148;). The First Lien Collateral Agent is initially JPMorgan Chase Bank, N.A., in its capacity of collateral agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Security Agreement, the &#147;Applicable Authorized Representative&#148; has the right to direct foreclosures and take other actions
with respect to the Common Collateral. No Authorized Representative of any First Lien Obligations secured by the Common Collateral (other than the Applicable Authorized Representative) will instruct the First Lien Collateral Agent to take any action
with respect to the Common Collateral. The Applicable Authorized Representative will initially be the administrative agent under the Senior Credit Facility, and the Trustee will have no rights to take any action under the Security Agreement other
than as the Applicable Authorized Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The administrative agent under the Senior Credit Facility will remain the Applicable
Authorized Representative until the earlier of (1)&nbsp;the Discharge of Senior Credit Facility Obligations and (2)&nbsp;the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative Enforcement Date (such date, the
&#147;Applicable Authorized Agent Date&#148;). After the Applicable Authorized Agent Date, the Applicable Authorized Representative will be the Authorized Representative of the Series of First Lien Obligations that constitutes the largest
outstanding principal amount of any then outstanding Series of First Lien Obligations, other than the Senior Credit Facility Obligations, with respect to the Common Collateral (the &#147;Major <FONT STYLE="white-space:nowrap">Non-Controlling</FONT>
Authorized Representative&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">&#147;Non-Controlling</FONT> Authorized Representative Enforcement
Date&#148; is the date that is 90 days (throughout which <FONT STYLE="white-space:nowrap">90-day</FONT> period the applicable <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative was the Major <FONT
STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative) after the occurrence of both (a)&nbsp;an event of default, as defined in the Indentures or other applicable agreement for the Series of First Lien Obligations for which
such <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 37 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Representative is an Authorized Representative, and (b)&nbsp;the First Lien Collateral Agents and each other Authorized Representative&#146;s receipt of written notice from that <FONT
STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative certifying that (i)&nbsp;such <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative is the Major
<FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative and that an event of default, as defined in the Indentures or other applicable agreement for that Series of First Lien Obligations, has occurred and is continuing and
(ii)&nbsp;the First Lien Obligations of that Series are currently due and payable in full (whether as a result of acceleration thereof or otherwise) in accordance with the Indentures or other applicable agreement for that Series of First Lien
Obligations; provided that the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative Enforcement Date shall be stayed and shall not occur and shall be deemed not to have occurred with respect to any Common Collateral
(1)&nbsp;at any time the First Lien Collateral Agent has commenced and is diligently pursuing any enforcement action with respect to such Common Collateral or (2)&nbsp;at any time the Issuer or the Secured Guarantor that has granted a security
interest in such Common Collateral is then a debtor under or with respect to (or otherwise subject to) any Insolvency or Liquidation Proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided above, the Applicable Authorized Representative shall have the sole right to instruct the First Lien Collateral Agent to
act or refrain from acting with respect to the Common Collateral, the First Lien Collateral Agent shall not follow any instructions with respect to such Common Collateral from any Person (other than the Applicable Authorized Representative), and no
Authorized Representative (other than the Applicable Authorized Representative) will instruct the First Lien Collateral Agent to commence any judicial or <FONT STYLE="white-space:nowrap">non-judicial</FONT> foreclosure proceedings with respect to,
seek to have a trustee, receiver, liquidator or similar official appointed for or over, attempt any action to take possession of, exercise any right, remedy or power with respect to, or otherwise take any action to enforce its interests in or
realize upon, or take any other action available to it in respect of, the Common Collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the equal priority of the
Liens, the First Lien Collateral Agent, acting on the instructions of the Applicable Authorized Representative, may deal with the Common Collateral as if such Applicable Authorized Representative had a senior Lien on such Common Collateral. No
Authorized Representative of any Series of First Lien Obligations (other than the Applicable Authorized Representative) may contest, protest or object to any foreclosure proceeding or action brought by the First Lien Collateral Agent (acting on the
instruction of the Applicable Authorized Representative) or the Applicable Authorized Representative with respect to the Common Collateral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a First Lien Event of Default has occurred and is continuing and the First Lien Collateral Agent is taking action to enforce rights in
respect of any Common Collateral, or any distribution is made with respect to any Common Collateral in any bankruptcy case of the Issuer or any Secured Guarantor, the proceeds of any sale, collection or other liquidation of any such Common
Collateral by the First Lien Collateral Agent or any other First Lien Secured Party as applicable, shall be applied among the First Lien Obligations to the payment in full of the First Lien Obligations on a ratable basis, after payment of all
amounts owing to the First Lien Collateral Agent and the Authorized Representatives, in their capacities as such. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Release of
Collateral </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Security Agreement, if at any time the Applicable Authorized Representative forecloses upon or otherwise
exercises remedies against any Common Collateral, then (whether or not any Insolvency or Liquidation Proceeding is pending at the time) the Liens in favor of the First Lien Collateral Agent for the benefit of the Trustee and the Holders of the Notes
and each other Series of First Lien Secured Parties upon such Common Collateral will automatically be released and discharged. However, any proceeds of any Common Collateral realized therefrom will be applied as described under
&#147;&#151;Intercreditor provisions in the security agreement.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 38 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Secured Guarantors will be entitled to the release of property and other
assets constituting Collateral from the Liens securing the Notes, the Notes Obligations and the Guarantees of the Secured Guarantors under any one or more of the following circumstances: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to enable us to consummate the sale, transfer or other disposition of such property or assets (other than to
the Issuer or a Guarantor); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of one or more Secured Guarantors that are released from their Guarantees with respect to the Notes
pursuant to the terms of the Indentures, the release of the property and assets and Equity Interests of such Secured Guarantors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the extent that such Collateral is released or no longer required to be pledged pursuant to the terms of the
Senior Credit Facility, any other First Lien Obligations and any Junior Lien Obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">with the consent of the Holders of at least 75% of the aggregate principal amount of the Notes then outstanding
and affected thereby; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as described under &#147;&#151;Release of Collateral and Guarantees upon Investment Grade Rating Event&#148;;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a release of assets permitted not to be included in the Collateral pursuant to clause (7)&nbsp;under
&#147;&#151;Certain limitations on the collateral&#148; in connection with a Qualified Receivables Transaction (including any Receivables Financing) permitted under the Indenture; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as described under &#147;&#151;Modification and Waiver&#148; below. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Liens on the Collateral securing the Notes and the applicable Guarantees also will be released upon (i)&nbsp;payment in full of the
principal of, together with accrued and unpaid interest on, the Notes and all other Obligations under the Indentures, the Guarantees and the Security Documents that are due and payable at or prior to the time such principal, together with accrued
and unpaid interest, are paid or (ii)&nbsp;a defeasance under the Indentures as described below under &#147;&#151;Defeasance&#148; or discharge of the Issuer&#146;s and the Guarantor&#146; Obligations under the Indentures in accordance with the
Indentures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Liens securing the Senior Credit Facility Obligations are released in connection with the repayment (including cash
collateralization of letters of credit) of the Senior Credit Facility Obligations in full and termination of the commitments thereunder, the Liens on the Collateral securing the Notes, the Notes Obligations and the Guarantees of the Secured
Guarantors will not be released, except to the extent the Collateral or any portion thereof was disposed of in order to repay the Senior Credit Facility Obligations secured by the Collateral. From and after any such time when all the Liens securing
the First Lien Obligations other than the Notes and the Notes Obligations are released and the Liens on the Collateral securing the Notes remain in existence, if the Issuer or any Secured Guarantor acquires any property or asset constituting
Collateral, it shall grant a first-priority perfected security interest (subject to Permitted Liens) upon such property as security for the Notes to the extent then required under &#147;&#151;After-Acquired Collateral.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent the Trustee is required to execute any release or to direct the First Lien Collateral Agent to execute any release, prior
thereto, the Trustee shall have received an Officers&#146; Certificate and Opinion of Counsel that all conditions precedent to such release in the Indentures and the Security Documents have been complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After such time as the Indentures are qualified under the Trust Indenture Act, any certificate or opinion required by Section&nbsp;314(d) of
the Trust Indenture Act may be made by an Officer of the Company, except in cases where Section&nbsp;314(d) requires that such certificate or opinion be made by an independent engineer, appraiser or other expert. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary herein, after such time as the Indentures are qualified under the Trust Indenture Act, the Issuer and
its Subsidiaries will not be required to comply with all or any portion of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 39 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;314(d) of the Trust Indenture Act if they determine, in good faith based on advice of counsel, that under the terms of that section and/or any interpretation or guidance as to the
meaning thereof of the SEC and its staff, including &#147;no action&#148; letters or exemptive orders, all or any portion of Section&nbsp;314(d) of the Trust Indenture Act is inapplicable to the released Collateral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the generality of the foregoing, certain no action letters issued by the SEC have permitted the release of Liens on
collateral securing indebtedness issued under an indenture qualified under the Trust Indenture Act without requiring the issuer to provide certificates and other documents under Section&nbsp;314(d) of the Trust Indenture Act where such release
occurs as a result of the release of such collateral from Liens securing a credit facility or other indebtedness. In addition, certain no action letters issued by the SEC have permitted the release of collateral from Liens securing indebtedness
issued under an indenture qualified under the Trust Indenture Act resulting from transactions in the ordinary course of the Issuer&#146;s business without requiring the issuer to provide such certificates and other documents. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Certain Limitations on the Collateral </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Collateral securing the Notes will not include any of the following assets: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any interest in <FONT STYLE="white-space:nowrap">fee-owned</FONT> or leased real property of the Issuer and the
Secured Guarantors (except as provided for under the &#147;&#151;Certain Covenants&#151;Limitations on Mortgages&#148; section herein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any property to the extent that such grant of a security interest is prohibited by any requirements of law of a
governmental authority, requires a consent not obtained of any governmental authority pursuant to such requirement of law or is prohibited by, or constitutes a breach or default under or results in the termination of or requires any consent not
obtained under, any contract, license, agreement, instrument or other document evidencing or giving rise to such property (other than Investment Property or Pledged Stock issued by a Subsidiary of the Issuer or a Receivables Subsidiary) or, in the
case of any Investment Property or Pledged Stock issued by a Person that is not a Subsidiary of the Issuer or a Receivables Subsidiary, any applicable shareholder or similar agreement, except to the extent that such requirement of law or the term in
such contract, license, agreement, instrument or other document or shareholder or similar agreement providing for such prohibition, breach, default or termination or requiring such consent is ineffective under applicable law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any interest in any Voting Stock that is issued by any Foreign Subsidiary, if and to the extent that the
inclusion of such Voting Stock in the Collateral would cause the Collateral pledged by the Issuer or the applicable Secured Guarantor, as the case may be, to include in the aggregate more than 65% of the total combined voting power of all classes of
Voting Stock of such Foreign Subsidiary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Letter-of-Credit</FONT></FONT> Rights that do
not constitute Supporting Obligations (each as defined in the New York UCC); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Deposit Accounts (as defined in the New York UCC); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Intellectual property to the extent perfection of a security interest therein requires any filing to be made
outside of the United States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Receivables sold, or with respect to which Participation Interests are sold, and all Related Security and
Collections with respect to such Receivables pursuant to any Receivables Financing to the extent that the aggregate outstanding amount of the purchase price or loan from the applicable lenders or investors under all Receivables Financing at any time
does not exceed the greater of (i) $600.0&nbsp;million and (ii) 50% of accounts receivable, net, as shown on the Issuer&#146;s most recent consolidated balance sheet for which internal financial statements for the Issuer are available plus the
allowance for doubtful accounts with respect to such accounts receivable, as set forth in the footnotes to such financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Gift Shop Assets of the Issuer and any Secured Guarantor which is a party to a Receivables Financing that
includes the Gift Shop Assets; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the assets of any Unsecured Guarantor. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 40 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Sufficiency of Collateral </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair market value of the Collateral is subject to fluctuations based on factors that include, among others, the condition of the health
care industry, the ability to sell the Collateral in an orderly sale, general economic conditions, the availability of buyers and similar factors. The amount to be received upon a sale of the Collateral would also be dependent on numerous factors,
including, but not limited to, the actual fair market value of the Collateral at such time and the timing and the manner of the sale. By their nature, portions of the Collateral may be illiquid and may have no readily ascertainable market value.
Accordingly, there can be no assurance that the Collateral can be sold in a short period of time or in an orderly manner. In addition, in the event of a bankruptcy, the ability of the Holders to realize upon any of the Collateral may be subject to
certain bankruptcy law limitations as described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Certain Bankruptcy Limitations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The right of the First Lien Collateral Agent acting at the direction of the Applicable Authorized Representative to repossess and dispose of
the Collateral upon the occurrence of an Event of Default would be significantly impaired by any Bankruptcy Law in the event that a bankruptcy case were to be commenced by or against the Issuer or any Secured Guarantor prior to the First Lien
Collateral Agent having repossessed and disposed of the Collateral. Upon the commencement of a case for relief under the Bankruptcy Code, a secured creditor such as the First Lien Collateral Agent is prohibited from repossessing its security from a
debtor in a bankruptcy case, or from disposing of security without bankruptcy court approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In view of the broad equitable powers of a
U.S. bankruptcy court, it is impossible to predict how long payments under the Notes could be delayed following commencement of a bankruptcy case, whether or when the First Lien Collateral Agent acting at the direction of the Applicable Authorized
Representative could repossess or dispose of the Collateral, the value of the Collateral at any time during a bankruptcy case or whether or to what extent Holders of the Notes would be compensated for any delay in payment or loss of value of the
Collateral. The Bankruptcy Code permits only the payment and/or accrual of post-petition interest, costs and attorneys&#146; fees to a secured creditor during a debtor&#146;s bankruptcy case to the extent the value of such creditor&#146;s interest
in the Collateral is determined by the bankruptcy court to exceed the aggregate outstanding principal amount of the obligations secured by the Collateral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, in the event a domestic or foreign bankruptcy court determines that the value of the Collateral is not sufficient to repay all
amounts due on the Notes, the Holders of the Notes would hold secured claims only to the extent of the value of the Collateral to which the Holders of the Notes are entitled, and unsecured claims with respect to such shortfall. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Principal, Maturity and Interest </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Issuer has issued $700,000,000 in aggregate principal amount of 2026 Original Notes, $800,000,000 in aggregate principal amount of 2030 Original Notes and $500,000,000 in aggregate principal amount of 2032 Original Notes. The issuer will issue up to
$700,000,000 in aggregate principal amount of 2026 Exchange Notes, $800,000,000 in aggregate principal amount of 2030 Exchange Notes and $500,000,000 in aggregate principal amount of 2032 Exchange Notes in exchange for validly tendered Original
Notes in the Exchange Offer. The 2026 Notes will mature on September&nbsp;1, 2026, the 2030 Notes will mature on October&nbsp;15, 2030 and the 2032 Notes will mature on January&nbsp;15, 2032. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2026 Notes will bear interest at the rate of 1.650% per annum, the 2030 Notes will bear interest at the rate of 2.650% per annum, and the
2032 Notes will bear interest at the rate of 2.650% per annum, each computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. Interest on the Original Notes began
accruing on the Issue Date. Interest on the Exchange Notes will accrue from the date it was most recently paid on the applicable Original Notes. Interest on the 2026 Notes will be payable on March&nbsp;1 and September&nbsp;1 of each year. Interest
on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 41 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the 2030 Notes will be payable on April&nbsp;15 and October&nbsp;15 of each year. Interest on the 2032 Notes will be payable on January&nbsp;15 and July&nbsp;15 of each year. Interest payable on
any Note that is punctually paid or duly provided for on any interest payment date shall be paid to the person in whose name such Note is registered at the close of business on February&nbsp;15 and August&nbsp;15, in the case of the 2026 Notes,
April&nbsp;15 and October&nbsp;1, in the case of the 2030 Notes, or January&nbsp;1 and July&nbsp;1, in the case of the 2032 Notes, as the case may be, preceding such interest payment date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may issue additional Notes of any series from time to time after this offering under the Indentures (any such Notes of such series,
&#147;Additional Notes&#148;). Each series of Notes and any Additional Notes of such series subsequently issued under the Indentures will be treated as a single class for all purposes under the Indentures, including waivers, amendments, redemptions
and offers to purchase. Unless the context requires otherwise, references to &#147;Notes&#148; for all purposes of the Indentures and this &#147;Description of the Notes&#148; include any Additional Notes of such series that are actually issued.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will also pay Additional Interest to Holders if we fail to complete the Exchange Offer described in the Registration Rights Agreement
on or prior to March&nbsp;21, 2023, in the case of the 2030 Original Notes, and February&nbsp;24, 2024, in the case of the 2026 Original Notes and the 2032 Original Notes, or if certain other conditions contained in the Registration Rights
Agreements are not satisfied. See &#147;Exchange Offer; Additional Interest.&#148; All references in the Indentures and this &#147;Description of the Notes,&#148; in any context, to any interest or other amount payable on or with respect to the
Notes shall be deemed to include any Additional Interest required to be paid pursuant to the Registration Rights Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes
will be issued in book-entry form only. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mandatory Redemption; Offers to Purchase; Open Market Purchases </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer will not be required to make any mandatory redemption or sinking fund payments with respect to the Notes. However, under certain
circumstances, the Issuer may be required to offer to purchase Notes as described under the caption &#147;&#151;Repurchase at the Option of Holders.&#148; The Issuer may at any time and from time to time purchase Notes in the open market or
otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Optional Redemption </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Notes of each series may be redeemed, in whole or in part, at any time prior to the applicable Par Call Date, at the option of the Issuer, at a redemption, or &#147;make whole,&#148; price as calculated by the Issuer equal to the greater of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">100% of the aggregate principal amount of the Notes of such series to be redeemed, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an amount equal to the sum of the present value of the remaining scheduled payments of principal of and interest
on the Notes of such series to be redeemed (excluding accrued and unpaid interest to the redemption date and subject to the right of Holders on the relevant record date to receive interest due on the relevant interest payment date) discounted from
the redemption date to the applicable Par Call Date on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months) using a discount rate equal to
the Treasury Rate plus 15 basis points, in the case of the 2026 Notes, plus 30 basis points, in the case of the 2030 Notes, and 20 basis points, in the case of the 2032 Notes, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">plus accrued and unpaid interest, if any, to the redemption date. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Notes of any series are redeemed on or after the applicable Par Call Date, the redemption price for the Notes of such series to be
redeemed will equal 100% of the principal amount of such Notes of such series plus accrued and unpaid interest, if any, to such redemption date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 42 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption Procedure </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice of any redemption may be given prior to the redemption thereof, and any such redemption or notice may, at the Issuer&#146;s
discretion, be subject to one or more conditions precedent, including, but not limited to, completion of a financing transaction or other corporate transaction. Notes called for redemption will become due on the date fixed for redemption. Notices of
redemption will be mailed at least 15 days but not more than 60 days before the redemption date to each Holder of the Notes to be redeemed at its registered address. The notice of redemption for the Notes will state, among other things, the amount
of Notes to be redeemed, if less than all of the outstanding Notes are to be redeemed, the redemption date, the redemption price (or the method of calculating it) and each place that payment will be made upon presentation and surrender of Notes to
be redeemed. If the Trustee is to mail the notice to the Holders then (i)&nbsp;the notice should be given to the Trustee at least five business days prior to the date the notice is to be mailed (or such shorter period as the Trustee shall agree) and
(ii)Trustee shall receive an Officers&#146; Certificate and an Opinion of Counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless we default in payment of the redemption price,
interest will cease to accrue on any Notes that have been called for redemption on the redemption date. If the Issuer redeems less than all of the outstanding Notes of any series, the registrar and paying agent shall select the Notes of such series
to be redeemed in the manner described under &#147;&#151;Repurchase at the Option of Holders-Selection and Notice.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of
determining the optional redemption price, the following definitions are applicable: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Comparable Treasury Issue&#148; means, the
United States Treasury security selected by an Independent Investment Banker as having a maturity comparable to the Par Call Date that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new
issues of corporate debt securities of comparable maturity to the Par Call Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Comparable Treasury Price&#148; means, with
respect to any redemption date for any Note: (1)&nbsp;the average of the Reference Treasury Dealer Quotations for that redemption date, after excluding the highest and lowest of four such Reference Treasury Dealer Quotations; or (2)&nbsp;if the
Independent Investment Banker is given fewer than four Reference Treasury Dealer Quotations, the average of all quotations obtained by the Independent Investment Banker. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Independent Investment Banker&#148; means one of the Reference Treasury Dealers, to be appointed by the Issuer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Par Call Date&#148; means August&nbsp;1, 2026 (the date that is one month prior to the maturity date of the 2026 Notes) with respect to
the 2026 Notes, July&nbsp;15, 2030 (the date that is three months prior to the maturity date of the 2030 Notes) with respect to the 2030 Notes, and October&nbsp;15, 2031 (the date that is three months prior to the maturity date of the 2032 Notes)
with respect to the 2032 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Reference Treasury Dealer&#148; means each of J.P. Morgan Securities LLC, BofA Securities, Inc.,
Goldman Sachs&nbsp;&amp; Co. LLC and a Primary Treasury Dealer (as defined herein) selected by Trust Securities, Inc., and each of their respective successors and any other nationally recognized investment banking firm that is a primary U.S.
government securities dealer in New York City (a &#147;Primary Treasury Dealer&#148;) appointed from time to time by us; provided that if any of the foregoing shall cease to be a Primary Treasury Dealer, we shall substitute for such entity another
nationally recognized investment banking firm that is a Primary Treasury Dealer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Reference Treasury Dealer Quotations&#148; means,
with respect to each Reference Treasury Dealer and any redemption date for any Note, the average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue, expressed in each case as a
percentage of its principal amount, quoted in writing to the Independent Investment Banker by such Reference Treasury Dealer at 3:00 p.m., New York City time, on the third Business Day preceding such redemption date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 43 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Treasury Rate&#148; means, at the time of computation, (1)&nbsp;the semi-annual
equivalent yield to maturity of the United States Treasury Securities with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15 which has become publicly available at least two Business Days
prior to the redemption date or, if such Statistical Release is no longer published, any publicly available source of similar market data) for the maturity corresponding to the Comparable Treasury Issue; provided, however, that if no maturity is
within three months before or after the Par Call Date, yields for the two published maturities most closely corresponding to the Comparable Treasury Issue will be determined and the Treasury Rate will be interpolated or extrapolated from those
yields on a straight line basis, rounding to the nearest month; or (2)&nbsp;if that release, or any successor release, is not published during the week preceding the calculation date or does not contain such yields, the rate per annum equal to the
semiannual equivalent yield to maturity of the Comparable Treasury Issue, calculated using a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that redemption date.
The Treasury Rate will be calculated on the third Business Day preceding the redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth above, the Notes will
not be redeemable by us prior to maturity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Denominations, Registration and Transfer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer will issue the Notes in registered form and in denominations of $2,000 or any integral multiple of $1,000 in excess thereof. We have
appointed the Trustee as security registrar. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Repurchase at the Option of Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Change of Control Following a Downgrade from Investment Grade Ratings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If on any date following the Issue Date, one or both of the Rating Agencies (a)&nbsp;withdraw their Investment Grade Rating or downgrade the
rating assigned to the Notes below an Investment Grade Rating and/or (b)&nbsp;the Issuer or any of its Affiliates enters into an agreement to effect a transaction that would result in a Change of Control and one or both of the Rating Agencies
indicate that if consummated, such transaction (alone or together with any related recapitalization or refinancing transactions) would cause such Rating Agency to withdraw its Investment Grade Rating or downgrade the ratings assigned to the Notes
below an Investment Grade Rating, then the Issuer and the Subsidiaries will thereafter (the &#147;Reversion Date&#148;) be subject to the covenant described in this subsection &#147;&#151;Change of Control Following a Downgrade from Investment Grade
Ratings&#148; (the &#147;Suspended Covenant&#148;) under the Indentures with respect to future events, including, without limitation, a proposed transaction described in clause (b)&nbsp;above. As of the date of this prospectus, the Notes do not have
Investment Grade Ratings from both Rating Agencies. Accordingly, the Suspended Covenant is in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Suspended Covenant provides
that if a Change of Control occurs, unless the Issuer has previously or concurrently mailed a redemption notice with respect to all the outstanding Notes as described under &#147;&#151;Optional Redemption,&#148; the Issuer will make an offer to
purchase all of the Notes of each series pursuant to the offer described below (the &#147;Change of Control Offer&#148;) at a price in cash (the &#147;Change of Control Payment&#148;) equal to 101% of the aggregate principal amount of the Notes of
such series plus accrued and unpaid interest, if any, to the date of purchase, subject to the right of Holders of the Notes of record on the relevant record date to receive interest due on the relevant interest payment date. Within 30 days following
any Change of Control, the Issuer will send notice of such Change of Control Offer by first-class mail, with a copy to the Trustee and the registrar, to each Holder of Notes to the address of such Holder appearing in the security register with a
copy to the Trustee and the registrar, or otherwise deliver such notice in accordance with the procedures of DTC, with the following information: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that a Change of Control Offer is being made pursuant to the covenant entitled &#147;Change of Control&#148;
and that all Notes properly tendered pursuant to such Change of Control Offer will be accepted for payment by the Issuer; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 44 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the purchase price and the purchase date, which will be no earlier than 30 days nor later than 60 days from the
date such notice is mailed (the &#147;Change of Control Payment Date&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that any Note not properly tendered will remain outstanding and continue to accrue interest;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that unless the Issuer defaults in the payment of the Change of Control Payment, all Notes accepted for payment
pursuant to the Change of Control Offer will cease to accrue interest on the Change of Control Payment Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that Holders electing to have any Notes purchased pursuant to a Change of Control Offer will be required to
surrender such Notes, with the form entitled &#147;Option of Holder to Elect Purchase&#148; on the reverse of such Notes completed, to the paying agent specified in the notice at the address specified in the notice prior to the close of business on
the third Business Day preceding the Change of Control Payment Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that Holders will be entitled to withdraw their tendered Notes and their election to require the Issuer to
purchase such Notes; provided that the paying agent receives, not later than the close of business on the 30th day following the date of the Change of Control notice, a facsimile transmission or letter setting forth the name of the Holder of the
Notes, the principal amount of Notes tendered for purchase, and a statement that such Holder is withdrawing its tendered Notes and its election to have such Notes purchased; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that Holders tendering less than all of their Notes of any series will be issued new Notes of such series and
such new Notes will be equal in principal amount to the unpurchased portion of the Notes of such series surrendered. The unpurchased portion of the Notes of such series must be equal to $2,000 or an integral multiple of $1,000 in excess thereof; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the other instructions, as determined by us, consistent with the covenant described hereunder, that a Holder
must follow. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer will comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14e-1</FONT> under
the Exchange Act and any other securities laws and regulations thereunder to the extent such laws or regulations are applicable in connection with the repurchase of Notes pursuant to a Change of Control Offer. To the extent that the provisions of
any securities laws or regulations conflict with the provisions of the Indentures, the Issuer will comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations described in the Indentures by
virtue thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Payment Date, the Issuer will, to the extent permitted by law, </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">accept for payment all Notes issued by it or portions thereof properly tendered pursuant to the Change of
Control Offer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deposit with the paying agent an amount equal to the aggregate Change of Control Payment in respect of all
Notes or portions thereof so tendered; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deliver, or cause to be delivered, to the Trustee for cancellation the Notes so accepted together with an
Officers&#146; Certificate to the Trustee stating the aggregate principal amount of such Notes or portions thereof that have been tendered to and purchased by the Issuer and an Opinion of Counsel, in each case, stating that all conditions precedent
to the consummation of the Change of Control Offer have been complied with. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Senior Credit Facility provides, and
future credit agreements or other agreements relating to senior Indebtedness to which the Issuer becomes a party may provide, that certain change of control events with respect to the Issuer would constitute a default thereunder (including a Change
of Control under the Indenture). If we experience a change of control that triggers a default under our Senior Credit Facility, we could seek a waiver of such default or seek to refinance our Senior Credit Facility. In the event we do not obtain
such a waiver or refinance the Senior Credit Facility, such default could result in amounts outstanding under our Senior Credit Facility being declared due and payable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 45 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer&#146;s ability to pay cash to the Holders of the Notes following the occurrence
of a Change of Control may be limited by its then-existing financial resources. Therefore, sufficient funds may not be available when necessary to make any required repurchases. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Change of Control purchase feature of the Notes may in certain circumstances make more difficult or discourage a sale or takeover of us
and, thus, the removal of incumbent management. The Change of Control purchase feature is a result of negotiations between the Initial Purchasers and us. We have no present intention to engage in a transaction involving a Change of Control, although
it is possible that we could decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control under the
Indentures, but that could increase the amount of indebtedness outstanding at such time or otherwise affect our capital structure or credit ratings. Certain provisions under the Indentures relative to the Issuer&#146;s obligation to make an offer to
repurchase the Notes as a result of a Change of Control may be waived or modified with the written consent of the Holders of a majority in principal amount of the Notes. The Indentures will not contain any covenants or provisions that may afford
Holders of the Notes protection in the event of a highly leveraged transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer will not be required to make a Change of
Control Offer following a Change of Control if a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in the Indentures applicable to a Change of Control Offer made by
us and purchases all Notes validly tendered and not withdrawn under such Change of Control Offer. Notwithstanding anything to the contrary herein, a Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change
of Control, if a definitive agreement is in place for the Change of Control at the time of making of the Change of Control Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
definition of &#147;Change of Control&#148; includes a disposition of all or substantially all of the assets of the Issuer to any Person. Although there is a limited body of case law interpreting the phrase &#147;substantially all,&#148; there is no
precise established definition of the phrase under applicable law. Accordingly, in certain circumstances there may be a degree of uncertainty as to whether a particular transaction would involve a disposition of &#147;all or substantially all&#148;
of the assets of the Issuer. As a result, it may be unclear as to whether a Change of Control has occurred and whether a Holder of Notes may require the Issuer to make an offer to repurchase the Notes as described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions under the Indentures relating to the Issuer&#146;s obligation to make an offer to repurchase the Notes as a result of a Change
of Control may be waived or modified with the written consent of the Holders of a majority in principal amount of the Notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Selection and Notice </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Issuer is redeeming less than all of the Notes of any series issued by it at any time, the Notes of such series will be selected for
redemption (a)&nbsp;if the Notes of such series are listed on any national securities exchange, in compliance with the requirements of the principal national securities exchange on which the Notes of such series are listed, (b)&nbsp;on a pro rata
basis to the extent practicable or (c)&nbsp;by lot or such other similar method in accordance with the procedures of DTC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices of
purchase or redemption shall be mailed by first-class mail, postage prepaid, at least 15 but not more than 60 days before the purchase or redemption date to each Holder of Notes at such Holder&#146;s registered address or otherwise in accordance
with the procedures of DTC, except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the Notes or a satisfaction and discharge of the Indentures. If any Note
of a series is to be purchased or redeemed in part only, any notice of purchase or redemption that relates to such Note of such series shall state the portion of the principal amount thereof that has been or is to be purchased or redeemed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 46 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer will issue a new Note of any series in a principal amount equal to the unredeemed
portion of the original Note of such series in the name of the Holder upon cancellation of the original Note. Notes called for redemption become due on the date fixed for redemption. On and after the redemption date, interest ceases to accrue on
Notes of such series or portions thereof called for redemption. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Release of Collateral and Guarantees upon Investment Grade Rating Event </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If on any date following the Issue Date, (a)(i) the Notes have Investment Grade Ratings from both Rating Agencies and (ii)&nbsp;no Default has
occurred and is continuing under the Indentures (the occurrence of the events described in the foregoing clauses (i)&nbsp;and (ii) being collectively referred to as an &#147;Investment Grade Rating Event&#148;), and (b)&nbsp;the terms of all other
First Lien Obligations and Junior Lien Obligations provide that the Liens on the Collateral securing such First Lien Obligations and Junior Lien Obligations shall be, and substantially concurrently are, released, then, beginning on that day (such
date, the &#147;Collateral Release Date&#146;&#148;), the Guarantees shall be released (to the extent the guarantees by the Guarantors of all other First Lien Obligations and Junior Lien Obligations are also released, whether or not such other
guarantees can be reinstated), the Liens on the Collateral securing the Notes, the Notes Obligations and the Guarantees of the Secured Guarantors shall be released, and the Issuer and its Restricted Subsidiaries will not be subject to the covenant
under &#147;&#151;Additional subsidiary guarantees&#148; (the &#147;Guarantees Covenant&#148;) or the covenant under &#147;&#151;After-acquired collateral&#148; (the &#147;Collateral Covenant&#148;). In the event the collateral and Guarantees are
released and the Guarantees Covenant is no longer in effect upon an Investment Grade Rating Event, the collateral and the Guarantees will not be reinstated upon any subsequent downgrade or withdrawal of the Investment Grade Ratings, even if the
collateral and the Guarantees are reinstated with respect to other First Lien Obligations and Junior Lien Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of
this prospectus, the Notes do not have Investment Grade Ratings from both Rating Agencies. In addition, as of the date of this prospectus, the condition in clause (b)&nbsp;of the preceding paragraph has not been met because the conditions to the
release of the Collateral under the Senior Credit Facilities have not been met. In order for the Collateral to be released under the terms of the Senior Credit Facilities, we must receive an investment grade corporate rating from both Moody&#146;s
and S&amp;P, no default or event of default shall have occurred and be continuing under the Senior Credit Facilities and the liens on the Collateral securing the Notes must be released contemporaneously. Accordingly, if we were to receive investment
grade corporate ratings from both Rating Agencies and the other conditions to release of the Collateral under the Senior Credit Facilities are met, or if we were to amend the Senior Credit Facilities in the future to otherwise permit the release of
the Collateral, the Collateral securing the Notes and the Guarantees will be released. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Covenants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Set forth below are summaries of certain covenants contained in the Indentures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Limitations on Mortgages </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in the Indentures or in the Notes shall in any way restrict or prevent the Issuer or any Subsidiary from incurring any Indebtedness;
provided, however, that the Indentures provide that neither the Issuer nor any of its Subsidiaries will issue, assume or guarantee any indebtedness or obligation secured by Mortgages (other than Permitted Liens) upon any Principal Property, unless
the Notes shall be secured equally and ratably with (or prior to) such Indebtedness. This restriction will not apply to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages securing all or any part of the purchase price of property acquired or cost of construction of
property or cost of additions, substantial repairs, alterations or improvements or property, if the Indebtedness and the related Mortgages are incurred within 12 months of the later of the acquisition or completion of construction and full operation
or additions, repairs, alterations or improvements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages existing on property at the time of its acquisition by the Issuer or a Subsidiary or on the property
of a Person at the time of the acquisition of such Person by the Issuer or a Subsidiary (including acquisitions through merger or consolidation); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 47 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages to secure Indebtedness on which the interest payments to holders of the related Indebtedness are
excludable from gross income for federal income tax purposes under Section&nbsp;103 of the Code; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages in favor of the Issuer or any Subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages existing on the date of the 2020 Indenture or the 2021 Indenture, as applicable;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages in favor of a government or governmental entity that (i)&nbsp;secure Indebtedness which is guaranteed
by the government or governmental entity, (ii)&nbsp;secure Indebtedness incurred to finance all or some of the purchase price or cost of construction of goods, products or facilities produced under contract or subcontract for the government or
governmental entity, or (iii)&nbsp;secure Indebtedness incurred to finance all or some of the purchase price or cost of construction of the property subject to the Mortgage; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages incurred in connection with the borrowing of funds where such funds are used to repay, within 120
days after entering into such Mortgage, Indebtedness in the same principal amount secured by other Mortgages on Principal Property with at least the same appraised fair market value; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extension, renewal or replacement of any Mortgage referred to in clauses (a)&nbsp;through (g) above;
provided the amount secured is not increased and such extension, renewal or replacement Mortgage relates to the same property. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Limitations on Sale and Lease-Back Transactions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indentures provide that neither the Issuer nor any Subsidiary will, after the Issue Date, enter into any Sale and Lease-Back Transaction
with respect to any Principal Property with another person (other than with the Issuer or a Subsidiary) unless either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer or such Subsidiary could incur Indebtedness secured by a mortgage on the property to be leased
without equally and ratably securing the Notes; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">within 150 days, the Issuer applies the greater of the net proceeds of the sale of the leased property or the
fair value of the leased property, net of all Notes delivered under the Indentures, to the voluntary retirement of the Funded Debt of the Issuer and its Restricted Subsidiaries and/or the acquisition or construction of a Principal Property.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing limitation shall not apply to any Sale and Lease-Back Transaction that is in effect on the Issue Date and
any renewals or extensions thereof; provided that if any Principal Property is substituted for a Principal Property that is a subject of a Sale and Lease-Back Transaction that is in effect on the Issue Date, for purposes of &#147;&#151;Certain
Covenants&#151;Exempted transactions,&#148; any increase in Attributable Indebtedness shall be counted as Indebtedness for purposes of the calculation set forth thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Exempted Transactions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions described above under &#147;&#151;Limitations on Mortgages&#148; and &#147;&#151;Limitations on Sale
and Lease-Back Transactions,&#148; if the aggregate outstanding principal amount of all Indebtedness of the issuer and its Subsidiaries that is subject to and not otherwise permitted under these restrictions does not exceed 15.0% of the Consolidated
Net Tangible Assets of the issuer and its Subsidiaries, then: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issuer or any of its Subsidiaries may issue, assume or guarantee Indebtedness secured by Mortgages without
any requirement to equally and ratably secure the notes; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issuer or any of its Subsidiaries may enter into any Sale and Lease-Back Transaction.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 48 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Additional Subsidiary Guarantees </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time prior to the Collateral Release Date, if any Restricted Subsidiary of the issuer other than a Guarantor (i)&nbsp;guarantees any
Indebtedness under the Senior Credit Facility, any other First Lien Obligations or any Junior Lien Obligations or (ii)&nbsp;if the issuer or the Guarantors have no Indebtedness outstanding, and all commitments thereunder have been terminated under
the Senior Credit Facility, any other First Lien Obligations or any Junior Lien Obligations, guarantees any Additional Indebtedness, then within 30 days thereof, the issuer shall cause such Restricted Subsidiary to execute and deliver to the Trustee
a supplemental indenture pursuant to which such Restricted Subsidiary will guarantee payment of the Notes on the same terms and conditions as those applicable to the Guarantors under the Indentures and will deliver to the Trustee an Officers&#146;
Certificate and Opinion of Counsel that such supplemental indenture is authorized or permitted by the indenture, and an Opinion of Counsel that such supplemental indenture has been duly authorized, executed and delivered and constitutes a legally
valid and enforceable obligation (subject to customary qualifications and exceptions). In addition, at any time prior to the Collateral Release Date, if such Restricted Subsidiary grants any Lien to secure any Indebtedness described in clause
(i)&nbsp;or (ii) above, such Restricted Subsidiary shall grant a first-priority perfected security interest in the Collateral as security for the Notes, shall execute and deliver to the Trustee joinders to any applicable Security Document for the
benefit of the holders of the Notes and shall be a &#147;Secured Guarantor&#148; for all purposes under the Indentures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Thereafter, such
Restricted Subsidiary will be a Guarantor with respect to the Notes until such Restricted Subsidiary&#146;s Guarantee with respect to the Notes is released in accordance with the Indentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the issuer may elect, in its sole discretion, to cause any Restricted Subsidiary that is not otherwise required to be a Guarantor
to become a Guarantor by complying with the applicable provisions of the second preceding paragraph until such Restricted Subsidiary&#146;s Guarantee with respect to the Notes is released in accordance with the Indentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, any Restricted Subsidiary that becomes a Guarantor pursuant to the third preceding paragraph will be an Unsecured
Guarantor unless such Restricted Subsidiary grants any Lien to secure any Indebtedness described in clause (i)&nbsp;or (ii) of the third preceding paragraph above, in which case, and only such case, such Restricted Subsidiary shall grant a
first-priority perfected security interest in the Collateral as security for the Notes and shall execute and deliver to the Trustee joinders to any applicable Security Document for the benefit of the holders of the Notes, upon which such Restricted
Subsidiary shall be a &#147;Secured Guarantor&#148; for all purposes under the Indentures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SEC reports </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding that the Issuer may not be subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act or otherwise
report on an annual and quarterly basis on forms provided for such annual and quarterly reporting pursuant to rules and regulations promulgated by the SEC, if not filed electronically with the SEC through EDGAR (or any successor system), the Issuer
will file with the SEC (to the extent permitted by the Exchange Act), and make available to the Trustee and the Holders, without cost to any Holder, the annual reports and the information, documents and other reports (or copies of such portions of
any of the foregoing as the SEC may by rules and regulations prescribe) that are specified in Sections 13 and 15(d) of the Exchange Act with respect to U.S. issuers within the time periods specified therein or in the relevant forms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the Issuer is not permitted to file such reports, documents and information with the SEC pursuant to the Exchange Act, the
Issuer will nevertheless make available such Exchange Act reports, documents and information to the Trustee and the Holders as if the Issuer were subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act within the time
periods specified therein or in the relevant forms, which requirement may be satisfied by posting such reports, documents and information on its website within the time periods specified by this covenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 49 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, no later than five Business Days after the date the quarterly and annual
financial information for the prior fiscal period have been furnished pursuant to clause (1)&nbsp;above, the Issuer shall also hold live quarterly conference calls with the opportunity to ask questions of management. No fewer than three Business
Days prior to the date such conference call is to be held, the Issuer shall issue a press release to the appropriate U.S. wire services announcing such quarterly conference call for the benefit of the Trustee, the Holders, beneficial owners of the
Notes, prospective investors in the Notes (which prospective investors shall be limited to &#147;qualified institutional buyers&#148; within the meaning of Rule 144A of the Securities Act or non U.S. persons (as defined in Regulation S under the
Securities Act) that certify their status as such to the reasonable satisfaction of the Issuer), and securities analysts and market making financial institutions (collectively, &#147;Eligible Institutions&#148;), which press release shall contain
the time and the date of such conference call and direct the recipients thereof to contact an individual at the Issuer (for whom contact information shall be provided in such notice) to obtain information on how to access such quarterly conference
call. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Issuer has designated any of its Subsidiaries as Unrestricted Subsidiaries and such Unrestricted Subsidiaries, either
individually or collectively, would otherwise have been a Significant Subsidiary, then the quarterly and annual financial information required by the preceding paragraph shall include a reasonably detailed presentation, as determined in good faith
by Senior Management of the Issuer, either on the face of the financial statements or in the footnotes to the financial statements and in the &#147;Management&#146;s discussion and analysis of financial condition and results of operations&#148;
section, of the financial condition and results of operations of the Issuer and its Restricted Subsidiaries separate from the financial condition and results of operations of the Unrestricted Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Issuer and the Guarantors have agreed that they will make available to the Holders and to prospective investors, upon the
request of such Holders, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act so long as the Original Notes are not freely transferable under the Securities Act. For purposes of this covenant, the Issuer and
the Guarantors will be deemed to have furnished the reports to the Trustee and the Holders as required by this covenant if the Issuer has filed such reports with the SEC via the EDGAR filing system and such reports are publicly available. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Indentures,
an &#147;Event of Default&#148; applicable to the Notes of any series means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to pay the principal or any premium on the Notes of such series when due; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to pay any interest or Additional Interest (as required by the Registration Rights Agreement) on the
Notes of such series when due, and such default continues for a period of 30 days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to perform, or the breach of, any of our other applicable covenants or warranties in the Indentures with
respect to such series, and such default continues for a period of 60 days after written notice by Holders of at least 10% in principal amount of the outstanding Notes of such series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default under any mortgage, indenture or instrument under which there is issued or by which there is secured or
evidenced any Indebtedness for money borrowed by the Issuer or any of its Restricted Subsidiaries (or the payment of which is guaranteed by the Issuer or any of its Restricted Subsidiaries), other than Indebtedness owed to the Issuer or a Restricted
Subsidiary, whether such Indebtedness or guarantee now exists, or is created after the Issue Date, which default: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">is caused by a failure to pay principal of, or interest or premium, if any, on such Indebtedness prior to the
expiration of the grace period provided in such Indebtedness (&#147;payment default&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results in the acceleration of such Indebtedness prior to its maturity (the &#147;cross acceleration
provision&#148;), </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and, in each case, the principal amount of any such Indebtedness, together with the principal amount
of any other such Indebtedness under which there has been a payment default or the maturity of which has </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 50 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
been so accelerated, aggregates $50.0&nbsp;million or more; provided that in connection with any series of Convertible Notes, (a)&nbsp;any conversion of such Indebtedness by a holder thereof into
shares of Common Stock, cash or a combination of cash and shares of Common Stock, (b)&nbsp;the rights of holders of such Indebtedness to convert into shares of Common Stock, cash or a combination of cash and shares of Common Stock and (c)&nbsp;the
rights of holders of such Indebtedness to require any repurchase by the Issuer of such Indebtedness in cash upon a fundamental change shall not, in itself, constitute an Event of Default under this clause. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by the Issuer or any Significant Subsidiary or group of Restricted Subsidiaries that, taken together (as
of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary to pay final judgments aggregating in excess of $50.0&nbsp;million (net of any amounts that a
reputable and creditworthy insurance company has acknowledged liability for in writing), which judgments are not paid, discharged or stayed for a period of 60 days or more after such judgment becomes final (the &#147;judgment default
provision&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">events in bankruptcy, insolvency or reorganization of the Issuer or any Significant Subsidiary or group of
Restricted Subsidiaries that, taken together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Guarantee of any Significant Subsidiary or group of Guarantors that, taken together (as of the latest audited
consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary shall for any reason cease to be in full force and effect or be declared null and void or any responsible officer of any
Guarantor that is a Significant Subsidiary or group of Guarantors that, taken together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary, as the
case may be, denies that it has any further liability under its Guarantee or gives notice to such effect, other than by reason of the termination of the Indentures or the release of any such Guarantee in accordance with the Indenture; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent applicable, with respect to any Collateral having a fair market value in excess of
$100.0&nbsp;million, individually or in the aggregate, (a)&nbsp;the security interest under the Security Documents, at any time, ceases to be in full force and effect for any reason other than in accordance with the terms of the Indentures and the
Security Documents, (b)&nbsp;any security interest created thereunder or under the Indentures is declared invalid or unenforceable by a court of competent jurisdiction or (c)&nbsp;the Issuer or any Secured Guarantor asserts, in any pleading in any
court of competent jurisdiction, that any such security interest is invalid or unenforceable. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Event of Default
(other than events in bankruptcy, insolvency or reorganization) with respect to the Notes of a series occurs and is continuing, either the Trustee or the Holders of at least 25% in aggregate principal amount of the outstanding Notes of such series
may declare the principal amount of, premium, if any, and accrued and unpaid interest, if any, on all the Notes of such series to be due and payable immediately. If an Event of Default constituting an event in bankruptcy, insolvency or
reorganization above occurs and is continuing, the principal of, premium, if any, and accrued and unpaid interest, if any, on all the Notes of such series will become and be immediately due and payable without any declaration or other act on the
part of the Trustee or any Holders. The Holders of a majority in principal amount of the outstanding Notes of a series may waive all past defaults (except with respect to nonpayment of principal, premium or interest) and rescind any such
acceleration with respect to the Notes of such series and its consequences if (1)&nbsp;rescission would not conflict with any judgment or decree of a court of competent jurisdiction and (2)&nbsp;all existing Events of Default, other than the
nonpayment of the principal of, premium, if any, and interest on the Notes of such series that have become due solely by such declaration of acceleration, have been cured or waived. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a declaration of acceleration of the Notes of a series because an Event of Default described in the fourth bullet point of the
second preceding paragraph has occurred and is continuing, the declaration of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 51 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acceleration of the Notes of such series shall be automatically annulled if the default triggering such Event of Default shall be remedied or cured by the Issuer or a Restricted Subsidiary or
waived by the holders of the relevant Indebtedness within 20 days after the declaration of acceleration with respect thereto and if (1)&nbsp;the annulment of the acceleration of the Notes of such series would not conflict with any judgment or decree
of a court of competent jurisdiction and (2)&nbsp;all existing Events of Default, except nonpayment of principal, premium, if any, or interest on the Notes of such series that became due solely because of the acceleration of the Notes of such
series, have been cured or waived. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the duties of the Trustee during a default to act with the required standard of care, the
Trustee is not obligated to exercise any of its rights or powers under the Indentures at the request or direction of any of the Holders unless the Holders shall have offered to the Trustee indemnity reasonably satisfactory to it. Subject to these
indemnification provisions, the Holders of a majority in aggregate principal amount of the outstanding Notes of the applicable series may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or
exercising any trust or power conferred on the Trustee, with respect to the Notes of such series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will furnish the Trustee annually
with a statement as to our performance of certain obligations under the Indentures. Upon becoming aware of any Default or Event of Default, we will deliver to the Trustee a notice specifying such Default or Event of Default. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Without
Holder Consent </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without the consent of any Holders of Notes of the applicable series, the Issuer, any Guarantor (with respect to a
Guarantee or the Indentures to which it is a party) and the Trustee may amend or supplement the Indentures, any Security Document and any Guarantee or Notes of such series for any of the following purposes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to evidence the succession of another corporation to the Issuer and the assumption by such successor of the
covenants of the Issuer in compliance with the requirements set forth in the Indenture; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add to the covenants for the benefit of the Holders or to surrender any right or power herein conferred upon
the Issuer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add any additional Events of Default; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to change or eliminate any of the provisions of the Indentures; provided that any such change or elimination
shall become effective only when there are no outstanding Notes of such series created prior to the execution of such supplemental indenture that are entitled to the benefit of such provision and as to which such supplemental indenture would apply;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add a Guarantor to the Notes of such series; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to supplement any of the provisions of the Indentures to such extent necessary to permit or facilitate the
defeasance and discharge of the Notes of such series; provided that any such action does not adversely affect the interests of the Holders of the Notes of such series in any material respect; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to evidence and provide for the acceptance of appointment hereunder by a successor Trustee and to add to or
change any of the provisions of the Indentures necessary to provide for or facilitate the administration of the trusts by more than one Trustee; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to cure any ambiguity, to correct or supplement any provision of the Indentures which may be defective or
inconsistent with any other provision; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to conform the text of the Indentures, the Notes of such series, the Guarantees or the Security Documents to
any provision of this &#147;Description of the Notes&#148; section to the extent that such provision was intended to be a verbatim recitation of a provision of the Indentures, the Notes of such series, the Guarantees or the Security Documents;
provided that, in each instance, the Issuer delivers to the Trustee an Officers&#146; Certificate to such effect; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 52 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to change any place or places where the principal of and premium, if any, and interest, if any, on the Notes of
such series shall be payable, the Notes of such series may be surrendered for registration or transfer, the Notes of such series may be surrendered for exchange, and notices and demands to or upon the Issuer may be served; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to mortgage, pledge, hypothecate or grant any other Lien in favor of the First Lien Collateral Agent for the
benefit of the Trustee and the Holders of the Notes of such series, as additional security for the payment and performance of all or any portion of the Obligations, in any property or assets, including any which are required to be mortgaged, pledged
or hypothecated, or in which a Lien is required to be granted in favor of the First Lien Collateral Agent for the benefit of the Trustee and the Holders of the Notes of such series pursuant to the Indentures, any of the Security Documents or
otherwise; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to release Collateral from the Lien of the Indentures and the Security Documents when permitted or required by
the Security Documents or the Indentures; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to add Additional First Lien Secured Parties to any Security Documents in accordance with such Security
Documents; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">provide for the issuance of Exchange Notes of such series or private exchange notes (which shall be identical
to Exchange Notes of such series except that they will not be freely transferable) and which shall be treated, together with any outstanding Notes of such series, as a single class of securities; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">comply with any requirement of the SEC in connection with any required qualification of the Indentures under
the Trust Indenture Act. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the incurrence of any Junior Lien Obligations permitted under the terms of
the Indentures, without the consent of any Holder of Notes of such series, the First Lien Collateral Agent shall, on behalf of the holders of the First Lien Obligations, enter into a customary intercreditor agreement with the representative of such
Junior Lien Obligations. The Trustee and First Lien Collateral Agent shall be entitled to rely upon an Officers&#146; Certificate certifying that such Junior Lien Obligations, as the case may be, were incurred and secured in compliance with the
Indentures and the Security Documents, and no Opinion of Counsel shall be required in connection therewith (unless the Trustee is an Applicable Authorized Representative). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>With Holder Consent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer and the Trustee may modify and amend the Indentures, any Guarantee or any Security Document with the consent of the Holders of a
majority in aggregate principal amount of the outstanding Notes of the applicable series; however, we must have the consent of the Holder of each outstanding Note of such series affected to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">change the stated maturity of the principal of, or installment of interest, if any, on, such Notes of such
series, or reduce the principal amount thereof or the interest thereon or any premium payable upon redemption thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">change the currency in which the principal of (and premium, if any) or interest on such Notes of such series
are denominated or payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">waive a Default or Event of Default in the payment of principal of, premium, if any, or interest on the Notes
of such series (except a rescission of acceleration of the Notes of such series by the Holders of at least a majority in aggregate principal amount of the then outstanding Notes of such series with respect to a nonpayment default and a waiver of the
payment default that resulted from such acceleration); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">reduce the premium payable upon the redemption or repurchase of any Note of such series or change the time at
which any Note of such series may be redeemed or repurchased as described above under &#147;&#151;Optional redemption&#148; or &#147;&#151;Repurchase at the option of holders&#151;Change of control,&#148; whether through an amendment or waiver of
provisions in the covenants, definitions or otherwise (except amendments to the definitions of &#147;Change of Control&#148; and &#147;Permitted Holders&#148;); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 53 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">impair the right of any Holder to receive payment of principal of, premium, if any, or interest on such
Holder&#146;s Notes of such series on or after the due dates therefor or impair the right to institute suit for the enforcement of any payment on or after the stated maturity thereof (or, in the case of redemption, on or after the redemption date);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">modify the provisions that require Holder consent to modify or amend the Indentures or that permit Holders to
waive compliance with certain provisions of the Indentures or certain defaults; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make any change to or modify the ranking of such Notes of such series or the ranking of the Liens with respect
to such Notes of such series that would adversely affect the Holders; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">except as expressly permitted by the Indentures, modify the Guarantees of any Significant Subsidiary in any
manner adverse to the Holders of the Notes of such series. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, without the consent of at least 75% in
aggregate principal amount of Notes of such series then outstanding, an amendment, supplement or waiver may not modify any Security Document or the provisions of the Indentures dealing with the Security Documents or application of trust moneys, or
otherwise release any Collateral, in any manner materially adverse to the Holders of the Notes of such series other than in accordance with the Indentures and the Security Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Holders of a majority in aggregate principal amount of the outstanding Notes of the applicable series may, on behalf of all Holders of
Notes of such series, waive any past default under the Indentures with respect to Notes of such series. However, such Holders may not waive a past default in the payment of principal, premium or interest, or any sinking fund installment with respect
to the Notes of such series, or waive a covenant or provision that cannot be modified or amended, without the consent of the Holders of each outstanding Note of such series affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger, Sale or Lease of Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Issuer may consolidate with or merge into, or transfer or lease all or substantially all of its assets to another Person (whether or not
the Issuer is the surviving corporation) without the consent of the Holders of the Notes under the Indentures if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Issuer is the surviving entity or the Person formed by or surviving any such consolidation or merger, or to
whom any such transfer or lease will have been made, is a corporation, partnership, limited partnership, limited liability corporation or trust organized or existing under the laws of the United States, any state thereof, the District of Columbia,
or any territory thereof (the Issuer or such Person, as the case may be, being herein called the &#147;Successor Person&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Successor Person assumes the Issuer&#146;s obligations on the Notes and under the Indentures, as if such
Successor Person were an original party to the Indentures and assumes by written agreement all of the obligations of the Issuer under the Registration Rights Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">after giving effect to the transaction, no Event of Default, and no event which, after notice or lapse of time or
both, would become an Event of Default, shall have occurred and be continuing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, as a result of any such consolidation or merger or such conveyance, transfer or lease, properties or assets
of the Issuer would become subject to a mortgage, pledge, lien, security interest or other encumbrance that would not be permitted by the Indentures, the Issuer or such Successor Person, as the case may be, shall take such steps as shall be
necessary effectively to secure all the Notes equally and ratably with (or prior to) all Indebtedness secured thereby; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each Guarantor, unless it is the other party to the transactions described above, shall have by supplemental
indenture confirmed that its Guarantee shall apply to such Person&#146;s obligations under the Indentures and the Notes and shall have by written agreement confirmed that its obligations under the Registration Rights Agreement shall continue to be
in effect; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 54 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the Collateral Release Date, the Collateral owned by the Successor Person will (a)&nbsp;continue to
constitute Collateral under the Indentures and the Security Documents, (b)&nbsp;be subject to a Lien in favor of the First Lien Collateral Agent for the benefit of the Trustee and the Holders of the Notes and (c)&nbsp;not be subject to any other
Lien, other than Permitted Liens; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the Collateral Release Date, to the extent any assets of the Person which is merged or consolidated with
or into the Successor Person are assets of the type which would constitute Collateral under the Security Documents, the Successor Person will take such action as may be reasonably necessary to cause such property and assets to be made subject to the
Lien of the Security Documents in the manner and to the extent required in the Indentures or any of the Security Documents and shall take all reasonably necessary action so that such Lien is perfected to the extent required by the Security
Documents; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Issuer has delivered to the Trustee an Officers&#146; Certificate and an Opinion of Counsel each stating that
such consolidation, merger, conveyance, transfer or lease and such supplemental indenture comply with this covenant and that all conditions precedent (including, without limitation, under the Indentures and the Security Documents) provided for
relating to such transaction have been complied with. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations described in the Indentures, the
Successor Person will succeed to, and be substituted for, the Issuer under the Notes, the Guarantees and the Registration Rights Agreements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Defeasance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be discharged from our
obligations under the applicable series of Notes, and we will not be subject to the limitations in the Indentures discussed in the above sections, if we deposit with the Trustee trust money or U.S. government obligations that are sufficient (as
certified by an independent public accountant designated by the Issuer) to pay all principal, premium and interest on the Notes of such series and the Holders of the Notes of such series have a valid perfected exclusive security interest on such
deposit. We would deliver to the Trustee an Officers&#146; Certificate and an Opinion of Counsel to the effect that the deposit and related defeasance would not (1)&nbsp;cause the beneficial owners of the Notes of such series to recognize income,
gain or loss for United States federal income tax purposes, (2)&nbsp;result in the delisting of the Notes of such series from any national securities exchange (if so listed) and (3)&nbsp;all conditions precedent under the Indentures and the Security
Documents relating to the defeasance of the Notes of such series have been complied with. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notices </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices to Holders will be mailed to the addresses of the holders listed in the security register. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will construe the
Indentures and the Notes in accordance with the laws of the State of New York. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concerning the trustee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee has normal banking relationships with us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain definitions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Additional
First Lien Obligations&#148; means Obligations in respect of any Indebtedness incurred after the applicable Issue Date that is secured by a Lien on the Common Collateral pursuant to the applicable First Lien Security Documents, which Lien is
permitted to be incurred under the Indentures, the Security Documents and all other then-existing First Lien Security Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 55 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Additional First Lien Secured Parties&#148; means the holders of any Additional First
Lien Obligations and any Authorized Representative with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Additional Indebtedness&#148; means Indebtedness of the
Issuer for borrowed money (excluding Indebtedness under the Senior Credit Facility, any First Lien Obligations or any Junior Lien Obligations) under any debt securities or term loans broadly syndicated to institutional investors in a principal
amount in excess of $50.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Additional Interest&#148; means the interest payable as a consequence of the failure to
effectuate in a timely manner the Exchange Offer and/or shelf registration procedures set forth in the Registration Rights Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Affiliate&#148; of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or
indirect common control with such specified Person. For purposes of this definition, &#147;Control&#148; (including, with correlative meanings, the terms &#147;Controlling,&#148; &#147;Controlled By&#148; and &#147;Under Common Control With&#148;),
as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Applicable Authorized Representative&#148; means, (1)&nbsp;with respect to any Common Collateral, (i)&nbsp;until the
earlier of (x)&nbsp;the Discharge of Senior Credit Facility Obligations and (y)&nbsp;the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative Enforcement Date, the administrative agent under the Senior Credit Facility
and (ii)&nbsp;from and after the earlier of (x)&nbsp;the Discharge of Senior Credit Facility Obligations and (y)&nbsp;the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative Enforcement Date, the Major <FONT
STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative and (2)&nbsp;with respect to any Collateral that is not Common Collateral, the Authorized Representative of the Series of First Lien Obligations that is secured by such
Collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, with respect to actions with respect to Collateral that is not Common Collateral, (a)&nbsp;the
Authorized Representative of the Series of First Lien Obligations secured by such Collateral shall have the sole right to instruct the First Lien Collateral Agent to act or refrain from acting with respect to the Collateral that is not Common
Collateral, (b)&nbsp;the First Lien Collateral Agent shall not follow any instructions with respect to such Collateral that is not Common Collateral from any Person (other than such Authorized Representative), and (c)&nbsp;no Authorized
Representative (other than the Authorized Representative of the Series of First Lien Obligations secured by such Collateral) will instruct the First Lien Collateral Agent to commence any judicial or
<FONT STYLE="white-space:nowrap">non-judicial</FONT> foreclosure proceedings with respect to, seek to have a trustee, receiver, liquidator or similar official appointed for or over, attempt any action to take possession of, exercise any right,
remedy or power with respect to, or otherwise take any action to enforce its interests in or realize upon, or take any other action available to it in respect of, the Collateral that is not Common Collateral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Attributable Indebtedness&#148; in respect of a Sale and Lease-Back Transaction means, as at the time of determination, the present
value (discounted at the interest rate implicit in the transaction) of the total obligations of the lessee for rental payments during the remaining term of the lease included in such Sale and Lease-Back Transaction (including any period for which
such lease has been extended), determined in accordance with GAAP; provided, however, that if such Sale and Lease-Back Transaction results in a Capitalized Lease Obligation, the amount of Indebtedness represented thereby will be determined in
accordance with the definition of &#147;Capitalized Lease Obligations.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Authorized Representative&#148; means: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of any Senior Credit Facility Obligations or the Credit Agreement Secured Parties (as defined in
the Security Agreement), the administrative agent under the Senior Credit Facility, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of the Notes Obligations or the Holders, the Trustee, and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 56 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of any Series of Additional First Lien Obligations or Additional First Lien Secured Parties that
become subject to the Security Agreement, the Authorized Representative named for such Series in the applicable joinder agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Bankruptcy Code&#148; means Title 11 of the United States Code, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Bankruptcy Law&#148; means the Bankruptcy Code and any similar federal, state or foreign law for the relief of debtors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Base Security Agreement&#148; means the Amended and Restated Collateral Agreement, dated as of August&nbsp;7, 2014, by and among the
Issuer, the subsidiary grantors named therein, the First Lien Collateral Agent and the Authorized Representatives, as supplemented by the Additional Authorized Representative Joinders, dated as of June&nbsp;3, 2016 and September&nbsp;21, 2020,
respectively, and as the same may be further amended, restated or modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Business Day&#148; means each day
which is not a Legal Holiday. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Capital Stock&#148; means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a corporation, corporate stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of an association or business entity, any and all shares, interests, participations, rights or
other equivalents (however designated) of corporate stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of a partnership or limited liability company, partnership or membership interests (whether general
or limited); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other interest or participation that confers on a Person the right to receive a share of the profits and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">losses of, or distributions of assets of, the issuing Person. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Capitalized Lease Obligations&#148; means an obligation that is required to be classified and accounted for as a capitalized lease for
financial reporting purposes in accordance with GAAP, and the amount of Indebtedness represented by such obligation will be the capitalized amount of such obligation at the time any determination thereof is to be made as determined in accordance
with GAAP, and the stated maturity thereof will be the date of the last payment of rent or any other amount due under such lease prior to the first date such lease may be terminated without penalty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Cash Equivalents&#148; means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">United States dollars; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">euros or any national currency of any participating member state of the EMU or such local currencies held by
the Issuer and its Restricted Subsidiaries from time to time in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">securities issued or directly and fully and unconditionally guaranteed or insured by the U.S. government (or
any agency or instrumentality thereof the securities of which are unconditionally guaranteed as a full faith and credit obligation of the U.S. government) with maturities of 24 months or less from the date of acquisition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">certificates of deposit, time deposits and eurodollar time deposits with maturities of one year or less from
the date of acquisition, bankers&#146; acceptances with maturities not exceeding one year and overnight bank deposits, in each case with any commercial bank having capital and surplus of not less than $500.0&nbsp;million in the case of U.S. banks
and $100.0&nbsp;million (or the U.S. dollar equivalent as of the date of determination) in the case of <FONT STYLE="white-space:nowrap">non-U.S.</FONT> banks; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">repurchase obligations for underlying securities of the types described in clauses (3)&nbsp;and (4) entered
into with any financial institution meeting the qualifications specified in clause (4)&nbsp;above; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 57 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">commercial paper rated at least <FONT STYLE="white-space:nowrap">P-1</FONT> by Moody&#146;s or at least <FONT
STYLE="white-space:nowrap">A-1</FONT> by S&amp;P and in each case maturing within 24 months after the date of creation thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">marketable short-term money market and similar securities having a rating of at least <FONT
STYLE="white-space:nowrap">P-2</FONT> or <FONT STYLE="white-space:nowrap">A-2</FONT> from either Moody&#146;s or S&amp;P, respectively (or, if at any time neither Moody&#146;s nor S&amp;P shall be rating such obligations, an equivalent rating from
another Rating Agency) and in each case maturing within 24 months after the date of creation thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">investment funds investing 95% of their assets in securities of the types described in clauses (1)&nbsp;through
(7) above; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">readily marketable direct obligations issued by any state, commonwealth or territory of the United States or
any political subdivision or taxing authority thereof having an Investment Grade Rating from either Moody&#146;s or S&amp;P with maturities of 24 months or less from the date of acquisition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indebtedness or Preferred Stock issued by Persons with a rating of A or higher from S&amp;P or A2 or higher
from Moody&#146;s with maturities of 24 months or less from the date of acquisition; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Investments with average maturities of 24 months or less from the date of acquisition in money market funds
rated <FONT STYLE="white-space:nowrap">AAA-</FONT> (or the equivalent thereof) or better by S&amp;P or Aaa3 (or the equivalent thereof) or better by Moody&#146;s. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, Cash Equivalents shall include amounts denominated in currencies other than those set forth in clauses
(1)&nbsp;and (2) above; provided that such amounts are converted into any currency listed in clauses (1)&nbsp;and (2) as promptly as practicable and in any event within ten Business Days following the receipt of such amounts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;CFC&#148; means a &#147;controlled foreign corporation&#148; within the meaning of Section&nbsp;957(a) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Change of Control&#148; means the occurrence of any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any &#147;person&#148; or &#147;group&#148; of related persons (as such terms are used in Sections 13(d) and
14(d) of the Exchange Act), other than one or more Permitted Holders, becomes the beneficial owner (as defined in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act, except
that such person or group shall be deemed to have &#147;beneficial ownership&#148; of all shares that any such person or group has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly or
indirectly, of more than 35% of the total voting power of the Voting Stock of the Issuer or any of its direct or indirect parent entities (or their successors by merger, consolidation or purchase of all or substantially all of their assets); or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the first day on which a majority of the members of the Board of Directors of the Issuer are not Continuing
Directors; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the sale, assignment, conveyance, transfer, lease or other disposition (other than by way of merger or
consolidation), in one or a series of related transactions, of all or substantially all of the assets of the Issuer and its Restricted Subsidiaries taken as a whole to any &#147;person&#148; (as such term is used in Sections&nbsp;13(d) and 14(d) of
the Exchange Act) other than transactions with a Permitted Holder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the adoption by the stockholders of the Issuer of a plan or proposal for the liquidation or dissolution of the
Issuer. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Code&#148; means the Internal Revenue Code of 1986, as amended, or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Collateral&#148; means all property and assets of the Issuer or any Secured Guarantor, whether owned on the Issue Date or thereafter
acquired, in which Liens are, from time to time, granted or purported to be granted to secure the Notes and the Guarantees pursuant to the Indentures and the Security Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 58 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Collateral Release Date&#148; has the meaning assigned to such term under
&#147;&#151;Release of Collateral and Guarantees upon Investment Grade Rating Event.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Collections&#148; means (a)&nbsp;with
respect to any Receivable, all cash collections and other cash proceeds of such Receivable, including, without limitation, all cash proceeds of Related Security with respect to such Receivable, and all funds deemed to have been received by the
applicable Issuer or the Secured Guarantor or any other Person with respect thereto, and (b)&nbsp;with respect to any Participation Interest, all cash collections and other cash proceeds of the Receivable underlying such Participation Interest,
including, without limitation, all cash proceeds of Related Security with respect to such Participation Interest, and all funds deemed to have been received by the Issuer or the Secured Guarantor or any other Person with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Common Collateral&#148; means, at any time, Collateral in which the holders of two or more Series of First Lien Obligations (or their
respective Authorized Representatives or the First Lien Collateral Agent on behalf of such Authorized Representative) hold a valid security interest at such time. If more than two Series of First Lien Obligations are outstanding at any time and the
holders of less than all Series of First Lien Obligations hold a valid security interest in any Collateral at such time then such Collateral shall constitute Common Collateral for those Series of First Lien Obligations that hold a valid security
interest in such Collateral at such time and shall not constitute Common Collateral for any Series which does not have a valid security interest in such Collateral at such time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Common Stock&#148; means with respect to any Person, any and all shares, interest or other participations in, and other equivalents
(however designated and whether voting or nonvoting) of such Person&#146;s common stock whether or not outstanding on the Issue Date and includes, without limitation, all series and classes of such common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Consolidated Coverage Ratio&#148; means as of any date of determination, with respect to any Person, the ratio of (x)&nbsp;the aggregate
amount of Consolidated EBITDA of such Person for the period of the most recent four consecutive fiscal quarters ending prior to the date of such determination for which financial statements prepared on a consolidated basis in accordance with GAAP
are available to (y)&nbsp;Consolidated Interest Expense for such four fiscal quarters; provided, however, that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the Issuer or any Restricted Subsidiary: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has Incurred any Indebtedness since the beginning of such period that remains outstanding on such date of
determination or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio includes an Incurrence of Indebtedness, Consolidated EBITDA and Consolidated Interest Expense for such period will be calculated after giving
effect on a pro forma basis to such Indebtedness as if such Indebtedness had been Incurred on the first day of such period (except that in making such computation, the amount of Indebtedness under any revolving Credit Facility outstanding on the
date of such calculation will be deemed to be (i)&nbsp;the average daily balance of such Indebtedness during such four fiscal quarters or such shorter period for which such facility was outstanding or (ii)&nbsp;if such facility was created after the
end of such four fiscal quarters, the average daily balance of such Indebtedness during the period from the date of creation of such facility to the date of such calculation) and the discharge of any other Indebtedness repaid, repurchased, redeemed,
retired, defeased or otherwise discharged with the proceeds of such new Indebtedness as if such discharge had occurred on the first day of such period; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has repaid, repurchased, redeemed, retired, defeased or otherwise discharged any Indebtedness since the
beginning of the period that is no longer outstanding on such date of determination or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio includes a discharge of Indebtedness (in each case, other than
Indebtedness Incurred under any revolving Credit Facility unless such Indebtedness has been permanently repaid and the related commitment </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 59 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
terminated and not replaced), Consolidated EBITDA and Consolidated Interest Expense for such period will be calculated after giving effect on a pro forma basis to such discharge of such
Indebtedness, including with the proceeds of such new Indebtedness, as if such discharge had occurred on the first day of such period; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if since the beginning of such period, the Issuer or any Restricted Subsidiary will have disposed of any assets
or disposed of or discontinued (as defined under GAAP) any company, division, operating unit, segment, business, group of related assets or line of business or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio
includes such a transaction: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Consolidated EBITDA for such period will be reduced by an amount equal to the Consolidated EBITDA (if
positive) directly attributable to the assets that are the subject of such disposition or discontinuation for such period or increased by an amount equal to the Consolidated EBITDA (if negative) directly attributable thereto for such period; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consolidated Interest Expense for such period will be reduced by an amount equal to the Consolidated Interest
Expense directly attributable to any Indebtedness of the Issuer or any Restricted Subsidiary repaid, repurchased, redeemed, retired, defeased or otherwise discharged (to the extent the related commitment is permanently reduced) with respect to the
Issuer and its continuing Restricted Subsidiaries in connection with such transaction for such period (or, if the Capital Stock of any Restricted Subsidiary is sold, the Consolidated Interest Expense for such period directly attributable to the
Indebtedness of such Restricted Subsidiary to the extent the Issuer and its continuing Restricted Subsidiaries are no longer liable for such Indebtedness after such sale); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if since the beginning of such period the Issuer or any Restricted Subsidiary (by merger or otherwise) will
have made an Investment in any Restricted Subsidiary (or any Person that becomes a Restricted Subsidiary or is merged with or into the Issuer or a Restricted Subsidiary) or an acquisition of assets, including any acquisition of assets occurring in
connection with a transaction causing a calculation to be made hereunder, which constitutes all or substantially all of a company, division, operating unit, segment, business, group of related assets or line of business, Consolidated EBITDA and
Consolidated Interest Expense for such period will be calculated after giving pro forma effect thereto (including the Incurrence of any Indebtedness) as if such Investment or acquisition occurred on the first day of such period; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if since the beginning of such period any Person (that subsequently became a Restricted Subsidiary or was
merged with or into the Issuer or any Restricted Subsidiary since the beginning of such period) will have Incurred any Indebtedness or discharged any Indebtedness, made any disposition or any Investment or acquisition of assets that would have
required an adjustment pursuant to clause (1), (2) or (3)&nbsp;above if made by the Issuer or a Restricted Subsidiary during such period, Consolidated EBITDA and Consolidated Interest Expense for such period will be calculated after giving pro forma
effect thereto as if such transaction occurred on the first day of such period. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this definition,
whenever pro forma effect is to be given to any calculation under this definition, the pro forma calculations will be determined in good faith by a responsible financial or accounting officer of the Issuer (including pro forma expense and cost
reductions calculated on a basis consistent with Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act). If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest expense on
such Indebtedness will be calculated as if the rate in effect on the date of determination had been the applicable rate for the entire period (taking into account any Interest Rate Agreement applicable to such Indebtedness if such Interest Rate
Agreement has a remaining term in excess of 12 months). If any Indebtedness that is being given pro forma effect bears an interest rate at the option of the Issuer, the interest rate shall be calculated by applying such optional rate chosen by the
Issuer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 60 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Consolidated EBITDA&#148; means, with respect to any Person for any period, the
Consolidated Net Income of such Person for such period: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">increased (without duplication) by the following items to the extent deducted in calculating such Consolidated
Net Income: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consolidated Interest Expense; plus </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consolidated Income Taxes; plus </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">consolidated depreciation expense; plus </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">consolidated amortization expense or impairment charges recorded in connection with the application of
Accounting Standards Codification Topic 350, Intangibles&#151;Goodwill and Other, or Topic 360, Property, Plant and Equipment; plus </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">other <FONT STYLE="white-space:nowrap">non-cash</FONT> charges reducing Consolidated Net Income, including any
write-offs or write-downs (excluding any such <FONT STYLE="white-space:nowrap">non-cash</FONT> charge to the extent it represents an accrual of or reserve for cash charges in any future period or amortization of a prepaid cash expense that was
capitalized at the time of payment; provided that the Issuer is permitted to add back <FONT STYLE="white-space:nowrap">non-cash</FONT> charges representing an accrual or reserve relating to any legal, administrative or governmental claim,
litigation, investigation or proceedings, even if cash charges may be anticipated in any future period, so long as (i)&nbsp;adding back such <FONT STYLE="white-space:nowrap">non-cash</FONT> charges is consistent with the Issuer&#146;s past practice
in its publicly reported &#147;EBITDA&#148; or &#147;Adjusted EBITDA&#148; included in its annual or quarterly earnings reports and (ii)&nbsp;the aggregate amount of such <FONT STYLE="white-space:nowrap">non-cash</FONT> charges added pursuant to
this proviso shall not exceed $35.0&nbsp;million for any period of four consecutive fiscal quarters) and <FONT STYLE="white-space:nowrap">non-cash</FONT> compensation expense recorded from grants of stock appreciation or similar rights, stock
options, restricted stock or other rights to officers, directors or employees; plus </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extraordinary, <FONT STYLE="white-space:nowrap">non-recurring</FONT> or unusual cash expenses or losses,
including, without limitation, severance costs, relocation costs, consolidation and closing costs, integration and facilities opening costs, business optimization costs, transition costs, restructuring costs, signing, retention or completion
bonuses, and curtailments or modifications to pension and post-retirement employee benefit plans, in each case so long as adding back such expenses or losses is consistent with the Issuer&#146;s past practice in its publicly reported
&#147;EBITDA&#148; or &#147;Adjusted EBITDA&#148; included in its annual or quarterly earnings reports; plus </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any <FONT STYLE="white-space:nowrap">non-recurring</FONT> fees, charges or expenses paid in connection with the
Transactions within 180 days of the Issue Date that were deducted in computing Consolidated Net Income. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">decreased (without duplication) by the following items to the extent included in calculating such Consolidated
Net Income: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">non-cash</FONT> items increasing Consolidated Net Income of such Person for
such period (excluding any items which represent the reversal of any accrual of, or reserve for, anticipated cash charges that reduced Consolidated EBITDA in any prior period), plus </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extraordinary, <FONT STYLE="white-space:nowrap">non-recurring</FONT> or unusual cash gains or income so
long as deducting such gains or income is consistent with the Issuer&#146;s past practice in its publicly reported &#147;EBITDA&#148; or &#147;Adjusted EBITDA&#148; included in its annual or quarterly earnings reports, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">increased or decreased (without duplication) to eliminate the following items reflected in Consolidated Net
Income: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any unrealized net gain or loss resulting in such period from Hedging Obligations and the application of
Accounting Standards Codification Topic 815, Derivatives and Hedging; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any net gain or loss resulting in such period from currency translation gains or losses related to currency
remeasurements of Indebtedness; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 61 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">effects of adjustments (including the effects of such adjustments pushed down to the Issuer and its Restricted
Subsidiaries) in any line item in such Person&#146;s consolidated financial statements pursuant to GAAP resulting from the application of accounting in relation to any completed acquisition. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, clauses (1)(b) through (g)&nbsp;relating to amounts of a Restricted Subsidiary of a Person will be added to
Consolidated Net Income to compute Consolidated EBITDA of such Person only to the extent (and in the same proportion) that the net income (loss) of such Restricted Subsidiary was included in calculating the Consolidated Net Income of such Person
and, to the extent the amounts set forth in clauses (1)(b) through (g)&nbsp;are in excess of those necessary to offset a net loss of such Restricted Subsidiary or if such Restricted Subsidiary has net income for such period included in Consolidated
Net Income, only if a corresponding amount would be permitted at the date of determination to be dividended to the Issuer by such Restricted Subsidiary without prior approval (that has not been obtained), pursuant to the terms of its charter and all
agreements, instruments, judgments, decrees, orders, statutes, rules and governmental regulations applicable to that Restricted Subsidiary or its stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Consolidated Income Taxes&#148; means, with respect to any Person for any period, taxes imposed upon such Person or other payments
required to be made by such Person by any governmental authority which taxes or other payments are calculated by reference to the income or profits or capital of such Person or such Person and its Restricted Subsidiaries (to the extent such income
or profits were included in computing Consolidated Net Income for such period), including, without limitation, state, franchise and similar taxes and foreign withholding taxes regardless of whether such taxes or payments are required to be remitted
to any governmental authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Consolidated Interest Expense&#148; means, for any period, the total interest expense of the Issuer
and its consolidated Restricted Subsidiaries, whether paid or accrued, plus, to the extent not included in such interest expense: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interest expense attributable to Capitalized Lease Obligations and the interest portion of rent expense
associated with Attributable Indebtedness in respect of the relevant lease giving rise thereto, determined as if such lease were a capitalized lease in accordance with GAAP and the interest component of any deferred payment obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">amortization of debt discount (including the amortization of original issue discount resulting from the
issuance of Indebtedness at less than par) and debt issuance cost; provided, however, that any amortization of bond premium will be credited to reduce Consolidated Interest Expense unless, pursuant to GAAP, such amortization of bond premium has
otherwise reduced Consolidated Interest Expense; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">non-cash</FONT> interest expense, but any
<FONT STYLE="white-space:nowrap">non-cash</FONT> interest income or expense attributable to the movement in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> valuation of Hedging Obligations or other
derivative instruments pursuant to GAAP shall be excluded from the calculation of Consolidated Interest Expense; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">commissions, discounts and other fees and charges owed with respect to letters of credit and bankers acceptance
financing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the interest expense on Indebtedness of another Person that is Guaranteed by such Person or one of its
Restricted Subsidiaries or secured by a Lien on assets of such Person or one of its Restricted Subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">costs associated with entering into Hedging Obligations (including amortization of fees) related to
Indebtedness; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interest expense of such Person and its Restricted Subsidiaries that was capitalized during such period;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the product of (a)&nbsp;all dividends paid or payable, in cash, Cash Equivalents or Indebtedness or accrued
during such period on any series of Disqualified Stock of such Person or on Preferred Stock of its </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 62 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Restricted Subsidiaries that are not Guarantors payable to a party other than the Issuer or a Wholly Owned Subsidiary, times (b)&nbsp;a fraction, the numerator of which is one and the denominator
of which is one minus the then current combined federal, state, provincial and local statutory tax rate of such Person, expressed as a decimal, in each case, on a consolidated basis and in accordance with GAAP; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Receivables Fees; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cash contributions to any employee stock ownership plan or similar trust to the extent such contributions
are used by such plan or trust to pay interest or fees to any Person (other than the Issuer and its Restricted Subsidiaries) in connection with Indebtedness Incurred by such plan or trust. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purpose of calculating the Consolidated Coverage Ratio, the calculation of Consolidated Interest Expense shall include all interest
expense (including any amounts described in clauses (1)&nbsp;through (10) above) relating to any Indebtedness of the Issuer or any Restricted Subsidiary described in the final paragraph of the definition of &#147;Indebtedness.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, total interest expense will be determined (i)&nbsp;after giving effect to any net payments made or received by
the Issuer and its Subsidiaries with respect to Interest Rate Agreements and (ii)&nbsp;exclusive of amounts classified as other comprehensive income in the balance sheet of the Issuer. Notwithstanding anything to the contrary contained herein,
without duplication of clause (9)&nbsp;above, commissions, discounts, yield and other fees and charges Incurred in connection with any transaction pursuant to which the Issuer or its Restricted Subsidiaries may sell, convey or otherwise transfer or
grant a security interest in any accounts receivable or related assets shall be included in Consolidated Interest Expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Consolidated Net Income&#148; means, for any period, the net income (loss) of the Issuer and its consolidated Restricted Subsidiaries
determined on a consolidated basis in accordance with GAAP; provided, however, that there will not be included in such Consolidated Net Income on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any net income (loss) of any Person if such Person is not a Restricted Subsidiary or that is accounted for by
the equity method of accounting, except that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subject to the limitations contained in clauses (3)&nbsp;through (7) below, the Issuer&#146;s equity in the net
income of any such Person for such period will be included in such Consolidated Net Income up to the aggregate amount of cash actually distributed by such Person during such period to the Issuer or a Restricted Subsidiary as a dividend or other
distribution (subject, in the case of a dividend or other distribution to a Restricted Subsidiary, to the limitations contained in clause (2)&nbsp;below); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer&#146;s equity in a net loss of any such Person (other than an Unrestricted Subsidiary) for such
period will be included in determining such Consolidated Net Income to the extent such loss has been funded with cash from the Issuer or a Restricted Subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any net income (but not loss) of any Restricted Subsidiary (other than a Subsidiary that is a Guarantor) if
such Restricted Subsidiary is subject to prior government approval or other restrictions due to the operation of its charter or any agreement, instrument, judgment, decree, order statute, rule or government regulation (which have not been waived),
directly or indirectly, on the payment of dividends or the making of distributions by such Restricted Subsidiary, directly or indirectly, to the Issuer, except that: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">subject to the limitations contained in clauses (3)&nbsp;through (7) below, the Issuer&#146;s equity in the net
income of any such Restricted Subsidiary for such period will be included in such Consolidated Net Income up to the aggregate amount of cash that could have been distributed by such Restricted Subsidiary during such period to the Issuer or another
Restricted Subsidiary as a dividend (subject, in the case of a dividend to another Restricted Subsidiary, to the limitation contained in this clause); and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 63 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer&#146;s equity in a net loss of any such Restricted Subsidiary for such period will be included in
determining such Consolidated Net Income; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any gain or loss (less all fees and expenses relating thereto) realized upon sales or other dispositions of any
assets of the Issuer or such Restricted Subsidiary, other than in the ordinary course of business, as determined in good faith by the Board of Directors of the Issuer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any income or loss from discontinued operations and any gain or loss on disposal of discontinued operations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any income (loss) from the early extinguishment of Indebtedness or Hedging Obligations or other derivative
instruments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extraordinary gain or loss; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any net income (loss) included in the consolidated statement of operations as noncontrolling interests due to
the application of Accounting Standards Codification Topic 810, Consolidation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cumulative effect of a change in accounting principles. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Consolidated Net Tangible Assets&#148; means, with respect to any Person, the total amount of assets (less applicable reserves and other
properly deductible items) after deducting therefrom (a)&nbsp;all current liabilities as disclosed on the consolidated balance sheet of such Person (excluding any thereof which are by their terms extendible or renewable at the option of the obligor
thereon to a time more than 12 months after the time as of which the amount thereof is being computed and further excluding any deferred income taxes that are included in current liabilities) and (b)&nbsp;all goodwill, trade names, trademarks,
patents, unamortized debt discount and expense and other like intangible assets, all as set forth on the most recent consolidated balance sheet of the Issuer and computed in accordance with generally accepted accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Continuing Directors&#148; means, as of any date of determination, any member of the Board of Directors of the Issuer who: (1)&nbsp;was
a member of such Board of Directors on the Issue Date or (2)&nbsp;was nominated for election or elected to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board at the time of such
nomination or election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Convertible Notes&#148; means Indebtedness of the Issuer that is optionally convertible into Common Stock
of the Issuer (and/or cash based on the value of such Common Stock) and/or Indebtedness of a Subsidiary of the Issuer that is optionally exchangeable for Common Stock of the Issuer (and/or cash based on the value of such Common Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Credit Facilities&#148; means, with respect to the Issuer or any of its Restricted Subsidiaries, one or more debt facilities, including
the Senior Credit Facility and any Qualified Receivables Transaction, or other financing arrangements (including, without limitation, commercial paper facilities or indentures) providing for revolving credit loans, term loans, receivables financing,
letters of credit or other long-term Indebtedness, including any notes, mortgages, guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals,
restatements or refundings thereof and any indentures or credit facilities or commercial paper facilities that replace, refund or refinance any part of the loans, notes, other credit facilities or commitments thereunder, including any such
replacement, refunding or refinancing facility or indenture that increases the amount permitted to be borrowed thereunder or alters the maturity thereof or adds Restricted Subsidiaries as additional borrowers or guarantors thereunder and whether by
the same or any other agent, lender or group of lenders and whether or not the original administrative agent, lenders, trustees or other agents are parties thereto and whether provided under the original Senior Credit Facility, the Existing
Receivables Facility or any other credit agreement or indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Default&#148; means any event that is, or with the passage of time
or the giving of notice or both would be, an Event of Default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 64 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Discharge of Senior Credit Facility Obligations&#148; means, with respect to any
Common Collateral, the date on which the Senior Credit Facility Obligations are no longer secured by such Common Collateral; provided that the Discharge of Senior Credit Facility Obligations shall not be deemed to have occurred in connection with a
refinancing of such Senior Credit Facility Obligations with additional First Lien Obligations secured by such Common Collateral under an agreement relating to Additional First Lien Obligations which has been designated in writing by the
administrative agent under such refinancing Senior Credit Facility to the First Lien Collateral Agent and each other Authorized Representative as the Senior Credit Facility for purposes of the Security Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Disqualified Stock&#148; means, with respect to any Person, any Capital Stock of such Person which, by its terms, or by the terms of any
security into which it is convertible or for which it is putable or exchangeable, or upon the happening of any event, matures or is mandatorily redeemable (other than solely as a result of a change of control or asset sale) pursuant to a sinking
fund obligation or otherwise, or is redeemable at the option of the holder thereof (other than solely as a result of a change of control or asset sale), in whole or in part, in each case prior to the date 91 days after the earlier of the maturity
date of the Notes or the date the Notes are no longer outstanding; provided, however, that if such Capital Stock is issued to any plan for the benefit of employees of the Issuer or its Subsidiaries or by any such plan to such employees, such Capital
Stock shall not constitute Disqualified Stock solely because it may be required to be repurchased by the Issuer or its Subsidiaries in order to satisfy applicable statutory or regulatory obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Domestic Subsidiary&#148; means any Subsidiary of the Issuer organized under the laws of the United States, any state, territory or
commonwealth thereof or the District of Columbia (other than any such Subsidiary that is treated as a disregarded entity for United States federal income tax purposes, is a CFC or substantially all of whose assets consist (directly or indirectly
through disregarded entities) of the Equity Interests and/or Indebtedness of one or more CFCs). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;EMU&#148; means the economic and
monetary union as contemplated in the Treaty on European Union. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Equity Interests&#148; means Capital Stock and all warrants,
options or other rights to acquire Capital Stock, but excluding any debt security that is convertible into, or exchangeable for, Capital Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Exchange Act&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Existing 2022 Notes&#148; means the $700.0&nbsp;million aggregate principal amount of 4.75% senior secured notes due
2022 issued by the Issuer and outstanding on the Issue Date in respect of the 2030 Original Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Existing 2022 Notes
Indenture&#148; means the indenture, dated as of August&nbsp;7, 2014, among the Issuer, the Guarantors, U.S. Bank National Association (as successor to MUFG Union Bank, N.A.), as trustee, and JPMorgan Chase Bank, N.A. as collateral agent, as it
relates to the Existing 2022 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Existing 2026 Notes&#148; means the $400.0&nbsp;million aggregate principal amount of 5.00%
senior secured notes due 2026 issued by the Issuer and outstanding on the Issue Date in respect of the 2026 Original Notes and the 2032 Original Notes, and any Additional Notes (as defined in the Existing 2026 Notes Indenture) issued with respect to
the initial 5.00% senior secured notes due 2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Existing 2026 Notes Indenture&#148; means the indenture, dated as of June&nbsp;3,
2016, among the Issuer, the Guarantors, U.S. Bank National Association (as successor to MUFG Union Bank, N.A.), as trustee, and JPMorgan Chase Bank, N.A. as collateral agent, as it relates to the Existing 2026 Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Existing Receivables Facility&#148; means the receivables facility governed by (a)&nbsp;the Amended and Restated Credit and Security
Agreement, dated as of October&nbsp;27, 2010 (as amended, amended and restated, modified, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 65 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
renewed or replaced from time to time), among the borrowers identified therein, UHS Receivables Corp., as Collection Agent, UHS of Delaware, Inc., as Servicer, Universal Health Services, Inc., as
Performance Guarantor, PNC Bank, National Association, as LC Bank and Administrative Agent, and the certain other parties thereto and (b)&nbsp;each of the Receivables Sale Agreements referred to in such Amended and Restated Credit and Security
Agreement, between the respective Grantors and &#147;Buyers&#148; specified therein, in each case, as the same may be amended or otherwise modified from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Fair Market Value&#148; means, with respect to any asset or liability, the fair market value of such asset or liability as determined by
Senior Management of the Issuer in good faith; provided that if the fair market value exceeds $10.0&nbsp;million, such determination shall be made by the Board of Directors of the Issuer or an authorized committee thereof in good faith (including as
to the value of all <FONT STYLE="white-space:nowrap">non-cash</FONT> assets and liabilities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;First Lien Collateral Agent&#148;
shall mean JPMorgan Chase Bank, N.A., in its capacity as collateral agent for the lenders and other secured parties under the Senior Credit Facility, the Indentures and the other First Lien Documents, together with its successors and permitted
assigns exercising substantially the same rights and powers and, in each case, provided that if such First Lien Collateral Agent is not JPMorgan Chase Bank, N.A., such First Lien Collateral Agent shall have become a party to the Security Agreement,
any intercreditor agreement with respect to Junior Lien Obligations and the other applicable First Lien Security Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;First
Lien Documents&#148; means the credit, guarantee and security documents governing the First Lien Obligations, including, without limitation, the Indentures and the First Lien Security Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;First Lien Event of Default&#148; means an &#147;Event of Default&#148; under and as defined in the Senior Credit Facility, the
Indentures or any other First Lien Documents governing First Lien Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;First Lien Obligations&#148; means, collectively,
(a)&nbsp;all Senior Credit Facility Obligations, (b)&nbsp;the Notes Obligations, and (c)&nbsp;any Series of Additional First Lien Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;First Lien Secured Parties&#148; means (a)&nbsp;the Credit Agreement Secured Parties (as defined in the Security Agreement), (b) the
Notes Secured Parties, and (c)&nbsp;any Additional First Lien Secured Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;First Lien Security Documents&#148; means the
Security Documents and any other agreement, document or instrument pursuant to which a Lien is granted or purported to be granted securing First Lien Obligations or under which rights or remedies with respect to such Liens are governed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Foreign Subsidiary&#148; means, with respect to any Person, any Restricted Subsidiary of such Person that is not a Domestic Subsidiary.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Foreign Subsidiary Voting Stock&#148; means the voting Capital Stock of any Foreign Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Funded Debt&#148; means any Indebtedness for money borrowed, created, issued, incurred, assumed or guaranteed that would, in accordance
with generally accepted accounting principles, be classified as long-term debt, but in any event including all Indebtedness for money borrowed, whether secured or unsecured, maturing more than one year, or extendible at the option of the obligor to
a date more than one year, after the date of determination thereof (excluding any amount thereof included in current liabilities). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;GAAP&#148; means generally accepted accounting principles in the United States as in effect on the Issue Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Gift Shop Assets&#148; means all cash and other amount paid or owed to the Issuer or any Secured Guarantor for purchases from its gift
shops or cafeterias and all goods held for sale in any such gift shop or cafeteria. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Guarantee&#148; means the guarantee by any
Guarantor of the Issuer&#146;s Obligations under the Indentures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 66 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Guarantor&#148; means each Restricted Subsidiary that Guarantees the Notes in
accordance with the terms of the Indentures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Hedging Obligations&#148; means, with respect to any Person, the obligations of such
Person under any interest rate swap agreement, interest rate cap agreement, interest rate collar agreement, commodity swap agreement, commodity cap agreement, commodity collar agreement, foreign exchange contract, currency swap agreement or similar
agreement providing for the transfer or mitigation of interest rate or currency risks either generally or under specific contingencies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Holder&#148; means the Person in whose name a Note is registered on the registrar&#146;s books. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Incur&#148; means issue, create, assume, Guarantee, incur or otherwise become liable for; provided, however, that any Indebtedness or
Capital Stock of a Person existing at the time such Person becomes a Restricted Subsidiary (whether by merger, consolidation, acquisition or otherwise) will be deemed to be Incurred by such Restricted Subsidiary at the time it becomes a Restricted
Subsidiary; and the terms &#147;Incurred&#148; and &#147;Incurrence&#148; have meanings correlative to the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Indebtedness&#148; means, with respect to any Person on any date of determination (without duplication): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal of and premium (if any) in respect of indebtedness of such Person for borrowed money;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal of and premium (if any) in respect of obligations of such Person evidenced by bonds, debentures,
notes or other similar instruments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component of all obligations of such Person in respect of letters of credit, bankers&#146;
acceptances or other similar instruments (including reimbursement obligations with respect thereto except to the extent such reimbursement obligation relates to a trade payable and such obligation is satisfied within 30 days of Incurrence);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component of all obligations of such Person to pay the deferred and unpaid purchase price of
property (including <FONT STYLE="white-space:nowrap">earn-out</FONT> obligations), which purchase price is due after the date of placing such property in service or taking delivery and title thereto, except (i)&nbsp;any such balance that constitutes
a trade payable or similar obligation to a trade creditor, in each case accrued in the ordinary course of business and (ii)&nbsp;any <FONT STYLE="white-space:nowrap">earn-out</FONT> obligation until the amount of such obligation becomes a liability
on the balance sheet of such Person in accordance with GAAP; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Capitalized Lease Obligations and all Attributable Indebtedness of such Person (whether or not such items would
appear on the balance sheet of the guarantor or obligor); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component or liquidation preference of all obligations of such Person with respect to the
redemption, repayment or other repurchase of any Disqualified Stock or, with respect to any Subsidiary that is not a Guarantor, any Preferred Stock (but excluding, in each case, any accrued dividends); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component of all Indebtedness of other Persons secured by a Lien on any asset of such Person,
whether or not such Indebtedness is assumed by such Person; provided, however, that the amount of such Indebtedness will be the lesser of (a)&nbsp;the Fair Market Value of such asset at such date of determination and (b)&nbsp;the amount of such
Indebtedness of such other Persons; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the principal component of Indebtedness of other Persons to the extent Guaranteed by such Person (whether or
not such items would appear on the balance sheet of the guarantor or obligor); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the extent not otherwise included in this definition, net obligations of such Person under Hedging
Obligations (the amount of any such obligations to be equal at any time to the termination value of such agreement or arrangement giving rise to such Obligation that would be payable by such Person at such time); and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 67 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the extent not otherwise included in this definition, the amount of Obligations outstanding under the legal
documents entered into as part of a Qualified Receivables Transaction on any date of determination that would be characterized as principal if such Qualified Receivables Transaction were structured as a secured lending transaction rather than as a
purchase. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, money borrowed and set aside at the time of the Incurrence of any Indebtedness
in order to <FONT STYLE="white-space:nowrap">pre-fund</FONT> the payment of interest on such Indebtedness shall not be deemed to be &#147;Indebtedness&#148;; provided that such money is held to secure the payment of such interest. In addition, for
the avoidance of doubt, obligations of any Person under a Permitted Bond Hedge or a Permitted Warrant shall not be deemed to be &#147;Indebtedness.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, &#147;Indebtedness&#148; of any Person shall include Indebtedness described in the preceding paragraph that would not appear as a
liability on the balance sheet of such Person if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Indebtedness is the obligation of a partnership or joint venture that is not a Restricted Subsidiary (a
&#147;Joint Venture&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Person or a Restricted Subsidiary of such Person is a general partner of the Joint Venture (a
&#147;General Partner&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there is recourse, by contract or operation of law, with respect to the payment of such Indebtedness to
property or assets of such Person or a Restricted Subsidiary of such Person; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and then such Indebtedness shall be included in an amount
not to exceed: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the lesser of (i)&nbsp;the net assets of the General Partner and (ii)&nbsp;the amount of such obligations to
the extent that there is recourse, by contract or operation of law, to the property or assets of such Person or a Restricted Subsidiary of such Person; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if less than the amount determined pursuant to clause (a)&nbsp;immediately above, the actual amount of such
Indebtedness that is recourse to such Person or a Restricted Subsidiary of such Person, if the Indebtedness is evidenced by a writing and is for a determinable amount. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Initial Purchasers&#148; means J.P. Morgan Securities LLC, BofA Securities, Inc., Goldman Sachs&nbsp;&amp; Co. LLC, Trust Securities,
Inc. and the other initial purchasers party to the purchase agreements related to the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Insolvency or Liquidation
Proceeding&#148; means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any case commenced by or against the Issuer or any Secured Guarantor under any Bankruptcy Law for the relief of
debtors, any other proceeding for the reorganization, recapitalization or adjustment or marshalling of the assets or liabilities of the Issuer or any Secured Guarantor, any receivership or assignment for the benefit of creditors relating to the
Issuer or any Secured Guarantor or any similar case or proceeding relative to the Issuer or any Secured Guarantor or its creditors, as such, in each case whether or not voluntary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any liquidation, dissolution, marshalling of assets or liabilities or other winding up of or relating to the
Issuer or any Secured Guarantor, in each case whether or not voluntary and whether or not involving bankruptcy or insolvency; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other proceeding of any type or nature in which substantially all claims of creditors of the Issuer or any
Secured Guarantor are determined and any payment or distribution is or may be made on account of such claims. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;interest&#148; with respect to the Notes means interest with respect thereto and Additional Interest, if any. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 68 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Interest Rate Agreement&#148; means, with respect to any Person, any interest rate
protection agreement, interest rate future agreement, interest rate option agreement, interest rate swap agreement, interest rate cap agreement, interest rate collar agreement, interest rate hedge agreement or other similar agreement or arrangement
as to which such Person is party or a beneficiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Investment Grade Ratings&#148; means a rating equal to or higher than Baa3 (or
the equivalent) by Moody&#146;s and <FONT STYLE="white-space:nowrap">BBB-</FONT> (or the equivalent) by S&amp;P, or an equivalent rating by any other Rating Agency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Investment Property&#148; means (i)&nbsp;all &#147;investment property&#148; as such term is defined in
<FONT STYLE="white-space:nowrap">Section&nbsp;9-102(a)(49)</FONT> of the New York UCC (other than any Foreign Subsidiary Voting Stock excluded from the definition of &#147;Pledged Stock&#148;) and (ii)&nbsp;whether or not constituting
&#147;investment property&#148; as so defined, all Pledged Notes and all Pledged Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Investments&#148; means, with respect to
any Person, all investments by such Person in other Persons (including Affiliates) in the form of loans (including guarantees), advances or capital contributions (excluding accounts receivable, trade credit, advances to customers, commissions,
travel and similar advances to officers and employees, in each case made in the ordinary course of business), purchases or other acquisitions for consideration of Indebtedness, Equity Interests or other securities issued by any other Person and
investments that are required by GAAP to be classified on the balance sheet (excluding the footnotes) of the Issuer in the same manner as the other investments included in this definition to the extent such transactions involve the transfer of cash
or other property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Issue Date&#148; means September&nbsp;21, 2020, in the case of the 2030 Notes, and August&nbsp;24, 2021, in the
case of the 2026 Notes and the 2032 Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Joinder to the Security Agreement&#148; means the Additional Authorized Representative
Joinder Agreement entered into by the Issuer, the subsidiary grantors named therein, the First Lien Collateral Agent, the Authorized Representatives and the Trustee as an Additional Authorized Representative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Junior Lien Obligations&#148; means the Obligations with respect to Indebtedness permitted to be incurred under the Indentures which by
its terms is or will be secured on a basis junior to the Liens securing the Notes pursuant to an intercreditor agreement; provided such Liens are permitted to be incurred under the Indentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Legal Holiday&#148; means a Saturday, a Sunday or a day on which commercial banking institutions are not required to be open in the
State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Lien&#148; means, with respect to any asset, any mortgage, lien (statutory or otherwise), pledge, hypothecation,
charge, security interest, preference, priority or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention agreement, any
lease in the nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any jurisdiction; provided
that in no event shall an operating lease be deemed to constitute a Lien. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Major
<FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Authorized Representative&#148; has the meaning set forth under &#147;&#151;Intercreditor Provisions in the Security Agreement.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Moody&#146;s&#148; means Moody&#146;s Investors Service, Inc. and any successor to its rating agency business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Mortgages&#148; means mortgages, liens, pledges or other encumbrances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Net Income&#148; means, with respect to any Person, the net income (loss) of such Person, determined in accordance with GAAP and before
any reduction in respect of Preferred Stock dividends. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 69 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;New York UCC&#148; means the Uniform Commercial Code as from time to time in effect in
the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">&#147;Non-Controlling</FONT> Authorized Representative&#148; means, at any time
with respect to any Common Collateral, any Authorized Representative that is not the Applicable Authorized Representative at such time with respect to such Common Collateral. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">&#147;Non-Recourse</FONT> Debt&#148; means Indebtedness of a Person: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as to which neither the Issuer nor any Restricted Subsidiary (a)&nbsp;provides any guarantee or credit support
of any kind (including any undertaking, guarantee, indemnity, agreement or instrument that would constitute Indebtedness) or (b)&nbsp;is directly or indirectly liable (as a guarantor or otherwise); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no default with respect to which (including any rights that the holders thereof may have to take enforcement
action against an Unrestricted Subsidiary) would permit (upon notice, lapse of time or both) any holder of any other Indebtedness of the Issuer or any Restricted Subsidiary to declare a default under such other Indebtedness or cause the payment
thereof to be accelerated or payable prior to its stated maturity; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the explicit terms of which provide there is no recourse against any of the assets of the Issuer or its
Restricted Subsidiaries, except that Standard Securitization Undertakings shall not be considered recourse. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Notes
Obligations&#148; means Obligations in respect of the Notes, the Indentures or the Security Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Notes Secured Parties&#148;
means, at any relevant time, the holders of Notes Obligations at such time, including without limitation the Trustee, the registrar, paying agent and transfer agent, and the Holders (including the Holders of any Additional Notes subsequently issued
under and in compliance with the terms of the Indentures). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Obligations&#148; means all advances to, and debts, liabilities,
obligations, covenants and duties arising under any Indebtedness, whether or not direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including any
principal, interest (including any interest accruing subsequent to the filing of a petition in bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest is an
allowed claim under applicable state, federal or foreign law), premium, penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and bankers acceptances), damages and other liabilities,
and guarantees of payment of such principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities, payable under the documentation governing such Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Officer&#148; means the Chairman of the Board, the Chief Executive Officer, the President, any Executive Vice President, Senior Vice
President or Vice President, the Treasurer or the Secretary of the Issuer or a Guarantor, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Officers&#146;
Certificate&#148; means a certificate signed on behalf of the Issuer by two Officers of the Issuer or on behalf of a Guarantor by two Officers of such Guarantor, one of whom must be the principal executive officer, the principal financial officer,
the treasurer or the principal accounting officer of the Issuer or Guarantor, as applicable, that meets the requirements set forth in the Indentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Opinion of Counsel&#148; means a written opinion from legal counsel who is acceptable to the Trustee. The counsel may be an employee of
or counsel to the Issuer or the Trustee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 70 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Participation Interest&#148; means with respect to any Receivable, a beneficial
interest in the Issuer&#146;s or the applicable Secured Guarantor&#146;s right, title and interest, whether now owned or hereafter arising and wherever located, in, to and under (i)&nbsp;such Receivable, (ii)&nbsp;all Related Security and
Collections with respect to such Receivable and (iii)&nbsp;all proceeds of such Receivable, Related Security and Collections. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Permitted Bond Hedge&#148; means any call options or capped call options referencing the Issuer&#146;s Common Stock purchased by the
Issuer concurrently with the issuance of Convertible Notes to hedge the Issuer&#146;s or any Subsidiary issuer&#146;s obligations under such Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Permitted Holders&#148; means Alan B. Miller, Marc D. Miller, A. Miller Family, LLC, MMA Family LLC and any trust or other entity owned
by or formed for the benefit of the spouses, children, descendants and other family members of Alan B. Miller and Marc D. Miller. Any Person or group whose acquisition of beneficial ownership constitutes a Change of Control in respect of which a
Change of Control Offer is made in accordance with the requirements of the Indentures (or would result in a Change of Control Offer in the absence of the waiver of such requirement by Holders in accordance with the Indenture) will thereafter
constitute additional Permitted Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Permitted Liens&#148; means, with respect to any Person: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens for taxes not yet due or that are being contested in good faith by appropriate proceedings, provided that
adequate reserves with respect thereto are maintained on the books of the Issuer or its Subsidiaries, as the case may be, in conformity with GAAP; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">carriers&#146;, warehousemen&#146;s, mechanics&#146;, materialmen&#146;s, repairmen&#146;s or other like Liens
arising in the ordinary course of business that are not overdue for a period of more than 30 days or that are being contested in good faith by appropriate proceedings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pledges or deposits in connection with workers&#146; compensation, unemployment insurance and other social
security legislation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">deposits to secure the performance of bids, trade contracts (other than for borrowed money), leases, statutory
obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">easements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT>
restrictions and other similar encumbrances incurred in the ordinary course of business that, in the aggregate, are not substantial in amount and that do not in any case materially detract from the value of the property subject thereto or materially
interfere with the ordinary conduct of the business of the Issuer or any of its Subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Liens in existence on the Issue Date (other than Liens described in clauses (7), (8) and (10)&nbsp;of this
definition); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Collateral Release Date, Liens in existence on the Issue Date securing Indebtedness permitted by
the Senior Credit Facility; provided that no such Lien is spread to cover any additional property after the Issue Date and that the amount of Indebtedness secured thereby is not increased; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Collateral Release Date, Liens created pursuant to the Security Documents (including, for the
avoidance of doubt, Liens securing the Senior Credit Facility and the Notes); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any interest or title of a lessor under any lease entered into by the Issuer or any Subsidiary in the ordinary
course of its business and covering only the assets so leased; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Collateral Release Date, Liens arising out of the Existing Receivables Facility and any future
Qualified Receivables Transaction (including any Receivables Financing); provided that the aggregate outstanding amount of the purchase price or loan from the lenders or investors under the Existing Receivables Facility and all other Qualified
Receivables Transactions (including any Receivables Financing) shall not at any time exceed the greater of (i) $600.0&nbsp;million and (ii) 50% of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 71 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
accounts receivable, net, as shown on the Issuer&#146;s most recent consolidated balance sheet for which internal financial statements for the Issuer are available plus the allowance for doubtful
accounts with respect to such accounts receivable, as set forth in the footnotes to such financial statements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Lien existing on any asset of any Person at the time such Person becomes a Subsidiary and not created in
contemplation of such event; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Lien existing on any asset prior to the acquisition thereof by the Issuer or a Subsidiary and not created
in contemplation of such acquisition; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Lien securing Indebtedness incurred to refinance, replace, renew or refund amend, extend or modify, as a
whole or in part, Indebtedness that was previously so secured pursuant to clauses (6), (7), (8), (11), (12) and (13)&nbsp;of this definition; provided that any such Lien is limited to all or part of the same property or assets (plus improvements,
accessions, proceeds or dividends or distributions in respect thereof) that secured (or, under the written arrangements under which the original Lien arose, could secure) the Indebtedness being refinanced or is in respect of property that is the
security for a Permitted Lien hereunder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the Collateral Release Date, Liens not otherwise permitted by this section so long as the aggregate
outstanding principal amount of the obligations secured thereby does not exceed (as to the Issuer and all Subsidiaries) $350.0&nbsp;million at any one time. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this definition, the term &#147;Indebtedness&#146;&#148; shall be deemed to include interest on such Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Permitted Warrant&#148; means any call option in respect of the Issuer&#146;s Common Stock sold by the Issuer concurrently with the
issuance of Convertible Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Person&#148; means any individual, corporation, limited liability Issuer, partnership, joint
venture, association, joint stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Pledged Notes&#148; means all promissory notes listed in the Collateral Agreement, all intercompany notes at any time issued to the
Issuer or the Secured Guarantors and all other promissory notes issued to or held by the Issuer or the Secured Guarantors (other than promissory notes issued in connection with extensions of trade credit by the Issuer or the Secured Guarantors in
the ordinary course of business). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Pledged Stock&#148; means the shares of Capital Stock, together with any other shares, stock
certificates, options, interests or rights of any nature whatsoever in respect of the Capital Stock of any Person that may be issued or granted to, or held by, any grantor; provided that in no event shall more than 65% of the total outstanding
Foreign Subsidiary Voting Stock of any Foreign Subsidiary be required to be pledged hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Preferred Stock&#148; means any
Equity Interest with preferential rights of payment of dividends or upon liquidation, dissolution or winding up. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Principal
Property&#148; means any property, plant, equipment or facility of the Issuer or any of its Restricted Subsidiaries, except that any property, plant, equipment or facility of the Issuer or any of its Restricted Subsidiaries which does not equal or
exceed 3% of the Issuer&#146;s Consolidated Net Tangible Assets shall not constitute a Principal Property of the Issuer unless its Board of Directors or its management deems it to be material to the Issuer and its Restricted Subsidiaries, taken as a
whole. Accounts receivable, inventory and Equity Interests of the Issuer or any of its Restricted Subsidiaries are not &#147;Principal Property&#148;; provided, however, that individual items of property, plant, equipment or individual facilities of
the Issuer or any of its Restricted Subsidiaries shall not be combined in determining whether that property, plant, equipment or facility constitutes a Principal Property of the Issuer, whether or not they are the subject of the same transaction or
series of transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 72 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Qualified Receivables Transaction&#148; means any transaction or series of
transactions that may be entered into by the Issuer or any of its Restricted Subsidiaries pursuant to which the Issuer or any of its Restricted Subsidiaries may sell, convey or otherwise transfer to (1)&nbsp;a Receivables Subsidiary (in the case of
a transfer by the Issuer or any of its Restricted Subsidiaries) and (2)&nbsp;any other Person (in the case of a transfer by a Receivables Subsidiary), or may grant a security interest in, any Receivables (whether now existing or arising in the
future) of the Issuer or any of its Restricted Subsidiaries, and any assets related thereto, all contracts and all Guarantees or other obligations in respect of such accounts receivable, the proceeds of such Receivables and other assets that are
customarily transferred (including, without limitation, assets of the type transferred pursuant to the Existing Receivables Facility) or in respect of which security interests are customarily granted, in connection with asset securitizations
involving Receivables. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Rating Agencies&#148; means Moody&#146;s and S&amp;P or if Moody&#146;s or S&amp;P or both shall not make a
rating on the Notes publicly available, a nationally recognized statistical rating agency or agencies, as the case may be, selected by the Issuer which shall be substituted for Moody&#146;s or S&amp;P or both, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Receivable&#146;&#146; means all indebtedness and other obligations owed to the Issuer or a Secured Guarantor (including, without
limitation, any indebtedness, obligation or interest constituting an account, chattel paper, instrument or general intangible) arising in connection with the sale of goods or rendering of services by the Issuer or such Secured Guarantor (including
any Account (as defined in the New York UCC)) including, without limitation, the obligation to pay any finance charges or similar amounts with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Receivables Fees&#148; means any fees or interest paid to purchasers or lenders providing the financing in connection with a Qualified
Receivables Transaction, factoring agreement or other similar agreement, including any such amounts paid by discounting the face amount of receivables or participations therein transferred in connection with a Qualified Receivables Transaction,
factoring agreement or other similar arrangement, regardless of whether any such transaction is structured as <FONT STYLE="white-space:nowrap">on-balance</FONT> sheet or <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet or through a
Restricted Subsidiary or an Unrestricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Receivables Financing&#148; means the Existing Receivables Facility and any
future financing arrangement among the Issuer, certain Subsidiaries of the Issuer, including Receivables Subsidiaries, and certain other parties pursuant to which Subsidiaries of the Borrower will sell substantially all of their accounts receivable
from time to time to Receivables Subsidiaries, which will, in turn, sell or pledge such receivables to certain third-party lenders or investors for a purchase price or loan from such lenders or investors, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Receivables Subsidiary&#148; means any Subsidiary formed for the purpose of facilitating or entering into one or more Qualified
Receivables Transaction, and in each case engages only in activities reasonably related or incidental thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Registration Rights
Agreements&#148; means that certain Registration Rights Agreements, dated as of the Issue Date, by and among the Issuer, the Guarantors and the initial purchasers set forth therein and, with respect to any Additional Notes, one or more substantially
similar registration rights agreements among the Issuer and the other parties thereto, as such agreements may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Related Security&#148; means with respect to any Receivable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all of the Issuer&#146;s and Secured Guarantor&#146;s interest in the inventory and goods (including returned
or repossessed inventory or goods), if any, the sale, financing or lease of which by the Issuer and Secured Guarantor gave rise to such Receivable, and all insurance contracts with respect thereto, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all other security interests or liens and property subject thereto from time to time, if any, purporting to
secure payment of such Receivable, whether pursuant to a contract related to such Receivable or otherwise, together with all financing statements and security agreements describing any collateral securing such Receivable, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 73 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all guaranties, letters of credit, insurance and other agreements or arrangements of whatever character from
time to time supporting or securing payment of such Receivable whether pursuant to a contact related to such Receivable or otherwise, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all service contracts and other contracts and agreements associated with such Receivable,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all records related to such Receivable, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all of the Issuer&#146;s and Secured Guarantor&#146;s right, title and interest (if any) in any deposit or
other account into which such Receivables are paid or deposited, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all proceeds of any of the foregoing. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Restricted Subsidiary&#148;, means, at any time, any direct or indirect Subsidiary of the Issuer that is not then an Unrestricted
Subsidiary; provided, however, that upon an Unrestricted Subsidiary&#146;s ceasing to be an Unrestricted Subsidiary, such Subsidiary shall be included in the definition of &#147;Restricted Subsidiary.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;S&amp;P&#148; means Standard&nbsp;&amp; Poor&#146;s Ratings Services and any successor to its rating agency business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Sale and Lease-Back Transaction&#148; means any arrangement providing for the leasing by the Issuer or any of its Restricted
Subsidiaries for a period of more than three years of any Principal Property, which property is to be sold or transferred by the Issuer or such Subsidiary to a third Person in contemplation of such leasing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;SEC&#148; means the U.S. Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Secured Guarantor&#148; means each Guarantor which has granted a security interest pursuant to the Security Documents to secure such
Guarantor&#146;s Guarantee of the Notes and the Notes Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Securities Act&#148; means the Securities Act of 1933, as
amended, and the rules and regulations of the SEC promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Security Agreement&#148; means the Joinder to the
Security Agreement, together with the Base Security Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Security Documents&#148; means, collectively, the Security
Agreement, any intercreditor agreement related to the Junior Lien Obligations, other security agreements relating to the Collateral and instruments filed and recorded in appropriate jurisdictions to preserve and protect the Liens on the Collateral
(including, without limitation, financing statements under the Uniform Commercial Code of the relevant states) applicable to the Collateral, each as in effect on the Issue Date (as applicable) and as amended, amended and restated, modified, renewed
or replaced from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Senior Credit Facility&#148; means the senior credit agreement dated as of November&nbsp;15, 2010
and as amended on March&nbsp;15, 2011, September&nbsp;21, 2012, May&nbsp;16, 2013, August&nbsp;7, 2014, June&nbsp;7, 2016, October&nbsp;23, 2018, August&nbsp;24, 2021, September&nbsp;10, 2021 and June&nbsp;23, 2022, among the Issuer, the lenders
party thereto in their capacities as lenders thereunder and JPMorgan Chase Bank, N.A., as Administrative Agent, including any guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments,
supplements, modifications, extensions, renewals, restatements, replacements (which may occur after the termination of such senior credit agreement), refundings or refinancings thereof and any indentures or credit facilities or commercial paper
facilities with banks or other institutional lenders or investors that replace (which replacement may occur after the termination of such senior credit agreement or other facility), refund or refinance any part of the loans, notes, other credit
facilities or commitments thereunder, including any such replacement, refunding or refinancing facility or indenture that increases the amount borrowable thereunder or alters the maturity thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Senior Credit Facility Obligations&#148; means &#147;Obligations&#148; as defined in the Senior Credit Facility. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 74 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Senior Management&#148; means the Chief Executive Officer and the Chief Financial
Officer of the Issuer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series&#148; means (a)&nbsp;with respect to the First Lien Secured Parties, each of (i)&nbsp;the Senior
Credit Facility Secured Parties (in their capacities as such), (ii) the Holders and the Trustee (in its capacity as such) and (iii)&nbsp;the Additional First Lien Secured Parties that become subject to the Security Agreement after the date hereof
that are represented by a common Authorized Representative (in its capacity as such for such Additional First Lien Secured Parties) and (b)&nbsp;with respect to any First Lien Obligations, each of (i)&nbsp;the Senior Credit Facility Obligations,
(ii)&nbsp;the Notes Obligations with respect to the 2026 Notes, (iii)&nbsp;the Notes Obligations with respect to the 2030 Notes, (iv)&nbsp;the Notes Obligations with respect to the 2032 Notes and (v)&nbsp;Additional First Lien Obligations incurred
pursuant to any applicable agreement, which, pursuant to any joinder agreement, are to be represented under the Security Agreement by a common Authorized Representative (in its capacity as such for such Additional First Lien Obligations). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Significant Subsidiary&#148; means any Restricted Subsidiary that would be a &#147;Significant Subsidiary&#148; as defined in Article 1,
Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X,</FONT> promulgated pursuant to the Securities Act, as such regulation is in effect on the Issue Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Standard Securitization Undertakings&#148; means representations, warranties, covenants and indemnities entered into by the Issuer or
any Restricted Subsidiary that are reasonably customary in securitization of Qualified Receivables Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Subsidiary&#148;
means, with respect to any Person: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any corporation, association, or other business entity (other than a partnership, joint venture, limited
liability company or similar entity) of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at
the time of determination owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof or is consolidated under GAAP with such Person at such time; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any partnership, joint venture, limited liability company or similar entity of which more than 50% of the
equity ownership, whether in the form of membership, general, special or limited partnership interests or otherwise, is owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a
combination thereof or is consolidated under GAAP with such Person at such time. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Transactions&#148; means
(a)&nbsp;in the case of the 2030 Notes, the issuance of the 2030 Original Notes on the appliable Issue Date, the redemption of the Existing 2022 Notes and the payment of related fees and expenses, and (b)&nbsp;in the case of the 2026 Notes and the
2032 Notes, the issuance of the 2026 Original Notes and the 2032 Original Notes on the applicable Issue Date, the redemption of the Existing 2026 Notes and the payment of related fees and expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Unrestricted Subsidiary&#148; means: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Subsidiary of the Issuer which at the time of determination shall be designated an Unrestricted Subsidiary
by the Board of Directors of the Issuer in the manner provided below; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any Subsidiary of an Unrestricted Subsidiary. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors of the Issuer may designate any Subsidiary of the Issuer (including any newly acquired or newly formed Subsidiary or a
Person becoming a Subsidiary through merger or consolidation or investment therein) to be an Unrestricted Subsidiary only if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Subsidiary or any of its Subsidiaries does not own any Capital Stock or Indebtedness of or have any
investment in, or own or hold any Lien on any property of, any other Subsidiary of the Issuer that is not a Subsidiary of the Subsidiary to be so designated or otherwise an Unrestricted Subsidiary; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 75 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all the Indebtedness of such Subsidiary and its Subsidiaries shall, at the date of designation, and will at all
times thereafter, consist of <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Debt; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Subsidiary, either alone or in the aggregate with all other Unrestricted Subsidiaries, does not operate,
directly or indirectly, all or substantially all of the business of the Issuer and its Subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">such Subsidiary is a Person with respect to which neither the Issuer nor any of its Restricted Subsidiaries has
any direct or indirect obligation: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to subscribe for additional Capital Stock of such Person; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to maintain or preserve such Person&#146;s financial condition or to cause such Person to achieve any specified
levels of operating results; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">on the date such Subsidiary is designated an Unrestricted Subsidiary, such Subsidiary is not a party to any
agreement, contract, arrangement or understanding with the Issuer or any Restricted Subsidiary with terms substantially less favorable to the Issuer than those that might have been obtained from Persons who are not Affiliates of the Issuer.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such designation by the Board of Directors of the Issuer shall be evidenced to the Trustee by filing with the
Trustee a resolution of the Board of Directors of the Issuer, certified by the Secretary or an Assistant Secretary of the Issuer, giving effect to such designation and an Officers&#146; Certificate certifying that such designation complies with the
foregoing conditions. If, at any time, any Unrestricted Subsidiary would fail to meet the foregoing requirements as an Unrestricted Subsidiary, it shall thereafter cease to be an Unrestricted Subsidiary for purposes of the Indentures and any
Indebtedness of such Subsidiary shall be deemed to be Incurred as of such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors of the Issuer may designate any
Unrestricted Subsidiary to be a Restricted Subsidiary; provided that immediately after giving effect to such designation, no Default or Event of Default shall have occurred and be continuing or would occur as a consequence thereof and either: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Issuer and its Restricted Subsidiaries on a consolidated basis would have had a Consolidated Coverage Ratio
of at least 2.00 to 1.00; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Consolidated Coverage Ratio for the Issuer and its Restricted Subsidiaries would be greater than such ratio
for the Issuer and its Restricted Subsidiaries immediately prior to such designation, in each case on a pro forma basis taking into account such designation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Unsecured Guarantors&#148; means each of the Guarantors other than the Secured Guarantors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Voting Stock&#148; of any Person as of any date means the Capital Stock of such Person that is at the time entitled to vote in the
election of the board of directors of such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Wholly Owned Subsidiary&#148; of any Person means a Subsidiary of such Person,
100% of the outstanding Equity Interests of which (other than directors&#146; qualifying shares) shall at the time be owned by such Person or by one or more Wholly Owned Subsidiaries of such Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 76 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_7"></A>DESCRIPTION OF OTHER INDEBTEDNESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Overview
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have a credit agreement dated as of November&nbsp;15, 2010 (as amended from time to time, the &#147;credit agreement&#148;),
among UHS, as borrower, the several banks and other financial institutions from time to time parties thereto, as lenders, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents party thereto. The credit agreement, as amended, is a
senior secured facility which, as of September&nbsp;30, 2022, consists of: (i)&nbsp;a $1.2&nbsp;billion revolving credit facility; and (ii)&nbsp;a $2.4&nbsp;billion tranche A term loan facility. The maturity date of the revolving credit and tranche
A term loan facilities is August&nbsp;24, 2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The credit agreement is secured by certain assets of UHS and our material domestic
subsidiaries (excluding asset classes such as substantially all of the patient-related accounts receivable of our acute care hospitals, and certain real estate assets and assets held in joint ventures with third parties) and is guaranteed by those
subsidiaries. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Interest Rates and Availability </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revolving credit and tranche A term loan borrowings under the credit agreement bear interest at our election at either (1)&nbsp;the ABR rate
which is defined as the rate per annum equal to the greatest of (a)&nbsp;the lender&#146;s prime rate, (b)&nbsp;the weighted average of the federal funds rate, plus 0.5% and (c)&nbsp;one month Secured Overnight Financing Rate (&#147;SOFR&#148;) plus
1%, in each case, plus an applicable margin based upon our consolidated leverage ratio at the end of each quarter ranging from 0.25% to 0.625%, or (2)&nbsp;the one, three or six month SOFR plus 0.1% (at our election), plus an applicable margin based
upon our consolidated leverage ratio at the end of each quarter ranging from 1.25% to 1.625%. As of September&nbsp;30, 2022, the applicable margins were 0.50% for <FONT STYLE="white-space:nowrap">ABR-based</FONT> loans and 1.50% for SOFR-based loans
under the revolving credit and term loan A facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2022, we had $189&nbsp;million of borrowings outstanding
pursuant to our revolving credit facility and we had $1.007&nbsp;billion of available borrowing capacity net of $4&nbsp;million of outstanding letters of credit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The revolving credit facility is a five-year revolving facility in the initial amount of $1.2&nbsp;billion, available on a revolving basis. A
portion of the revolving facility not in excess of $125&nbsp;million will be available beginning on the effective date for the issuance of letters of credit by the administrative agent or other lenders reasonably satisfactory to us on terms and
conditions consistent with the existing credit agreement. A portion of the revolving facility not in excess of $75&nbsp;million will be available for swingline loans from the swingline lender on <FONT STYLE="white-space:nowrap">same-day</FONT>
notice on terms and conditions consistent with the existing credit agreement; provided that the aggregate exposure of the swingline lender in respect of the revolving facility (including any swingline loans made by it as a swingline lender) may not
exceed its revolving commitment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Amortization </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our tranche A term loan facility, which had approximately $2.353&nbsp;billion of borrowings outstanding as of September&nbsp;30, 2022, provides
for installment payments of $15&nbsp;million per quarter until maturity in September 2023, and $30&nbsp;million per quarter during the period of December, 2023 through June, 2026. The unpaid principal balance at June&nbsp;31, 2026 is payable on the
August&nbsp;23, 2026 maturity date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No amortization is required with respect to the revolving credit facility. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 77 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Prepayments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The senior credit facility requires us to make certain mandatory prepayments in case of asset sales, receipt of insurance proceeds or
incurrence of certain indebtedness or excess cash flow, each as defined in the credit agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The senior credit facility enables us to
voluntarily repay all or a portion of the senior credit facility without premium or penalty (other than certain break fees with respect to SOFR based loans), subject to the conditions set forth in the credit agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Guarantees and Security </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The senior credit facility is guaranteed by substantially all of our material wholly-owned domestic subsidiaries and is secured by certain of
the assets of our company and of the subsidiary guarantors, including, without limitation, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the capital stock of the material wholly owned domestic subsidiaries of our company and the subsidiary guarantors
and up to 65% of the voting stock of the first-tier foreign subsidiaries of our company and the subsidiary guarantors, except as provided below; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accounts receivable, except as provided below; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">equipment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general intangibles; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">intellectual property; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other investment property. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, the collateral securing the senior credit facility does not include, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our real property; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accounts receivable sold pursuant to our accounts receivable securitization program, real estate property and
certain other receivables financing facilities up to a maximum purchase price or loan of $600.0&nbsp;million. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These
assets are also excluded from the collateral securing the Exchange Notes offered hereby, as described in &#147;Description of the Notes&#151;Security General&#151;Certain Limitations on the Collateral.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Certain Covenants and Events of Default </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The senior credit facility contains various covenants, and the replacement senior credit facility will contain various revised covenants, that
may limit our ability to take certain actions, including our ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur, assume or guarantee additional indebtedness; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">create liens; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make restricted payments, including paying dividends and making investments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make capital expenditures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell or otherwise dispose of assets, including capital stock of subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into agreements that restrict liens securing the senior credit facility or dividends from subsidiaries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">merge, consolidate, sell or otherwise dispose of substantially all our assets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into transactions with affiliates; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">guarantee certain obligations. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 78 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the senior credit facility contains a maximum ratio of consolidated total debt
to consolidated EBITDA (as defined in the credit agreement) calculated net of unrestricted cash and cash equivalents, initially of no greater than 3.75 to 1.0 (or, at our election on or prior to consummation of a material permitted acquisition, 4.25
to 1.00 for four quarters following such material permitted acquisition; provided that such election may be exercised only up to three times during the term of the credit agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The senior credit facility also contains customary events of default, including customary cross-default provisions to other material
indebtedness. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounts Receivable Securitization Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have an accounts receivable securitization program (&#147;Securitization&#148;) with a group of conduit lenders, liquidity banks, and PNC
Bank, National Association, as administrative agent (collectively, the &#147;Bank Group&#148;), which provides for borrowings outstanding from time to time by certain of our subsidiaries in exchange for undivided security interests in their
respective accounts receivable. Substantially all of the patient-related accounts receivable of our acute care hospitals (&#147;Receivables&#148;) serve as collateral for the outstanding borrowings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April, 2021 our Securitization was amended (the eighth amendment) to: (i)&nbsp;reduce the aggregate borrowing commitments to
$20&nbsp;million (from $450&nbsp;million previously); (ii) slightly reduce the borrowing rates and commitment fee, and; (iii)&nbsp;extend the maturity date to April&nbsp;25, 2022. In April, 2022, the Securitization was amended (the ninth amendment)
to extend the maturity date to July&nbsp;22, 2022. In July, 2022, the Securitization was amended (the tenth amendment) to extend the maturity date to September&nbsp;20, 2022 and in September, 2022, the Securitization was amended (the eleventh
amendment) to extend the maturity date to December&nbsp;20, 2022. There were no borrowings outstanding pursuant to the Securitization as of September&nbsp;30, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have accounted for this Securitization as borrowings. We maintain effective control over the Receivables since, pursuant to the terms of
the Securitization, the Receivables are sold from certain of our subsidiaries to special purpose entities that are wholly-owned by us. The Receivables, however, are owned by the special purpose entities, can be used only to satisfy the debts of the
wholly-owned special purpose entities, and thus are not available to us except through our ownership interest in the special purpose entities. The wholly-owned special purpose entities use the Receivables to collateralize the loans obtained from the
group of third-party conduit lenders and liquidity banks. The group of third-party conduit lenders and liquidity banks do not have recourse to us beyond the assets of the wholly-owned special purpose entities that securitize the loans. At
September&nbsp;30, 2022, we had no Securitization borrowings outstanding and, pursuant to the terms and conditions of the program, we had approximately $20&nbsp;million of available borrowing capacity. Our Securitization program contains covenants
limiting, among other things, the ability of the special purpose entities that are parties to the agreement to incur indebtedness and the ability of the special purpose entities and our subsidiaries that sell them the Receivables to create liens on
the Receivables. The facility also includes customary events of default, including a cross-default provision to material debt of UHS and certain of its subsidiaries and a provision that would be triggered if any such material debt is required to be
prepaid before its stated maturity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Federal law generally prohibits Medicare or Medicaid payments to be made to any person or entity
other than the performing provider under a reassignment, a power of attorney or otherwise. However, federal law does not expressly prohibit a provider from reassigning or otherwise transferring the right to receive Medicare or Medicaid payments, so
long as the government is not required to make payment to a party other than the provider. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other UHS Debt </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the indebtedness described above, we had approximately $188&nbsp;million of other indebtedness as of September&nbsp;30, 2022
that we expect to remain outstanding following the Exchange Offer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 79 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_8"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary describes the material U.S. federal income tax consequences of exchanging Original Notes for Exchange Notes in the
Exchange Offer. It does not purport to be a complete analysis of all potential tax considerations relating to the Exchange Offer. This summary is based on the U.S. Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), Treasury
Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#147;IRS&#148;), in each case in effect as of the date hereof. These authorities may change or
be subject to differing interpretations, possibly with retroactive effect, so as to result in U.S. federal income tax consequences different from those discussed below. We have not sought and will not seek any rulings from the IRS and there can be
no assurance the IRS or a court will not take a contrary position regarding the matters discussed below. This summary is limited to beneficial owners who hold the Original Notes and the Exchange Notes as capital assets within the meaning of
Section&nbsp;1221 of the Code (generally, property held for investment). The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or foreign tax laws, are not discussed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion does not address all U.S. federal income tax consequences relevant to a beneficial owner&#146;s particular circumstances,
including the impact of the Medicare contribution tax on net investment income. In addition, it does not address consequences relevant to beneficial owners subject to special rules, including, without limitation, U.S. expatriates and former citizens
or long-term residents of the United States, persons subject to the alternative minimum tax, U.S. persons whose functional currency is not the U.S. dollar, persons holding Original Notes or Exchange Notes as part of a hedge, straddle or other risk
reduction strategy or as part of a conversion, constructive sale, wash sale or other integrated transaction, banks, insurance companies, and other financial institutions, real estate investment trusts or regulated investment companies, brokers,
dealers or traders in securities or currencies, controlled foreign corporations, passive foreign investment companies, corporations that accumulate earnings to avoid U.S. federal income tax, U.S. persons that hold Original Notes or the Exchange
Notes through <FONT STYLE="white-space:nowrap">non-U.S.</FONT> brokers or other <FONT STYLE="white-space:nowrap">non-U.S.</FONT> intermediaries, S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal
income tax purposes (and investors therein), <FONT STYLE="white-space:nowrap">tax-exempt</FONT> entities, retirement plans, individual retirement accounts, <FONT STYLE="white-space:nowrap">tax-deferred</FONT> accounts, and governmental organizations
and holders who are subject to special accounting rules (including rules requiring them to recognize income with respect to Original Notes or Exchange Notes no later than when such income is taken into account in an applicable financial statement).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds Original Notes or Exchange Notes, the
U.S. federal income tax treatment of a partner in the partnership generally will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, entities or arrangements
classified as partnerships for U.S. federal income tax holding Original Notes or Exchange Notes and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them of the Exchange Offer.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An exchange of Exchange Notes for Original Notes in the Exchange Offer will not be a taxable event for U.S. federal income tax purposes.
Accordingly, a beneficial owner of an Original Note will not recognize any gain or loss upon the receipt of an Exchange Note pursuant to the Exchange Offer, will be required to include interest on the Exchange Note in income in the same manner and
to the same extent as on the Original Note and will have the same adjusted tax basis, adjusted issue price and holding period in the Exchange Note immediately after the exchange as its adjusted tax basis, adjusted issue price and holding period in
the Original Note exchanged therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS DISCUSSION IS FOR INFORMATION PURPOSES ONLY AND IS NOT TAX ADVICE. EACH INVESTOR SHOULD
CONSULT ITS TAX ADVISOR WITH RESPECT TO THE SPECIFIC U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE EXCHANGE OFFER IN ITS PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCE ARISING UNDER OTHER U.S. FEDERAL, STATE, LOCAL OR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> TAX LAWS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 80 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_9"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on interpretations of the staff of the SEC, as described in <FONT STYLE="white-space:nowrap">no-action</FONT> letters issued to third
parties that are not related to us, we believe that the Exchange Notes will be freely transferable by holders other than our affiliates after the Exchange Offer without further registration under the Securities Act if the holder of the Exchange
Notes represents to us in the Exchange Offer that it is acquiring the Exchange Notes in the ordinary course of its business, that it has no arrangement or understanding with any person to participate in the distribution of the Exchange Notes and
that it is not our affiliate, as such terms are interpreted by the SEC; provided, however, that broker-dealers receiving Exchange Notes in the Exchange Offer will have a prospectus delivery requirement with respect to resales of such Exchange Notes
as further discussed below. We also believe that such broker-dealers may fulfill their prospectus delivery requirements with respect to Exchange Notes (other than a resale of an unsold allotment from the sale of the Original Notes) with this
prospectus. We have not entered into any arrangement or understanding with any person who will receive Exchange Notes in the Exchange Offer to distribute those securities following completion of the Exchange Offer. We are not aware of any person
that will participate in the Exchange Offer with a view to distribute the Exchange Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that you may not transfer Exchange
Notes issued in the Exchange Offer without further compliance with such requirements or an exemption from such requirements if you are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our affiliate within the meaning of Rule 405 under the Securities Act; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a broker-dealer that acquired Original Notes as a result of market-making or other trading activities.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information described above concerning interpretations of and positions taken by the SEC staff is not intended to
constitute legal advice. Broker-dealers should consult their own legal advisors with respect to these matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you wish to exchange
Exchange Notes for your Original Notes in the Exchange Offer, you will be required to make representations to us as described in &#147;The Exchange Offer&#151;Procedures for Tendering&#148; and &#147;The Exchange Offer&#151;Procedures for
Tendering&#151;Your Representations to Us&#148; of this prospectus and in the letter of transmittal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each broker-dealer that receives
Exchange Notes for its own account pursuant to the Exchange Offer must acknowledge that it will deliver a prospectus meeting the requirements of the Securities Act (or, to the extent permitted by law, make available a prospectus meeting the
requirements of the Securities Act to purchasers) in connection with any resale of such Exchange Notes. This prospectus, as it may be amended or supplemented from time to time, may be used by a broker-dealer in connection with resales of Exchange
Notes received in exchange for Original Notes where such Original Notes were acquired as a result of market-making or other trading activities. We have agreed that, for a period of 180 days following the expiration of the Exchange Offer, we will
make this prospectus, as amended or supplemented, available to any broker-dealer for use in connection with any such resale. Further, for a period of 180 days following the effective date of the registration statement of which this prospectus forms
a part, we will promptly send additional copies of this prospectus and any amendment or supplement to this prospectus to any broker-dealer that requests such documents in the letter of transmittal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any proceeds from any sale of Exchange Notes by broker-dealers. Exchange Notes received by broker-dealers for their own
accounts pursuant to the Exchange Offer may be sold from time to time in one or more transactions in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, in negotiated transactions, through the
writing of options on the Exchange Notes or a combination of such methods of resale, at market prices prevailing at the time of resale, at prices related to such prevailing market prices or negotiated prices. Any such resale may be made directly to
purchasers or to or through brokers or dealers who may receive compensation in the form of commissions or concessions from any such broker-dealer or the purchasers of any such Exchange Notes. Any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 81 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
broker-dealer that resells Exchange Notes that were received by it for its own account pursuant to the Exchange Offer and any broker or dealer that participates in a distribution of such Exchange
Notes may be deemed to be an &#147;underwriter&#148; within the meaning of the Securities Act and any profit on any such resale of Exchange Notes and any commissions or concessions received by any such persons may be deemed to be underwriting
compensation under the Securities Act. The letter of transmittal states that, by acknowledging that it will deliver and by delivering a prospectus, a broker-dealer will not be deemed to admit that it is an &#147;underwriter&#148; within the meaning
of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to pay expenses incident to the Exchange Offer other than commissions or concessions of any brokers
or dealers and will indemnify the holders of the Original Notes (including any broker-dealers) against certain liabilities, including liabilities under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 82 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_10"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available over the
Internet at the SEC&#146;s web site at www.sec.gov. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at http://www.sec.gov. Our
filings with the SEC are also available on our website at www.uhs.com. The information on our website is not incorporated by reference in this prospectus and you should not consider it a part of this prospectus (except for our SEC reports expressly
incorporated by reference herein). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_11"></A>INCORPORATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; the information we file with them, which means that we can disclose important
information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus and later information filed with the SEC will automatically update and supersede this information. We
incorporate by reference the documents listed below and all documents subsequently filed with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering under this prospectus (other than
information deemed furnished and not filed in accordance with SEC rules, including Items 2.02 and 7.01 of Form <FONT STYLE="white-space:nowrap">8-K):</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022006717/uhs-10k_20211231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2021 filed with the SEC on February&nbsp;24, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Proxy Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000119312522098067/d465454ddef14a.htm">Schedule
 14A</A> filed with the SEC on April&nbsp;
7, 2022, to the extent specifically incorporated by reference into Part III of our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022006717/uhs-10k_20211231.htm">Form <FONT
STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended March&nbsp;31,
2022, June&nbsp;30, 2022 and September&nbsp;
30, 2022 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022018570/uhs-10q_20220331.htm">May, 6, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022028437/uhs-10q_20220630.htm">August&nbsp;8,
 2022</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022037046/uhs-10q_20220930.htm">November&nbsp;8, 2022</A>, respectively; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022011986/uhs-8k_20220323.htm">March&nbsp;28,
 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022020883/uhs-8k_20220518.htm">May&nbsp;
20, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/352915/000156459022024223/uhs-8k_20220623.htm">June&nbsp;
27, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022024881/uhs-8k_20220630.htm">June&nbsp;
30, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022032142/uhs-8k_20220921.htm">September&nbsp;
22, 2022</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/352915/000156459022035152/uhs-8k_20221021.htm">October&nbsp;25, 2022</A>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to
be modified or superseded for purposes of this prospectus to the extent that a statement contained in any subsequently filed document which is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such
statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may request a copy of these filings (other than an exhibit to a filing unless that exhibit is specifically incorporated by reference in
that filing) at no cost, by writing to or telephoning us at the following address: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">UNIVERSAL HEALTH SERVICES, INC. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Universal Corporate Center </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">367
South Gulph Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">King of Prussia, Pennsylvania 19406 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(610) <FONT STYLE="white-space:nowrap">768-3300</FONT> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_12"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the securities to be issued hereunder will be passed upon for us by Norton Rose Fulbright US LLP, New York, New York and
Matthew D. Klein, Senior Vice President and General Counsel of UHS, or other counsel who is satisfactory to UHS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 83 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom391216_13"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements and management&#146;s assessment of the effectiveness of internal control over financial reporting (which is included
in Management&#146;s Report on Internal Control Over Financial Reporting) incorporated in this prospectus by reference to the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021 have been so
incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 84 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g391216g23a23.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Universal Health Services, Inc. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>OFFER TO EXCHANGE ITS </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>1.650% Senior Secured Notes due 2026, 2.650% Senior Secured Notes due 2030 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>and 2.650% Senior Secured Notes due 2032 and related guarantees </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>that have been registered under the Securities Act of 1933, as amended, </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>FOR AN EQUAL AMOUNT OF ITS OUTSTANDING </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>1.650% Senior Secured Notes due 2026, 2.650% Senior Secured Notes due 2030 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>and 2.650% Senior Secured Notes due 2032, and related guarantees, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>as applicable, that were issued and sold in transactions exempt from registration under the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Securities Act, as amended. </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>November 23, 2022 </B></P> <P STYLE="font-size:160pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g391216g11a11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g391216g11a11.jpg
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M2P=RRT?%QK!61<-U'BC./9-CK"BU0(1?UE?O5,C72K<M5T:DCLD%B6)2YGL
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MHM'&O&84P(;W$$4G@8-.DJJ(="B)R(H@?J +&( *"1.ALKMN+./)]X\VP/P
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MV!G#P44W,<R#"/; )@1;)&4.)$P$0 3#V)10Q01I#"BQQ1J%2-!LJJ/8%'N
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MU2,,Z(W0(L5(M<Q]V+(4J]R/95GC#\"P)1P2LD9/;<I(K)OL-^.^PWZQAJ+
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MFLQ6LY88WJ;ST:9U4"N<9[.42JQ[Q$XB!U44)>_TMX#=8#&$2.V+=8P"8%$
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g391216g23a23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g391216g23a23.jpg
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M 0$! 0$! 0$! 0$! ?_  !$( $, G@,!$0 "$0$#$0'_Q  =   " @,! 0$
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M3IPH5%NV;-T; =5===4Y$D44B&454,4A"F,8 %&#-9DD 9*^22  +,Q))[
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M[X=QR&-M1QEA]LF.R\D?\['CWC/RAB/C\N(IYGT:WQTR<?/'+6 ,W8;:P3E
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M9(]G1IE^T%VR_P!SG'/!$8$;E^7]CKHYRK[N:O1?S9^<0Y ;K6LR/S5&&^1
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MYD96&X()<[@"@7P\P@'/KV@YLWW\GU"D#C_I,/'W=,6/[$Q_(#?,#Q664_\
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M#\V:XFYX6$P&[=^4@#GDFW^1BC^T<0X&/Z?=P8/X\]2>A_@B;XK\W]!5/]?
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M%=B2=QWW/#6T9X?:&RND].Y&QI^G8LVL12DM3N]GFEM"!$LNW+.JAFG60D*
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M;(LF$='MD63%BS;)E2;M&;1L1-NV;()$*DB@BF1)),I2$(4H  %8 4!5 50
M     /( #L /4!PG'=Y':21VDD=BSN[%G=F.[,S,2S,222222>Y/'V=?O'GC
"_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
